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Summary 
Proteins of the Omp85 superfamily reside in the outer membranes of Gram-negative 
bacteria, mitochondria and chloroplasts and are responsible for the insertion of outer 
membrane β-barrel proteins into or the translocation of soluble proteins across the 
membrane. They contain a C-terminal membrane-embedded 16-stranded β-barrel and 
soluble substrate-interacting POTRA domains, which in Gram-negative bacteria locate to the 
periplasm. The underlying translocation and insertion mechanisms are poorly understood 
and atomic structures of Omp85 insertases have been missing. 
This thesis provides the structural basis for the insertion mechanism of substrates by the 
Escherichia coli Omp85 insertase TamA. The crystal structure of TamA reveals minimal 
interactions between the first and the last β-strand of the barrel with a lipid-occupied lateral 
gate, suggesting substrate β-barrel assembly via hybrid barrel formation and lateral release. 
Exemplified by the crystallization of TamA, a general crystal seeding protocol for optimization 
of membrane protein crystals grown from bicelle solution is described. Furthermore, 
interactions of TamA with its associated periplasmic complex partner TamB are investigated 
by experimental approaches and bioinformatics, revealing potential interaction sites between 
these two proteins. The organization of Omp85 insertases is then compared to Omp85 
translocases, represented by FhaC from Bordetella pertussis, and a mechanism for substrate 
selection by FhaC is deduced from a newly determined crystal structure of an FhaC double 
mutant defective in substrate recognition. 
Whereas protein import into chloroplasts is mediated by a member of the Omp85 
superfamily, in mitochondria this task is fulfilled by Tom40, a 19-stranded β-barrel outer 
membrane protein that lacks POTRA domains. As a basis for experimental in vitro 
approaches to gaining insights into the Tom40 translocation mechanism, a protocol for 
recombinant Tom40 over-expression, refolding and sample preparation is provided. NMR 
spectroscopy of isotope-labeled protein evidences the presence of folded Tom40 in our 
samples. 
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1.1. Gram-positive and Gram-negative bacteria 
In the 1880s, when looking for a method to selectively stain cytosol and nuclei of cells in 
human tissue, Hans Christian Gram invented a method that leaves eukaryotic cells 
unstained, but instead stains bacteria (Gram 1884). Furthermore, this method, now 
commonly known as Gram-staining, classifies bacteria into two major groups according to 
their staining behavior: Certain types of bacteria keep the primary crystal violet – iodine 
complex stain during the decolorization and counterstaining process and therefore are 
referred to as “Gram-positive” bacteria; others lose it and instead adopt the secondary 
safranin stain, and are thus called “Gram-negative” bacteria. 
It took decades until electron microscopy of thin-sectioned bacteria revealed that 
morphological differences in the cell envelope are the cause of the different staining 
properties (Glauert and Thornley 1969). In Gram-positive bacteria, a thick peptidoglycan 
(PG; also called murein) network of 30-100 nm thickness stabilizes the cell by surrounding 
the plasma membrane (PM) and a narrow periplasmic space (Silhavy et al. 2010) (Fig. 1.1a). 
PG is the actual component being stained by crystal violet in Gram-staining. Gram-negative 
bacteria contain a much thinner PG layer. In E. coli, for instance, most of the PG is single 
layered and has a maximum thickness of 7.5 nm (Labischinski et al. 1991). Additionally, 
Gram-negative bacteria possess an outer membrane (OM) (Glauert and Thornley 1969)  
(Fig. 1.1b). The thin PG layer, located in the periplasmic space between OM and PM, here 
also called inner membrane (IM), incorporates the stain during Gram’s method, but does not 
retain it. 
A few bacterial genera do not show canonical behavior in Gram-staining with respect to 
the number of cell membranes. Mycoplasma, for instance, show a negative response 
towards Gram-staining despite having only a single membrane, because they completely 
lack a PG cell wall (Rottem 2003, Vollmer et al. 2008a). Nevertheless, throughout the 
literature and in the following, “Gram-positive” generally refers to bacteria with a single 
membrane and “Gram-negative” to bacteria with an additional OM. 
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Figure 1.1 Cell envelopes in Gram-positive and Gram-negative bacteria. 
(a) The cell envelope of Gram-positive bacteria is constituted by the plasma membrane (PM), a 
narrow periplasmic space (highlighted in light yellow) and a thick peptidoglycan (PG) layer. (b) Gram-
negative bacteria contain a PM, here also called inner membrane (IM), a wider periplasmic space 
(highlighted in light yellow) with a thin PG layer, and additionally an outer membrane (OM) with an 
outer leaflet that is formed by lipopolysaccharides (LPS). Typical lengths are indicated. 
 
1.2. The bacterial cell envelope 
PG layer and membranes have different functions. In both Gram-positive and Gram-
negative bacteria the rigid yet elastic PG layer conveys stability to the cell and protects it 
from lysis due to mechanical and osmotic forces. Moreover, it gives rise to characteristic 
shapes of different bacteria (Silhavy et al. 2010). PG is composed of polymers of 
N-acetylglucosamine and N-acetylmuramic acid disaccharides. The average chain length of 
the polymers can vary depending on species and growth conditions between 20 and several 
hundreds of disaccharide units, but it does not correlate with the thickness of the PG layer. 
The chains are crosslinked via short stem peptides, which contain non-proteinogenic amino 
acids as e.g. D-enantiomers (Krause and McCarty 1961, Strange and Dark 1956, Typas et 
al. 2012, Vollmer et al. 2008a). 
In Gram-negative bacteria, the PG layer is connected to the OM via the small lipoprotein 
Lpp, the most abundant protein in E. coli (Braun 1975). Lpp contains an N-terminal cysteine, 
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covalently modified with a lipid group that is buried in the inner leaflet of the OM. The PG 
mesh has a porous structure, through which small compounds can easily diffuse and even 
proteins of up to a size of 50 – 100 kDa are able to cross it. For larger protein complexes, 
peptidoglycan hydrolases may locally disrupt the layer (Scheurwater and Burrows 2011, 
Silhavy et al. 2010, Vollmer and Bertsche 2008, Vollmer et al. 2008b). 
In contrast, cell membranes act as permeability barriers not only for macromolecules, but 
also for many small molecules and ions. Hence, they are responsible for keeping the integrity 
of the cell-interior intact and for protecting it from potentially harmful compounds. The OM of 
Gram-negative bacteria thus constitutes a protecting barrier in addition to the IM (Nikaido 
2003, Silhavy et al. 2010), which makes Gram-negative bacteria generally more tolerant 
towards antibiotics than Gram-positive bacteria (Page 2012, Silhavy et al. 2010). 
Bacterial plasma membranes form a lipid bilayer, composed of phospholipids as the major 
components in both leaflets. The most abundant phospholipids found in bacterial membranes 
are phosphatidylethanolamines (approx. 75%), followed by phosphatidylglycerols (approx. 
20%) and cardiolipins (approx. 5%) (Cronan 2003), which have acyl chains with between 14 
and 20 carbon atoms (Zhang and Rock 2008). The OM of Gram-negative bacteria, however, 
is distinct from the IM, as its outer leaflet contains lipopolysaccharides (LPS) and therefore 
the OM is asymmetric. LPS consist of lipid-A, containing six to seven hydrophobic acyl 
chains, and a branched polysaccharide chain attached to it facing the extracellular space 
(Chatterjee and Chaudhuri 2012, Silhavy et al. 2010, Whitfield and Trent 2014). Furthermore, 
a substantial amount of both membranes is composed of proteins that are embedded in or 
attached to the membranes. 
The OM and its integrity are essential for survival of Gram-negative bacteria. Contributing 
to this fact is plausibly the thin PG layer and the circumstance that essential periplasmic 
proteins rely on the OM to be kept in proximity, whereas corresponding proteins in Gram-
positive bacteria are either attached to the plasma membrane or the thick PG layer (Silhavy 
et al. 2010). 
 
1.3. Membrane proteins in bacteria 
Inner membrane proteins (IMPs) in all bacteria typically adopt α-helical secondary 
structure within the lipid bilayer of the membrane. These proteins can span the membrane 
with only one (single-pass) or with several α-helices (multi-pass), which are enriched in 
hydrophobic amino acids (Fig. 1.2a). Transmembrane α-helices of multi-pass IMPs interact 
with neighboring helices to form defined arrangements within the membrane. Homo- and 
hetero-oligomerization of IMPs to form membrane complexes is quite frequent. Homo-
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oligomers usually form rotation-symmetrical complexes in the layer of the membrane 
(Vinothkumar and Henderson 2010, von Heijne 2006). 
In addition to the transmembrane part, many IMPs contain cytoplasmic and/or periplasmic 
domains that can be N- or C-terminal or embedded in loops connecting transmembrane 
helices. These soluble domains can contain both α-helical and β-sheet structures (Du et al. 
2014, Kumazaki et al. 2014). Bacteria possess a lot of different IMPs. For instance, in E. coli 
approx. 20 – 30% of all genes encode for them (Facey and Kuhn 2010). Their functions are 
diverse and include synthesis of cell envelope components, ATP synthesis, signal 
transduction and transport of molecules across the IM (Vinothkumar and Henderson 2010). 
In contrast, outer membrane proteins (OMPs) in Gram-negative bacteria constitute only 
approx. 2% of all proteins and their functions are less diverse. Usually, they are involved in 
transport and cell adhesion, even though a few enzymatically active OMPs exist (Facey and 
Kuhn 2010, Tamm et al. 2004, Vinothkumar and Henderson 2010, Wimley 2003). 
Structurally, OMPs are completely different from IMPs, as they form β-barrels in the lipid 
bilayer. These consist of a β-sheet with antiparallel strands wrapping up to form a cylindrical 
shape in which the first and the last β-strand interact via hydrogen bonds (Fig. 1.2b). The 
number of strands is usually even and varies between 8 as in OmpA (Pautsch and Schulz 
1998) and 26 as in LptD (Qiao et al. 2014). The membrane-spanning part of β-strands in 
OMPs is amphipathic. It shows a typical alternating pattern of hydrophobic and hydrophilic 
residues, as sidechains alternatingly point to the hydrophobic lipid bilayer and the hydrophilic 
β-barrel lumen. Some OMPs form homo-oligomers, such as trimers (Cowan et al. 1992). A 
few special OMPs, like trimeric autotransporters and TolC, have a single homo-oligomeric  
β-barrel, in which each of the three proteins contributes four strands to form one trimeric  
12-stranded β-barrel (Koronakis et al. 2000, Shahid et al. 2012). 
Like IMPs, also OMPs can have additional periplasmic and/or extracellular domains that 
can contain both α-helical and β-sheet structures. These domains are often found N-terminal 
or embedded in extracellular loops between strands (Phan et al. 2011). C-terminal soluble 
domains are rare due to OMP biogenesis, but can be found as well, e.g. in OmpA (Pautsch 
and Schulz 1998) and in inverse autotransporters (Oberhettinger et al. 2015). 
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Figure 1.2 α-Helical and β-barrel transmembrane proteins. 
(a) The inner membrane of Gram-negative bacteria contains transmembrane proteins of α-helical 
structure. As an example the hetero-trimeric SecYEG is shown (SecY in red, SecE in purple and SecG 
in orange; PDB entry 3DIN (Zimmer et al. 2008)). (b) The outer membrane contains transmembrane 
proteins of β-barrel structure. As an example NanC (blue) is shown (PDB entry 2WJR (Wirth et al. 
2009)). The tilt angle β for this β-barrel is indicated. 
 
Geometrically, β-barrels can be described by their number of strands, tilt angle (Fig. 1.2b), 
and shear number (Pali and Marsh 2001). Importantly, all β-barrels with solved structure to 
date tilt to the same direction with similar angles between 35° and 45° (Pali and Marsh 2001). 
Viewed from the top, β-barrels can adopt different shapes; they can be almost perfectly 
round but they can also be e.g. elliptic or kidney-shaped. However, they may be intrinsically 
flexible if no further structures lead to stabilization of a certain shape. Another common 
feature of β-barrels is that the loops on the extracellular site connecting two neighboring 
strands are usually significantly longer than the periplasmic turns (Mirus et al. 2010). 
Whereas α-helical membrane proteins can also be found in most membranes of 
eukaryotic cells, β-barrels are restricted to outer membranes of eukaryotic organelles that 
derive from endosymbiosis like mitochondria and chloroplasts. The mitochondrial outer 
membrane protein VDAC is the only OMP to date with solved structure that has an uneven 
number of strands (19) and therefore, in this special case, the first and the last strand are 
parallel to each other (Hiller et al. 2008). 
Even though the OM is essential in Gram-negative bacteria, only two OMPs are essential: 
One is the protein LptD, which, together with periplasmic, IM and cytoplasmic proteins, is 
responsible for the transport of LPS molecules from the IM across the periplasmic space into 
the outer leaflet of the OM (Braun and Silhavy 2002, Qiao et al. 2014, Tokuda 2009, Whitfield 
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and Trent 2014). The other essential OMP is BamA. This protein forms a complex with non-
transmembrane but OM-anchored lipoproteins and is indispensable for the integration of new 
OMPs into the OM, including LptD and other BamA molecules (Doerrler and Raetz 2005, 
Voulhoux et al. 2003, Werner and Misra 2005, Wu et al. 2005). 
 
1.4. Transport of nutrients across membranes 
Whereas small hydrophobic molecules can cross lipid bilayers by passive diffusion at 
reasonable rates, ions and most nutrients cannot pass them. Therefore, it is essential for 
bacteria to be able to import them. This is achieved through transmembrane proteins 
embedded in the lipid bilayers of IM and OM that can be divided into two groups: The first 
group facilitates diffusion of certain molecules or ions by providing an aqueous path from one 
side of the membrane to the other. This group can be subdivided into channels and pores. 
The second group constitutes transporters that do not contain a continuous path through the 
membrane but can utilize energy sources to undergo conformational changes and thereby 
transport substrates against concentration gradients across membranes (Noinaj and 
Buchanan 2014, Vinothkumar and Henderson 2010). 
Pores provide a hydrophilic environment across the membrane between helices of IMPs 
or within the β-barrel of OMPs. These pores are often substrate-unspecific and facilitate 
diffusion of different molecules and ions across a membrane as long as their sizes do not 
exceed the pore diameter. Uncharged molecules diffuse solely along their concentration 
gradients, whereas for charged molecules additionally the membrane potential plays a role 
and therefore they diffuse along their electrochemical gradient. Channels contain specificity 
filters, which for instance let only certain ions pass. Many channels are not constitutively 
open; instead they can be gated and only open upon specific stimuli. These can include 
mechanical or chemical signals and changes in membrane potential (Alberts et al. 2008, 
Vinothkumar and Henderson 2010) (Fig. 1.3a). 
Transporters, or carriers, also completely span the membrane, but in contrast to channels 
and pores, they do not constitute a continuous aqueous path across the membrane. Instead, 
they bind molecules or ions to be transported very specifically on one side of the membrane 
and then undergo conformational changes that take the cargo to the other side of the 
membrane, where it is released. Therefore, the transport rates are usually significantly 
slower than for pores or channels. There are transporters that facilitate diffusion without input 
of external energy, but others are energized and can transport molecules against 
concentration resp. electrochemical gradients. These latter ones can be subdivided into 
primary active transporters, which couple transport to ATP hydrolysis, and secondary active 
transporters, which couple the transport of a molecule against its electrochemical gradient to 
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the transport of one or several others along their electrochemical gradient. The latter gradient 
is however in the first place established by ATP-driven transport, hence the term “secondary 
active” (Alberts et al. 2008, Chen 2013, Jaehme and Slotboom 2015, Noinaj and Buchanan 
2014, Robertson et al. 2012, Shi 2013, Vinothkumar and Henderson 2010, Wilkens 2015) 
(Fig. 1.3a). 
Whereas in the IM channels and pores for facilitated diffusion as well as energized 
transporters exist, the OM is usually constricted to channels and pores, due to the lack of 
energy sources like ATP in the periplasm or an electrochemical potential across the OM. 
OMP pores, called porins, contain a β-barrel with typically 16 or 18 strands, and form trimers 
of β-barrels in the membrane (Galdiero et al. 2012). Porins in E. coli, which allow nonspecific 
facilitated diffusion of ions, water and small molecules (<600 Da) like glucose, include OmpC, 
OmpF and PhoE (Cowan et al. 1992). More substrate-specific porins include e.g. the 
maltooligosaccharide-specific maltoporin LamB (Koebnik et al. 2000, Schirmer et al. 1995). 
Once maltose has entered the periplasm after diffusion through the LamB pore, it is bound 
by the maltose binding protein (MBP) and therefore pulled out from the pool of freely 
diffusing maltose molecules across the OM. MBP then binds to a specific maltose transporter 
at the inner membrane, which takes over the maltose and transports it across the IM under 
ATP consumption (Chen 2013, Oldham et al. 2007) (Fig. 1.3b). 
There are also exceptions of OMPs that constitute energy-driven transporters. Those usually 
release siderophores to the extracellular space to bind ferric chelates, nickel complexes, 
vitamin B12 or carbohydrates. The re-uptake of these siderophores is a process that requires 
energy. Due to the lack of energy sources at the OM, energy from the proton motif force at 
the IM is delivered from the TonB-ExbB-ExbD complex in the IM to these transporters in the 
OM. Those are therefore called TonB-dependent transporters but little is known about the 
details of energy transfer (Noinaj et al. 2010, Vinothkumar and Henderson 2010). 
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Figure 1.3 Transport of small molecules across membranes. 
(a) Schematic representation of a trimeric OM porin (blue, top), IM channel or pore (red, bottom left), 
IM primary active transporter (red, bottom center) and IM secondary active transporter, depicted as a 
cation symporter (red, bottom right). Small molecule or ion substrates are represented by colored 
stars. (b) Depiction of maltose import from the extracellular space to the cytoplasm across OM, 
periplasm and IM. Maltoporin LamB (blue, top; PDB entry 1MAL (Schirmer et al. 1995)) facilitates 
diffusion of maltose across the OM. Periplasmic maltose binding protein MBP/MalE (cyan) binds 
maltose and takes it to the IM maltose transporter MalFG (MalF in magenta and MalG in red), which is 
energized by the dimeric ATPase MalK (green) to transport maltose across the IM against its 
concentration gradient (MalEFGK: PDB entry 2R6G (Oldham et al. 2007)). 
 
1.5. Assembly of inner membrane proteins by SecYEG 
Both IMPs and OMPs, as well as all other bacterial proteins, are synthesized by 
ribosomes in the cytoplasm. Since integral membrane proteins naturally contain a lot of 
hydrophobic residues in the parts that will later face the lipid bilayer environment of the 
membranes, these proteins are prone to aggregation as long as they do not adopt their final 
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membrane-embedded structure. To reach their destination, IMPs are directly integrated into 
the IM, whereas OMPs first need to be transported to the periplasm and then cross it, before 
being integrated into the OM. 
IMPs contain a hydrophobic signal anchor sequence, which will also be the most  
N-terminal transmembrane helix in the folded protein. When it emerges from the ribosome 
early in the translation process, it interacts with the ribosome-associated chaperone trigger 
factor (TF), as most nascent chains do (Facey and Kuhn 2010, Hoffmann et al. 2010, Maier 
et al. 2005). Subsequently, signal recognition particle (SRP) competes with TF for interaction 
with the nascent chain as it has especially high affinity to hydrophobic sequences like the 
signal anchor sequence. Translation is stalled and SRP targets the ribosome – nascent chain 
– SRP complex to the inner membrane where it interacts with the membrane-bound SRP-
receptor FtsY (Akopian et al. 2013, Facey and Kuhn 2010, Valent et al. 1998). SRP 
dissociates from the signal anchor sequence, which is transferred to the inner membrane 
protein complex SecYEG. Translation continues and the emerging nascent polypeptide chain 
threads through the membrane pore formed by SecYEG (Cannon et al. 2005, Gogala et al. 
2014, Park et al. 2014, Spiess 2014, Van den Berg et al. 2004), pushed by the polypeptide 
synthesis at the ribosome (Facey and Kuhn 2010, Park and Rapoport 2012). When a 
hydrophobic stretch of amino acids, which will be a transmembrane helix in the mature 
protein, is recognized, it is transferred laterally into the IM through a lateral gate between two 
transmembrane helices (2 and 7) of SecY that opens up (Egea and Stroud 2010, Gogala et 
al. 2014, Park et al. 2014, Van den Berg et al. 2004). The nascent chain continues threading 
through SecYEG and with every new transmembrane helix a lateral insertion procedure 
takes place until the translation at the ribosome is finished and the IMP is completely inserted 
in the IM (Facey and Kuhn 2010, Xie and Dalbey 2008) (Fig. 1.4). 
This process of co-translational insertion overcomes the problem that a hydrophobic 
polypeptide chain may aggregate in the cytoplasm. Besides this canonical pathway for IMP 
insertion, other pathways also play a role for distinct proteins, involving another IMP 
insertase called YidC (Dalbey et al. 2014, Hennon et al. 2015, Xie and Dalbey 2008). 
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Figure 1.4 IMP biogenesis. 
SRP (brown) directs the stalled nascent chain (orange, signal anchor sequence in magenta) – 
ribosome (green) – mRNA (black) complex to the SRP receptor FtsY (purple) at the IM. Subsequently, 
the nascent chain is handed over to SecYEG (red). Translation continues and the nascent chain is 
threaded through SecYEG. Hydrophobic transmembrane α-helices of the newly synthesized IMP are 
recognized and released laterally into the membrane by SecYEG. 
 
1.6. Transport of proteins across the inner membrane by SecYEG 
OMPs and most periplasmic proteins use the Sec translocase for IM traversal. A co-
translational process is in some cases used, but usually OMPs and soluble periplasmic 
proteins are post-translationally transported to the periplasm. In this pathway, an N-terminal 
tripartite signal sequence (Hutchings et al. 2009) is recognized by trigger factor (TF) when 
emerging from the ribosome during translation of OMPs and periplasmic proteins. 
Subsequently, SecB chaperone molecules are recruited, displace TF and stabilize the 
nascent polypeptide chain (Bechtluft et al. 2010, Facey and Kuhn 2010). When the 
translation process is finished, the unfolded, chaperone-stabilized OMP or periplasmic 
protein is delivered to the IM, where the signal sequence is bound by SecYEG and the 
polypeptide it is threaded through the SecYEG translocon in a hairpin fashion in N- to  
C-terminal direction (Cannon et al. 2005, Gogala et al. 2014, Park et al. 2014). This process 
is energetically mainly driven by the ATPase SecA (Papanikou et al. 2007, Park and 
Rapoport 2012). As β-barrel OMPs do not contain stretches of purely hydrophobic amino 
acids as in transmembrane α-helices of IMPs, a lateral membrane insertion process into the 
IM is not triggered and instead the whole polypeptide chain is threaded through. Once this 
translocation process is completed, the N-terminal signal sequence, still bound to SecYEG, 
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is cleaved from the rest of the polypeptide chain by signal peptidase (SP) (Facey and Kuhn 
2010, Papanikou et al. 2007) (Fig. 1.5). 
In addition to OMPs and soluble periplasmic proteins, most lipoproteins from the IM and 
OM use this pathway as well to reach the periplasm. After translocation, these lipoproteins 
are still bound to Sec via their N-terminal signal sequence. A conserved cysteine residue 
directly behind the signal sequence is then modified with a lipid and the signal sequence is 
cleaved, which leaves the lipoprotein anchored with the lipid moiety in the outer leaflet of the 
IM. Most lipoproteins are then transported by the lipoprotein localization (Lol) pathway to the 
OM, where they are anchored to the inner leaflet. Lipoproteins that are destined to remain 
IM-anchored avoid this translocation pathway by containing special Lol avoidance signals 
(Hutchings et al. 2009, Zückert 2014). 
Besides the Sec pathway, which transports still unfolded proteins to the periplasm, 
another pathway for folded substrates exists, called the twin-arginine translocation (Tat) 
pathway. Certain proteins, including some lipoproteins, use this pathway instead of Sec to be 
transported in a folded state, but insights into its structural and mechanistic aspects are still 
limited (Kudva et al. 2013, Palmer and Berks 2012, Patel et al. 2014). 
 
1.7. Transport of outer membrane proteins across the periplasm 
Similarly to the recruitment of the chaperones TF and SecB during translation in the 
cytoplasm, periplasmic chaperones are recruited when an unfolded OMP is threaded through 
Sec in the IM and arrives at the periplasmic side of the membrane. The chaperone that is 
mainly involved in this process in E. coli is called SurA (Sklar et al. 2007b, Volokhina et al. 
2011) and multiple SurA molecules bind as monomers or dimers to multiple aromatic 
residue-rich sites of unfolded OMPs (Xu et al. 2007). Besides the SurA pathway, another 
pathway for OMPs exists, involving the chaperones Skp and DegP (Sklar et al. 2007b, 
Volokhina et al. 2011). This pathway is thought to work as a backup system for SurA in  
E. coli. Here, SurA is the generally preferred chaperone, but both pathways can substitute 
each other, whereas in other Gram-negative bacteria the Skp/DegP pathway may be the 
preferred one (Sklar et al. 2007b, Tommassen 2010, Ulrich and Rapaport 2015, Volokhina et 
al. 2011). Skp binds OMPs in a very different fashion than SurA by providing a cavity 
between three “arms” of this trimeric protein, where the substrate is kept in a fluid globule 
state (Burmann et al. 2013, Callon et al. 2014, Qu et al. 2007). The chaperones transport the 
unfolded OMP through the periplasm to the OM, where they hand it over to the BAM 
complex, which finally integrates this polypeptide as a β-barrel into the OM (Kim et al. 2012) 
(Fig. 1.5). 
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Figure 1.5 OMP biogenesis. 
During translation of an OMP at a ribosome (green) in the cytosol, TF (brown) is displaced by SecB 
chaperone molecules (brown), which guide the unfolded OMP (cyan, signal sequence in magenta) to 
SecYEG (red) in the IM. SecA ATPase (purple) drives the translocation of the substrate through 
SecYEG, after which the signal sequence is removed. Unfolded OMPs use either the SurA or the 
Skp/DegP chaperone (brown) pathway to be stabilized in the periplasm. The chaperones guide the 
unfolded OMP to the OM, where it is assembled by the BAM complex (blue). 
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1.8. Assembly of outer membrane proteins by BAM 
The BAM complex is responsible for the integration of newly synthesized OMPs into the 
OM of Gram-negative bacteria (Doerrler and Raetz 2005, Voulhoux et al. 2003, Werner and 
Misra 2005, Wu et al. 2005), ranging from the smallest OMPs, containing 8 β-strands to the 
largest ones with 26 β-strands (Doerrler and Raetz 2005, Palomino et al. 2011, Qiao et al. 
2014, Voulhoux et al. 2003, Werner and Misra 2005). It consists of BamA, which is an OMP 
itself (Flack et al. 1995, Manning et al. 1998, Ruffolo and Adler 1996, Thomas et al. 1990), 
and several lipoproteins, which are BamBCDE in E. coli (Anwari et al. 2012, Volokhina et al. 
2009, Wu et al. 2005). Despite consisting of five subunits, only BamA and BamD are 
essential for a functional BAM complex and cell viability (Malinverni et al. 2006, Rossiter et 
al. 2011, Voulhoux et al. 2003). However, deletions of any of the non-essential lipoproteins 
lead to compromised cell growth and OMP insertion. Furthermore, for BamA, which 
comprises a 16-stranded membrane-integrated β-barrel and five periplasmic POTRA (for 
“polypeptide transport associated”, (Sanchez-Pulido et al. 2003)) domains, only POTRA 
domain 5, which is most proximal to the barrel, and the barrel itself are essential in Neisseria 
meningitides (Bos et al. 2007). In E. coli, POTRA domains 3-5 and the barrel are essential 
(Kim et al. 2007), and deletions of non-essential POTRA domains compromise BAM function. 
POTRA domains share a typical β-α-α-β-β fold with a 3-stranded β-sheet and two 
proximal α-helices (Gatzeva-Topalova et al. 2008, Gatzeva-Topalova et al. 2010, Kim et al. 
2007, Zhang et al. 2011). BamA POTRA domain 5 interacts with BamD (Kim et al. 2007, 
Ricci et al. 2012), which in turn binds BamC and BamE (Kim et al. 2011a, Malinverni et al. 
2006, Rigel et al. 2012, Sklar et al. 2007a). BamB interacts directly with BamA POTRA 
domain 3 (Dong et al. 2012b, Jansen et al. 2015, Vuong et al. 2008) (Fig. 1.6). 
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Figure 1.6 Schematic representation of the BAM complex. 
Blue: the BamA β-barrel. Green – light green – yellow – orange – red: The BamA POTRA domains 1 
to 5. Grey: BamB, BamC, BamD and BamE, labeled with the respective letters. 
 
The process of OMP substrate processing by the BAM complex after delivery via the SurA 
or Skp/DegP chaperone pathways is not understood in detail. SurA interacts with BamA 
POTRA domain 1 (Bennion et al. 2010, Sauri et al. 2009, Sklar et al. 2007b). Upon arrival at 
the BAM complex, substrates are released from the chaperone, when presumably the 
conserved C-terminal “β-signal” motif, which is located in the last β-strand of a mature OMP 
and has a phenylalanine as the most frequent C-terminal residue (Struyvé et al. 1991), is 
recognized by the BAM complex. BamA POTRA domains interact with peptides 
corresponding to β-signals of OMPs (Knowles et al. 2008). The suggested mechanism is 
based on β-augmentation (Harrison 1996), which means that unfolded OMP substrates 
extend the 3-stranded β-sheets of the POTRA domains by providing one or more additional 
strands to transiently form larger β-sheets (Kim et al. 2012). Substrates may slide along the 
POTRA domains under reformation of β-augmentation interactions. This process has not 
been demonstrated directly, but in several crystal structures of BamA POTRA domains, 
crystal contacts between POTRA domains mimic β-augmentation (Gatzeva-Topalova et al. 
2008, Kim et al. 2007, Koenig et al. 2010). 
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The essential BamD interacts with β-signal motifs as well (Albrecht and Zeth 2011) and 
BamC may have a regulatory function, as in the BamCD crystal structure it binds to the 
presumable β-signal binding groove of BamD (Kim et al. 2011a). β-Augmentation is also 
proposed to take place with BamB, which forms a β-propeller with eight WD40 repeats, and 
therefore would offer several sites for β-sheet extension (Heuck et al. 2011). The non-
essential BamB may thus be especially important for OMPs containing many β-strands by 
providing additional interaction sites (Heuck et al. 2011, Palomino et al. 2011). BamE 
stabilizes the BAM complex (Sklar et al. 2007a) and binds phosphatidylglycerols (Knowles et 
al. 2011). Thereby, it may locate the BAM complex to regions rich in this lipid, which was 
shown to facilitate spontaneous membrane insertion of the BAM substrate OmpA in vitro 
(Patel et al. 2009). 
Despite available high-resolution structures for all BAM lipoproteins (Albrecht and Zeth 
2011, Dong et al. 2012a, Dong et al. 2012b, Heuck et al. 2011, Jansen et al. 2012, Kim et al. 
2011a, Kim et al. 2011b, Kim et al. 2011c, Kim and Paetzel 2011, Knowles et al. 2011, 
Noinaj et al. 2011, Sandoval et al. 2011) and for all BamA POTRA domains (Gatzeva-
Topalova et al. 2008, Gatzeva-Topalova et al. 2010, Kim et al. 2007, Zhang et al. 2011), the 
main mechanistic characterization of OMP assembly in the bacterial OM, especially of the 
final steps, is still missing. 
The conformation of the flexible BamA barrel (Stegmeier and Andersen 2006) is 
influenced by interactions with unfolded substrates and their C-terminal β-signals (Robert et 
al. 2006). The interaction of substrates and the BamA barrel happens at a late stage of OMP 
assembly since the barrel is the part of the BAM complex closest to and even inside the OM, 
the final destination of the substrates (Kim et al. 2012). 
The β-barrel formation process generally works without external energy provision, as the 
periplasm is devoid of ATP and the OM is not energized by an electrochemical potential. 
Moreover, proteoliposome-reconstituted BAM complex (Hagan and Kahne 2011, Hagan et 
al. 2010, Norell et al. 2014) and BamA alone (Patel and Kleinschmidt 2013) show OMP 
insertion activity without additional energy. Thus, the folding of such polypeptide chains into a 
membrane-embedded β-barrel is an energetic downhill process, driven by the energetically 
favorable formation of hydrogen bonds between β-strands, catalytically facilitated by the 
insertase BamA. This finding is well in line with the observation that several β-barrels can 
also fold spontaneously into lipid bilayers in vitro on their own, but with a rate much lower 
than observed in vivo (Burgess et al. 2008, Huysmans et al. 2010, Patel et al. 2009, Patel 
and Kleinschmidt 2013, Pocanschi et al. 2006, Surrey and Jahnig 1992, Surrey et al. 1996). 
Another reason why BamA is the central subunit in the BAM complex for the assembly of 
new OMPs is that it belongs to the Omp85 superfamily (Gentle et al. 2004). Omp85 proteins 
share a C-terminal 16-stranded β-barrel and a varying number of N-terminal POTRA 
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domains (Gentle et al. 2005). This protein family also exists in the OM of eukaryotic 
mitochondria and plastids. There, Omp85 proteins belong to complexes that utilize 
membrane assembly of OMPs as well. Furthermore, they are the only homologous proteins 
between the different complexes and therefore evolutionary most conserved and functionally 
most relevant (Gentle et al. 2004, Gentle et al. 2005, Walther et al. 2009). 
 
1.9. Transport of proteins across the outer membrane in two-partner secretion 
BamA is one of several Omp85 proteins found in Gram-negative bacteria. There is also 
TamA with three POTRA domains (formerly YtfM) (Stegmeier et al. 2007) and TpsB proteins 
with two POTRA domains (Jacob-Dubuisson et al. 2013), including the best-characterized 
member FhaC from the whooping cough agent Bordetella pertussis. 
TpsB proteins function in two-partner secretion (TPS) (Jacob-Dubuisson et al. 2000), 
which is also classified as type 5b secretion system (T5bSS) (Henderson et al. 2000). The 
name TPS derives from the fact that most TpsB Omp85 proteins have one distinct substrate 
protein, called TpsA, which is usually encoded in the same operon as the TpsB protein and 
which is in contrast to OMPs not integrated into, but instead translocated across the OM to 
the extracellular space (Barenkamp and St Geme 1994, Schiebel et al. 1989, Willems et al. 
1994). This transport through the OM is performed solely by the TpsB partner, which does 
not have complex partners, in contrast to Omp85 proteins from OMP insertion machineries 
(Fan et al. 2012). In some bacteria one TpsB protein can have several TpsA substrates (Julio 
and Cotter 2005, Plamondon et al. 2007). 
To date, in addition to type5 secretion systems (T5SS), five other secretion systems 
(T1SS to T4SS and T6SS) have been characterized in Gram-negative bacteria, which are all 
much more complex than T5SS. Those secretion systems are composed of large hetero-
oligomeric complexes that span both IM and OM and often can form a complete tunnel from 
the cytoplasm to the extracellular space, through which proteins, DNA or small molecules 
can be ejected (Costa et al. 2015). However, T5SS is the most abundant secretion pathway 
for proteins in Gram-negative bacteria. 
The general pathway of TpsA protein biogenesis is very similar to the one of OMPs. They 
are synthesized in the cytoplasm, containing an N-terminal, often extended signal sequence, 
which directs them through the IM and is cleaved off after arrival in the periplasm. There, 
even though still unfolded, they are less prone to aggregation than OMPs since they do not 
contain transmembrane regions and therefore not as many hydrophobic residues. There is 
however evidence that the chaperone DegP may play a role when they cross the periplasm 
to reach the OM (Baud et al. 2009). The greatest difference to the biogenesis of OMPs lies in 
the final step, when in contrast to unfolded OMPs, unfolded TpsA proteins are not processed 
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by the BAM complex, but instead by the TpsB partner protein, which mediates secretion to 
the extracellular space (Fig. 1.7a). 
Secreted TpsA proteins usually adopt similar overall folds as they form extended β-helical 
structures (Kajava and Steven 2006), but they vary in size from a few hundred to several 
thousand amino acids. Moreover, despite being structurally similar, TpsA functions are 
diverse. For instance, in the pathogenic bacterium Bordetella pertussis, filamentous 
hemagglutinin (FHA) is crucially involved in cell adhesion and biofilm formation during 
colonization of the respiratory tract (Serra et al. 2011), in Serratia marcenscens, Serratia 
hemolysin (ShlA) lyses erythrocytes by forming pores in their membrane (Poole et al. 1988, 
Schiebel et al. 1989) and in Haemophilus influenzae, two high-molecular-weight proteins 
(HMW-1 and HMW-2) mediate attachment to epithelial cells (St Geme et al. 1993). No TpsA 
proteins exist in laboratory E. coli K-12 strains, but in uropathogenic E. coli, where CdiA 
mediates contact-dependent growth inhibition to other bacteria (Aoki et al. 2005). Despite 
fulfilling important virulence functions, TPS systems also exist in non-pathogenic bacteria, 
where they are generally involved in attachment between bacteria and interactions of 
bacteria with their environment (Jacob-Dubuisson et al. 2013), but those TPS systems are 
less well studied. 
TpsA proteins share an N-terminal TPS domain as the most conserved region. It has a 
length of around 250 amino acids and is located directly behind the signal sequence. The 
TPS domain is necessary and sufficient for recognition and transport by the respective TpsB 
partner (Grass and St Geme 2000, Jacob-Dubuisson et al. 1997, Renauld-Mongenie et al. 
1996, Schönherr et al. 1993). This domain contains a conserved NPNG(I/M) motif, crucial for 
secretion (Hodak et al. 2006, Jacob-Dubuisson et al. 1997, Schönherr et al. 1993, St Geme 
and Grass 1998). Recognition of TpsA substrates by TpsB proteins is initially mediated via 
interactions of the unfolded TPS domain with the two POTRA domains of TpsB (Delattre et 
al. 2011, Hodak et al. 2006, Surana et al. 2004), presumably by β-augmentation (Jacob-
Dubuisson et al. 2013), and after secretion of the TpsA protein through the TpsB pore (Baud 
et al. 2014), the TPS domain adopts β-helical structure like usually most of the rest of the 
TpsA protein (Clantin et al. 2004, Weaver et al. 2009, Yeo et al. 2007) (Fig. 1.7b). For some 
TpsA proteins, as HMW-1, the TPS domain is cleaved off after translocation of the entire 
protein and released to the extracellular space (Grass and St Geme 2000, van Ulsen et al. 
2014). Many TpsA proteins also contain a C-terminal domain, which is not secreted, but 
tethers the protein to the membrane via interactions with the TpsB partner (Buscher et al. 
2006, Grass and St Geme 2000, Julio and Cotter 2005). For certain TpsA proteins, like FHA, 
this C-terminal domain can be cleaved off and is subsequently degraded in the periplasm 
(Julio and Cotter 2005, Noel et al. 2012, van Ulsen et al. 2008). 
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Figure 1.7 FHA translocation by FhaC and FHA TPS domain crystal structure. 
(a) Unfolded FHA arrives at the OM, where it engages in initial interactions of its TPS domain 
sequence with the FhaC POTRA domains. Subsequently, the plug helix is removed from the FhaC 
barrel and FHA is transported to the extracellular space, where it folds. (b) β-helical fold of the FHA 
TPS domain (PDB entry 1RWR (Clantin et al. 2004)). 
 
Like the BAM complex for the insertion of OMPs, TpsB proteins do not need external 
energy for the translocation of their TpsA substrates. In vitro assays demonstrated TpsA 
translocation into proteoliposomes containing only the corresponding TpsB transporter (Fan 
et al. 2012, Norell et al. 2014). The driving force for the directed translocation process is 
probably the initiation of folding that does not allow back diffusion. It is still under debate, how 
and in which direction translocation of TpsA proteins occurs. The two discussed possibilities 
include (i) N- to C-terminal translocation, so the TPS domain is transported first and initiates 
folding in the extracellular space, which gives the rest of the protein directionality in 
translocation, and (ii) a hairpin model, in which after recognition by the respective TpsB 
protein the TPS domain stays in the periplasm until the rest of the protein is threaded through 
the pore (Jacob-Dubuisson et al. 2013). 
FhaC is the only TpsB protein for which the three-dimensional full-length structure has 
been solved (Clantin et al. 2007). It reveals a 16-stranded C-terminal β-barrel with two 
periplasmic POTRA domains and an N-terminal α-helix, which is inside the β-barrel pore. 
This helix is connected to the first POTRA domain via a linker (Fig. 1.8). The crystal structure 
conformation exemplifies a resting state of TpsB proteins (Gabel et al. 2014), most of which 
contain an N-terminal α-helix that is removed from the pore during secretion and locates to 
the periplasm (Guérin et al. 2014) (Fig. 1.7a). 
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A remarkable feature of Omp85 proteins in general is that they share the same overall fold 
with periplasmic POTRA domains and a 16-stranded membrane-embedded β-barrel, but do 
not share high sequence identities. However, all Omp85 proteins contain two highly 
conserved sequence motifs, which are (G/F)xDxG (Jacob-Dubuisson et al. 2013) and 
VRG(Y/F) (Delattre et al. 2010). The FhaC crystal structure reveals that the former one is 
located in barrel strand 13, pointing the sidechains to the inside of the barrel, approximately 
at half barrel height. The latter one is located at the tip of the long extracellular L6 loop, which 
in the structure reaches all the way through the barrel to its periplasmic rim. Despite showing 
the general locations of these two highly conserved motifs, the crystal structure does not 
suffice for the elucidation of their functional importance nor does it allow the deduction of 
details about the transport mechanism in general. 
 
 
Figure 1.8 FhaC crystal structure. 
The crystal structure of FhaC (PDB entry 2QDZ (Clantin et al. 2007)) shows the C-terminal 
transmembrane β-barrel (blue), POTRA domains 1 (orange) and 2 (red), and the N-terminal plug helix 
(yellow). The linker connecting the plug helix to POTRA1 is not resolved in the electron density. 
 
1.10. Assembly of autotransporters by TAM 
The function of the Omp85 protein TamA (Stegmeier et al. 2007) is less well understood. 
Whereas BamA is present and essential in all Gram-negative bacteria and TpsB proteins are 
especially but not only found in pathogenic ones and contribute to virulence (Jacob-
Dubuisson et al. 2013), TamA is present in many but not all Gram-negative bacteria, 
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including pathogenic and non-pathogenic species (Heinz and Lithgow 2014, Selkrig et al. 
2012). In contrast to BamA, TamA is non-essential in E. coli, but TamA deletion mutants 
exhibit growth defects (Stegmeier et al. 2007). 
Its DNA usually appears in an operon together with a large protein (1259 amino acids in 
E. coli) called TamB (formerly YtfN) and thus resembles TPS systems with respect to its 
genomic organization. In Gammaproteobacteria, for instance in E. coli K-12 strains, another 
gene is found in this operon encoding a small cytoplasmic protein YtfP (113 amino acids in 
E. coli) with a gamma-glutamyl cyclotransferase-like fold (Aramini et al. 2007, Aramini et al. 
2005), but its functional relevance remains unclear. 
The structure of TamB is unknown. An N-terminal stretch of approx. 10 hydrophobic 
amino acids, included in the signal sequence, which is initially not cleaved, most likely forms 
a transmembrane helix, traversing the IM (Selkrig et al. 2012). There are also two domains 
annotated as members of the AsmA_2 superfamily in the NCBI database. One of the 
domains constitutes the C-terminal 336 residues of TamB and is additionally annotated as a 
DUF490 domain. The other AsmA_2 domain has a length of only 179 residues and ends 27 
residues before the C-terminal AsmA_2 domain starts. AsmA proteins, however, are 
structurally not characterized and are inconsistently described to be located either in the IM 
and to be involved in LPS biogenesis in E. coli (Deng and Misra 1996) or in the OM and to 
contribute to virulence in Salmonella (Prieto et al. 2009). In general, a large part of the TamB 
structure is predicted to adopt β-helical structure like TpsA proteins. Noteworthy, the very  
C-terminus of TamB resembles a β-signal that is usually found in the last transmembrane  
β-strand of OMPs (Struyvé et al. 1991), but TamB is not predicted to include a 
transmembrane β-barrel. 
In comparison to BamA and TpsB proteins, which have five and two POTRA domains, 
respectively, TamA contains three POTRAs (Stegmeier et al. 2007) and like BamA lacks an 
N-terminal plug-helix (Fig. 1.9a). On the one hand, TamA and TamB are genomically 
organized similar as TPS systems and TamB shares structural features with TpsA proteins, 
on the other hand, TamA shares higher sequence similarity to BamA than to TpsB proteins 
(Selkrig et al. 2012) and since crucial sequence motifs indicating a TPS domain are missing, 
TamB is clearly no TpsA protein. 
Instead of being translocase and substrate, TamA and TamB were shown to interact with 
each other and to be involved in the biogenesis of a subgroup of special OMPs called 
autotransporters (ATs), including Ag43 in E. coli (Selkrig et al. 2012). These proteins are 
classified as type 5a secretion systems (T5aSS) (Leo et al. 2012) and contain a 12-stranded 
C-terminal membrane-embedded β-barrel (Oomen et al. 2004) and an often large N-terminal 
extracellular passenger domain. This domain is for most ATs of β-helical structure, just like 
TpsA proteins (Kajava and Steven 2006, van Ulsen et al. 2014). Structurally, ATs can 
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therefore be seen as a fusion of an OMP, whose membrane integration usually depends on 
the BAM complex, and a TpsA protein, whose translocation depends on a conjugate TpsB 
protein. AT passenger domains can mediate diverse functions, which are in general similar to 
TpsA proteins, since they often contribute to virulence, work as proteases and mediate cell 
adhesion (van Ulsen et al. 2014). 
The name autotransporter derives from the initial idea that first the barrel of an AT is 
integrated into the OM and then the unfolded extracellular domain threads through the barrel 
without the need of other cofactors (Henderson et al. 1998, Pohlner et al. 1987). After 
completion, the extracellular domain is folded and connected to the first strand of the barrel 
at the periplasmic side via an α-helical linker through the barrel as can be seen in the full-
length crystal structure of an autotransporter (van den Berg 2010). For many 
autotransporters, this linker is subsequently autocatalytically cleaved within the barrel pore to 
release the passenger domain to the extracellular space (van Ulsen et al. 2014). 
The mechanism of autotransporter assembly has been controversially discussed 
(Bernstein 2007), as engineered folded secondary structure elements can be transported as 
well, for which the 12-stranded autotransporter barrel is actually too narrow (Jong et al. 2007, 
Skillman et al. 2005). Moreover, barrel integration and passenger domain translocation 
appear to be coupled processes (Pavlova et al. 2013) and some AT proteins could be 
crosslinked to BamA in vivo (Ieva and Bernstein 2009, Ieva et al. 2011, Sauri et al. 2009). 
Therefore, it seems that in T5aSS, ATs depend on the Omp85 proteins BamA or TamA for 
their OM barrel integration and passenger domain translocation (Figure 1.9b), whereas in 
T5bSS/TPS passenger domain-like TpsA proteins depend on a specific Omp85 TpsB partner 
protein for translocation. 
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Figure 1.9 Schematic representation of TamA and autotransporter assembly. 
(a) TamA consists of three N-terminal POTRA domains (yellow – orange – red) and a transmembrane 
β-barrel (blue). (b) Autotransporters are like other OMPs guided to the OM by SurA or Skp/DegP and 
then processed by the BAM or TAM complex for assembly into the OM. 
 
1.11. Translocation and assembly of proteins in outer membranes of 
mitochondria and chloroplasts 
In eukaryotic cells, proteins homologous to bacterial Omp85 proteins can be found as 
well. They are located in the outer membranes of mitochondria and chloroplasts (Jacob-
Dubuisson et al. 2013), which are the organelles that derive from endosymbiosis (Keeling 
2010, Kutschera and Niklas 2005, Timmis et al. 2004). This observation shows that Omp85 
proteins have been functionally conserved over billions of years. 
In the chloroplast outer envelope membrane (OEM), several Omp85 proteins can be 
found, some of which do not possess POTRA domains and have yet unknown functions 
(Hsueh et al. 2014, Nicolaisen et al. 2015). The essential Omp85 proteins Toc75-III and 
OEP80 (also called Toc75-V), however, contain three POTRA domains and are involved in 
translocation of nucleus-encoded proteins that are destined for one of the several chloroplast 
compartments, and probably in OMP insertion into the OEM. Whereas Toc75-III was shown 
to mediate the former task as part of the TOC complex together with the receptors Toc159 
and Toc34 (Paila et al. 2015, Schnell et al. 1994, Tranel et al. 1995, Walther et al. 2009), 
OEP80 is believed to mediate the latter (Eckart et al. 2002, Hsu et al. 2008, Paila et al. 
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2015). As more than 95% of chloroplast proteins are encoded in the nucleus and translated 
in the cytosol, the protein import routes into this organelle are of essential importance. 
Imported chloroplast proteins that are not OMPs usually contain an N-terminal targeting 
sequence, called transit peptide, which first directs them across the OEM and then to their 
final subcompartment within the chloroplast (Paila et al. 2015). Chloroplast OMPs usually do 
not contain this signal, but instead intrinsic targeting signals to be sorted to the OEM (Shi and 
Theg 2013). There is only one exception: the translocase Toc75-III itself. Its N-terminal 
transit peptide directs the protein not only across the OEM to the intermembrane space 
(IMS), the equivalent of the bacterial periplasm, but even further across the inner envelope 
membrane (IEM). There, it is cleaved off before the rest of the protein is released to the IMS, 
from where it is then probably integrated into the OEM (Tranel and Keegstra 1996, Ulrich and 
Rapaport 2015). 
Interestingly, the orientation of the Omp85 proteins may have inversed as compared to 
bacterial homologues: the POTRA domains seem to face the cytosol instead of the IMS 
(Sommer et al. 2011), but controversial results about the topology exist (Sveshnikova et al. 
2000). For Toc75-III an inversion would make sense from a mechanistic point of view, as the 
transportation direction of its substrates is inversed as compared to TpsA proteins. For  
β-barrel insertion however, in regard to the import route of Toc75-III, this would suggest that 
OMPs are inserted into the membrane from the side of the Omp85 proteins that does not 
contain the POTRA domains, in contrast to bacterial Omp85 insertases. However, since 
OMP biogenesis in chloroplasts is not yet well investigated, more research needs to be 
conducted before mechanistic conclusions can be drawn (Fig. 1.10a). 
Similar as for chloroplasts, most mitochondrial proteins (approx. 99%) are encoded in the 
nucleus and post-translationally imported. They usually contain an N-terminal sorting signal, 
called presequence, but some proteins like OMPs contain intrinsic targeting signals instead 
(Höhr et al. 2015). For the insertion of OMPs into the outer mitochondrial membrane (OMM) 
a mitochondrial Omp85 protein exists, called Sam50 (or Tob55), which forms a complex with 
the proteins Sam35 and Sam37 (Gentle et al. 2004, Milenkovic et al. 2004, Neupert and 
Herrmann 2007, Paschen et al. 2003, Pfanner et al. 2004, Walther et al. 2009, Wiedemann 
et al. 2003). The latter two proteins are embedded in the OMM via a single α-helix and 
contain cytosolic domains. The SAM complex can be seen as the mitochondrial pendant of 
the BAM complex; it assembles OMPs that were imported from the cytosol in an unfolded 
state to the IMS between OMM and inner mitochondrial membrane (IMM). The single 
POTRA domain of Sam50 is located in the IMS, and therefore Sam50 has the same 
orientation in the membrane and towards substrates as Omp85 proteins in Gram-negative 
bacteria (Paschen et al. 2003). The other subunits Sam35 and Sam37 cannot be compared 
to any of the BAM complex subunits, as their soluble parts are located in the cytosol rather 
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than the IMS. Nevertheless, the essential Sam35 was shown to interact with C-terminal  
β-signals of OMP substrates (Chan and Lithgow 2008, Kutik et al. 2008), which also e.g. the 
BamD subunit in the BAM complex does. The function of the non-essential Sam37 involves 
release of an OMP substrate into the membrane (Chan and Lithgow 2008). 
In mitochondria the OMP integration is done by a complex containing an Omp85 protein, 
but the protein import, in contrast to chloroplasts, is performed by a different protein complex, 
called the TOM (translocase of outer mitochondrial membrane) with its β-barrel pore formed 
by Tom40 (Chacinska et al. 2009, Hill et al. 1998, Suzuki et al. 2004, Vestweber et al. 1989). 
Like the homologous OMM protein VDAC (Hiller et al. 2008), Tom40 contains 19 β-strands 
(Gessmann et al. 2011, Lackey et al. 2014), but its structure has not been determined. 
Tom40 does not contain POTRA domains, but an N-terminal α-helical region and forms a 
complex with six other proteins: the small proteins Tom5, Tom6, Tom7 belong to the TOM 
core and presumably have a stabilizing function and Tom20, Tom22 and Tom70 are 
associated receptors (Ahting et al. 1999, Kato and Mihara 2008, Künkele et al. 1998, Model 
et al. 2002, Schmitt et al. 2005). These proteins are embedded in the OMM via a single-pass 
α-helix and contain cytosolic domains, Tom22 and Tom7 in addition possess small IMS 
domains. Tom20 and Tom22 recognize the N-terminal presequences of substrates (Brix et 
al. 1997, Mayer et al. 1995, Yamamoto et al. 2011). Those sequences usually have a length 
of 15 to 50 residues, are positively charged and form an amphipathic α-helix (Neupert and 
Herrmann 2007, Schmidt et al. 2010). Tom70 with its tetratricopeptide repeats preferably 
recognizes substrates with intrinsic sorting signals like OMPs (Brix et al. 1997, Neupert and 
Herrmann 2007). The import mechanism is not understood in detail, but usually proteins are 
translocated in N- to C-terminal direction and it is thought that affinities for the substrates 
increase from the cytosolic parts of the receptors across the Tom40 pore to the IMS exposed 
domains, which thus directs the translocation through the OMM (Neupert and Herrmann 
2007). Depending on the final destination of the imported protein, which may be the OMM, 
the IMS, the IMM or the inner matrix, further processing differs. For the insertion of β-barrel 
OMPs into the OMM, the substrates are handed over to the SAM complex (Neupert and 
Herrmann 2007, Schmidt et al. 2010, Wiedemann et al. 2003) (Fig. 1.10b). 
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Figure 1.10 OMP biogenesis in mitochondria and chloroplasts. 
(a) Chloroplast proteins are imported from the cytosol across the OEM via the TOC complex 
containing the Omp85 protein Toc75-III and the receptors Toc159 and Toc34. Assembly of β-barrels 
into the OEM has remained elusive but possibly involves the Omp85 protein OEP80. (b) Mitochondrial 
proteins are translocated from the cytosol across the OMM via the TOM complex containing the  
β-barrel protein Tom40, the receptors Tom70, Tom22 and Tom20 and the small subunits Tom5, Tom6 
and Tom7. Mitochondrial OMPs are inserted from the IMS into the OMM by the SAM complex 
containing the Omp85 protein Sam50 and the subunits Sam35 and Sam37. 
 
1.12. Aims of the thesis 
For translocation of protein substrates across the outer membranes of Gram-negative 
bacteria, mitochondria and chloroplasts, and for the insertion of β-barrels into these 
membranes, the general protein complexes and their components have been identified. 
However, the underlying translocation and insertion mechanisms have remained enigmatic, 
even though for the BAM complex structures of all complex members except for the barrel of 
the insertase BamA itself have been solved. Moreover, even the full-length structure of the 
translocase FhaC has not been able to suffice for the deduction of a bona fide translocation 
mechanism. Since translocation and insertion are two distinct processes, it has not been 
clear whether they share a common mechanistic basis, even though TpsB translocases and 
CHAPTER 1  Introduction 
39 
 
the central components of the other translocation and insertion complexes, except for 
Tom40, all belong to one superfamily of proteins. All these Omp85 proteins share the same 
principle architecture and therefore an evolutionary conserved common mechanistic basis for 
both insertion and translocation may exist. 
The general aim of my thesis was therefore to gain insights into insertion and 
translocation mechanisms at outer membranes. The newly discovered TAM complex is 
specialized in autotransporter assembly, which in essence is a coupled insertion and 
translocation process. Furthermore, as compared to the BAM complex, its architecture is 
relatively simple as the TAM most probably consists of only two subunits: the Omp85 protein 
TamA and the IM-associated protein TamB. Thus, TamA is an ideal target to reveal insights 
into Omp85-mediated translocation and insertion mechanisms at outer membranes. The first 
goal was therefore the structure determination at the atomic level. Knowledge of the structure 
is a good basis for the design of further experiments to answer mechanistic questions. It also 
provides a comparison with the existing structure of the translocase FhaC, yielding insights 
into common structural and mechanistic principles. 
The structure determination of TamA by X-ray crystallography is described in Chapter 2. It 
provides a structural basis for the deduction of a mechanism for the complex assembly of 
OMP autotransporter proteins. In a simplified version this mechanism can also hold true for 
OMP assembly in general. This chapter is reproduced from the publication “The structural 
basis of autotransporter translocation by TamA” (Gruss F, Zähringer F, Jakob RP, Burmann 
BM, Hiller S, Maier T, Nat Struct Mol Biol, 2013). 
Chapter 3 provides a step-by-step protocol for TamA production and crystallization as well 
as a general protocol for seeding in lipid phase membrane protein crystallization, exemplified 
for TamA. This chapter is reproduced from the publication “Purification and bicelle 
crystallization for structure determination of the E. coli outer membrane protein TamA” 
(Gruss F, Hiller S, Maier T, Methods Mol Biol, 2015, in press). 
Chapter 4 describes production and purification of the large TamA complex partner TamB 
in full-length. In addition, in vitro binding experiments using analytical size exclusion 
chromatography (SEC) and isothermal titration calorimetry (ITC) for TamB in combination 
with different TamA POTRA domain constructs are demonstrated and yield complementary 
information to published data about TamA – TamB interactions. Furthermore, a 
bioinformatics analysis of co-evolved residue pairs between TamA and TamB allows the 
mapping of the binding site of TamB at the TamA POTRA domains and reveals an additional 
binding site at the TamA barrel. The experimental work and bioinformatics were done by 
myself. 
The structural results from these chapters and the deduced mechanisms are generally 
consistent with the simultaneously published crystal structure of the general OMP insertase 
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BamA (Noinaj et al. 2013). However, important structural features in these two proteins, 
involving the two most conserved regions in Omp85 proteins in general, are inconsistent with 
the previously published crystal structure of the translocase FhaC (Clantin et al. 2007). 
Therefore, in Chapter 5 the determination of the crystal structure of an FhaC variant 
defective in substrate recognition is described. The determined crystal structure has better 
resolution and higher quality than the previously determined FhaC wild-type crystal structure. 
The results reveal that the previous model of wild-type FhaC is mistraced in the most highly 
conserved region within Omp85 proteins. The corrected structure is generally consistent with 
the structures of TamA and BamA and therefore a common structural basis for insertion and 
translocation mechanisms of Omp85 proteins is demonstrated. In addition, the FhaC variant 
structure reveals insights into substrate recognition mechanisms. This chapter is reproduced 
from the publication “Conserved Omp85 lid-lock structure and substrate recognition in FhaC” 
(Maier T, Clantin B, Gruss F, Dewitte F, Delattre AS, Jacob-Dubuisson F, Hiller S, Villeret V, 
Nat Commun, 2015) 
Chapter 6 delineates inclusion body expression, purification and refolding of human 
Tom40 for the preparation of samples for NMR spectroscopy. Whereas functionally refolded 
Tom40 has been described on a single molecule level, it has so far resisted structure 
determination via NMR spectroscopy or X-ray crystallography. The majority of Tom40 
molecules in the NMR samples within this work form micro-aggregates, as evaluated from 
SEC chromatograms. Consequently, the obtained NMR spectra show low signal intensity in 
comparison to equivalently prepared VDAC samples. However, the data demonstrate that 
folded Tom40 can be obtained in macroscopic amounts, and therefore can be used as a 
basis for further sample optimization towards crystallization or NMR structure determination. 
The protein expression, purification and NMR spectroscopy experiments were done by 
myself. 
 
41 
 
 
 
 
 
CHAPTER 2: 
 
The Structural Basis of Autotransporter Translocation  
by TamA 
 
 
 
Reproduced from: 
 
Nature Structural and Molecular Biology, 20(11):1318-1320; November 2013 
The structural basis of autotransporter translocation by TamA. 
Fabian Gruss, Franziska Zähringer, Roman P. Jakob, Björn M. Burmann, Sebastian Hiller, 
and Timm Maier 
Epub September, 22nd 2013 
DOI 10.1038/nsmb.2689 
 
With permission of Nature Publishing Group 
 
	    
Autotransporter Translocation by TamA  CHAPTER 2 
42 
 
2.1. Abstract 
TamA is an Escherichia coli Omp85 protein involved in autotransporter biogenesis. It 
comprises a 16-stranded transmembrane β-barrel and three POTRA domains. The 2.3 Å 
crystal structure reveals that the TamA barrel is closed at the extracellular face by a 
conserved lid loop. The C-terminal β-strand of the barrel forms an unusual inward kink, which 
weakens the lateral barrel wall and creates a gate for substrate access to the lipid bilayer. 
 
2.2. Introduction 
Proteins of the Omp85 superfamily are responsible for the insertion of β-barrel outer 
membrane proteins (OMPs) and the translocation of protein substrates across the outer 
membrane in bacteria, mitochondria and plastids (Chacinska et al. 2009, Fan et al. 2012, 
Kim et al. 2007, Walther et al. 2009). The membrane protein–biogenesis subclass of Omp85 
proteins catalyzes the insertion and folding of β-barrel OMPs and autotransporters, and this 
subclass includes bacterial BamA and mitochondrial Sam50 (Hagan et al. 2011, Wiedemann 
et al. 2003). A second subclass of Omp85 proteins includes bacterial two-partner secretion 
systems that translocate a specific partner protein across the outer membrane (Jacob-
Dubuisson et al. 2013). A well-characterized member of this subclass is FhaC (Clantin et al. 
2007). The 65-kDa Escherichia coli protein TamA is an Omp85 superfamily protein, which is 
evolutionarily more closely related to BamA than to FhaC (Supplementary Fig. 2.1) (Selkrig 
et al. 2012, Stegmeier et al. 2007). Although most autotransporters are processed by BamA, 
TamA has recently been implicated in passenger-domain translocation of a subset of 
autotransporters, but structural and mechanistic details of this function are unknown (Selkrig 
et al. 2012). Remarkably, TamA is the closest bacterial homolog of eukaryotic Tom40, which 
forms the functional pore of the mitochondrial translocase of the outer membrane (Pusnik et 
al. 2011, Vestweber et al. 1989). 
 
2.3. Results and Discussion 
To analyze how TamA contributes to the translocation of passenger domains, we 
determined the structure of full-length TamA, crystallized from bicelle solution, at 2.25 Å 
resolution (Supplementary Table 2.1). TamA comprises three N-terminal periplasmic 
polypeptide transport–associated (POTRA) domains (aa 22–264) followed by a 16-stranded 
membrane-integral β-barrel (aa 265–577) (Fig. 2.1a). We also separately determined the 
structure of a soluble fragment of TamA consisting of the three POTRA domains and the  
N-terminal strand of the TamA β-barrel at 1.9 Å resolution (Supplementary Table 2.1). 
CHAPTER 2  Autotransporter Translocation by TamA 
43 
 
 
Figure 2.1 TamA structure and interactions of its POTRA domains. 
(a) Structure of TamA in ribbon representation. TamA comprises a C-terminal 16-stranded β-barrel 
(blue) in the outer membrane and the periplasmic N-terminal POTRA domains 1–3 (yellow, orange 
and red). (b) View from the periplasm. (c) Conservation between TamA and BamA, indicated by 
cartoon representation (thin and blue, low conservation; thick and red, high conservation).  
(d) β-augmentation between POTRA2 (orange) and POTRA3 of a symmetry-related molecule (grey). 
(e) Part of the POTRA1–3 crystal structure positioned onto full-length TamA on the basis of the 
observed β-augmentation mode. 
 
The POTRA domains in full-length TamA wind ~50 Å in the periplasmic direction, away 
from their barrel-attachment site, in a C-shaped arrangement (Fig. 2.1b). The three domains 
adopt the same spatial organization in the isolated TamA POTRA1–3 fragment and in full-
length TamA, stabilized by substantial interdomain contacts (Supplementary Fig. 2.2). In 
comparison, the relative orientations of BamA POTRA3–4 and POTRA4–5 in the available 
fragment structures (Gatzeva-Topalova et al. 2010, Kim et al. 2007) reconstitute a similar  
C-shaped arrangement (Supplementary Fig. 2.2), and the corresponding interface regions 
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are conserved between BamA and TamA (Fig. 2.1c). The functional role of Omp85 POTRA 
domains is presumably the initial recognition of substrates mediated by β-strand 
augmentation, both in two-partner secretion and insertion of β-barrel membrane proteins, as 
evidenced biochemically for FhaC (Delattre et al. 2011) and in crystal structures of BamA 
POTRA domains (Kim et al. 2007), respectively. In the crystal structure of the soluble TamA 
fragment, an intermolecular β-strand augmentation is observed between POTRA domains 2 
and 3 (Fig. 2.1d). This interaction mode would position an extended substrate intermediate 
toward POTRA3 and the periplasmic face of the TamA barrel (Fig. 2.1e). These results 
suggest that both BamA and TamA can use similar β-strand-augmentation mechanisms to 
presumably guide unfolded substrate proteins from the periplasmic space toward the barrel. 
All Omp85 proteins feature a C-terminal 16-stranded β-barrel as a central structural 
element. The TamA β-barrel has a pronounced kidney shape with cross-section dimensions 
of 45 Å x 25 Å. At its periplasmic face, it is partly occluded by turns T4 and T5 
(Supplementary Fig. 2.3) opposite the POTRA-domain attachment site; the remaining 
opening has a diameter of 15 Å x 18 Å. The extracellular face is completely closed by a large 
lid formed by the 40-residue loop L6 (aa 456–495), such that a central hydrophilic cavity of 
~23 Å depth is formed (Fig. 2.2a–c). The irregular structure of the lid loop is stabilized by the 
two consecutive conserved proline residues near the lid base, Pro463 and Pro464, and by 
multiple specific polar and hydrophobic interactions between conserved side chains and the 
barrel wall. The contact between the lid tip and the barrel wall is formed by two sequence 
motifs that are highly conserved in the entire Omp85 family (Delattre et al. 2010): Arg477 
from the (I/V)RG(Y/F) motif (residues 476–479) in the L6 lid engages in a salt bridge with 
Asp521 and forms cation-π interactions with Phe519 from the (F/G)xDxG motif (residues 
519–523) in the barrel wall on strand 13. In addition, Glu505 of strand 12, Arg543 of strand 
14 and Asp554 of strand 15 are engaged in a salt-bridge network around the tip of the lid 
(Fig. 2.2c). Intriguingly, the two sequence motifs are not in close contact in the FhaC 
structure, but their direct interaction observed here explains their evolutionary co-
conservation and highlights the resulting ‘lid lock’ as a structural feature of central 
importance. 
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Figure 2.2 The closed lid and the lateral gate of TamA. 
(a) Cross-sectional view. Loop L6 (magenta) acts as a lid at the extracellular face (coloring as in  
Fig. 2.1 but with blue-white-green color gradient from N- to C-terminus for the barrel). (b) Top view of 
TamA. The lid folds into an irregular structure spanning the full barrel diameter. (c) Close-up view of 
the lid lock region. Conserved residues are shown as sticks and highly conserved residues additionally 
with spheres. (d) Side view of the TamA structure. The C-terminus (orange) of TamA kinks into the 
barrel, creating a gate to the lipid phase and a weak interstrand contact between strands 16 and 1.  
(e) Close-up view of the C-terminal segment and part of the TamA barrel. Spheres denote highly 
conserved residues. (f) Structure of TamA in ribbon representation. Additional 2Fo–Fc electron density 
map is shown at 1σ contour level around lipid molecules modeled as 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) fragments (stick representation). 
 
A second highly unusual structural feature is located at the C-terminal strand 16 of the 
TamA barrel. This strand is not fully zipped up to strand 1 but forms an inward kink in the 
vicinity of the conserved lid lock (Fig. 2.2d). The kink is initiated with the highly conserved 
Gly574 and stabilized by a salt bridge between Glu576 and the conserved Arg444 of strand 
11. The conserved Gly406 creates space for accommodating the terminal hydrophobic 
Leu577, and the hydroxyl group of Ser408 contacts the C-terminal carboxylate (Fig. 2.2e). As 
a consequence of the kink, strands 1 and 16 form a particular weak β-strand pair, with only 
three main chain hydrogen bonds between them, and a cleft opens between the periplasmic 
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ends of strands 1 and 15, near the POTRA3–barrel attachment site. In the crystal, electron 
density probably representing a lipid head group is observed in this cleft, thus suggesting 
that the cleft acts as an access gate for TamA substrates to the hydrophobic membrane 
phase (Fig. 2.2f). 
Autotransporter biogenesis comprises two coupled events: insertion of the autotransporter 
β-barrel into the membrane and translocation of the passenger domain into the extracellular 
space (Pavlova et al. 2013). TamA has been implicated in translocation of the passenger 
domains of a subset of bacterial autotransporters (Selkrig et al. 2012). Substrate 
translocation across the outer membrane by Omp85 proteins has been well studied for FhaC 
with its soluble substrate protein FHA. Thereby, FhaC is able to translocate its substrate in 
the absence of any other proteins, thus indicating that the FhaC barrel forms the functional 
pore (Fan et al. 2012), although in the FhaC crystal structure this pore is blocked by the L6 
loop (Clantin et al. 2007). TamA and FhaC share key conserved structural elements in the 
barrel domain, including the (I/V)RG(Y/F) and (F/G)xDxG motifs. They both use L6 for barrel 
closure, although it adopts somewhat different conformations in the two structures. Because 
the passenger domains of autotransporters are structurally similar to FHA, it appears most 
plausible that they are translocated through the central barrel pore of TamA. For 
translocation through FhaC, an opening of the pore is required, and indeed, conformational 
states with differential accessibility of L6 have been observed for FhaC, depending on its 
FHA substrate (Clantin et al. 2007, Guedin et al. 2000). On the basis of the conserved motifs 
in the L6 lid and the lock region, we assume that the TamA pore also opens during transport, 
and this could either be achieved by an opening of L6 itself or by structural changes creating 
a bypass around the lid. 
Based on this model, the linker peptide that connects the passenger domain to the barrel 
domain in autotransporters will end up threaded through the TamA pore at the end of the 
translocation process. However, in the mature autotransporter, this linker segment spans the 
inside of the C-terminal barrel domain of the autotransporter (Pavlova et al. 2013, van den 
Berg 2010). For the resulting topology conflict, which notably also arises in autotransporter 
assembly by BamA, no satisfactory mechanistic solution has been found so far (Bernstein 
2007, Sauri et al. 2012). The weak contact between strands 1 and 16 of TamA, also seen in 
the recently determined structure of the transmembrane domain of BamA (Noinaj et al. 
2013), now opens the possibility for a transient lateral opening of the barrel, which would 
elegantly resolve this conflict. Importantly, the release of the linker from TamA must occur 
before completion of the autotransporter barrel assembly, because a lateral insertion into the 
fully assembled autotransporter barrel is unlikely. At first sight, this transfer could be 
achieved by diffusion of the linker segment through the lipid phase to the nearby barrel-
folding intermediate. A second, intriguing possibility is a mechanism that couples passenger-
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domain translocation and barrel-domain membrane insertion by using a hybrid β-barrel as an 
intermediate step (Fig. 2.3). In this scenario, substrate β-strands would use the gate to 
integrate into the TamA barrel between the loosely connected strands 1 and 16. The 
resulting hybrid barrel would provide a wide pore for passenger-domain translocation and 
would also allow a direct transfer of the linker segment to the autotransporter β-domain. 
Correct folding of the substrate barrel would be coordinated by the strands of TamA, which 
would serve as a structural template. A final fission event would separate the two barrels, 
release the fully assembled substrate laterally into the membrane and return TamA into its 
original state. Importantly, such a hybrid barrel-formation mechanism would not only explain 
Omp85-dependent autotransporter folding but also be compatible with Omp85-dependent 
OMP assembly. It could even, with slight variations, serve as a recognition mode for the 
large β-strand signature domains in Omp85 two-partner secretion-system substrates. The 
pronounced conservation of key structural features in TamA, BamA and FhaC identified here 
makes it tempting to speculate that lateral opening and hybrid-barrel formation could be of 
mechanistic relevance in the entire Omp85 family. 
 
 
Figure 2.3 Proposed mechanism for substrate assembly through hybrid-barrel formation. 
A delivery factor (brown) shuttles an unfolded autotransporter (light pink) to TamA (blue), which is 
closed by the L6 lid (magenta). Initial contact is made at the POTRA domains (yellow, orange and 
red). Subsequently, a hybrid barrel is formed by insertion of substrate β-strands through the gate 
region between strands 1 and 16 of the TamA barrel. Barrel expansion results in pore opening, and 
the passenger domain protrudes through the hybrid barrel. A fission mechanism concludes the 
assembly and releases the autotransporter into the membrane. 
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2.4. Methods 
2.4.1. Plasmid construction 
Full-length E. coli TamA was cloned into a pET22b vector (Novagen) by standard cloning 
methods. Briefly, the pelB signal sequence was removed from the pET22b vector and 
replaced by a malE signal sequence, by use of the oligonucleotides sigseq_down (5’-
ATAGGAATTCCATATGAAAATAAAAACAGGTGCACGCATCCTCGCATTATCCGCATTAAC
GACG-3’) and sigseq_up (5’-GAGCGCATGCCATGGCGAGAGCCGAGGCGGAAAACATC 
ATCGTCGTTAATGCGGATAATGCGAGG-3’) and the restriction enzymes NdeI and NcoI. 
DNA for a hexahistidine tag followed by a cleavage site for TEV protease was produced by 
annealing of the oligonucleotides histev_down (5’-CATGGCCCACCACCACCACCACCACG 
AGAATCTGTATTTCCAGGG-3’) and histev_up (5’-AATTCCCTGGAAATACAGATTCTCGT 
GGTGGTGGTGGTGGTGGGC-3’) and use of the restriction enzymes NcoI and EcoRI for 
insertion into the vector. Genomic tamA DNA from E. coli DH10β lacking the signal 
sequence–encoding nucleotides 1–63 and containing the stop codon was amplified by PCR 
with the oligonucleotides tama_down (5’-GGAATTCAAGCGAACGTCCGTCTACAGGTCG 
-3’) and tama_up (5’-CCGCTCGAGTCATAATTCTGGCCCCAGACCGATG-3’), and the 
restriction enzymes EcoRI and XhoI were used to yield a plasmid for overexpression of full-
length TamA. For the expression of a construct comprising the three POTRA domains of 
TamA and the residues corresponding to the first strand of the β-barrel (aa 22–275), the 
gene fragment was PCR amplified from E. coli K12 and cloned into the expression plasmid 
pET29a through the NdeI and XhoI restriction sites, thus linking the protein to a C-terminal 
hexahistidine tag. 
 
2.4.2. Expression and purification 
Chemically competent E. coli BL21(λ DE3)-omp3 cells were transformed with the TamA 
expression plasmid. After growth of cells in LB medium at 37 °C to an OD600 of 0.8, the 
temperature was decreased to 20 °C. After 2 h, expression of TamA was induced by addition 
of 0.1 mM IPTG. Expression continued overnight before cells were harvested, resuspended 
in 25 mM NaPi, pH 7.5, and 150 mM NaCl and lysed. 
Unbroken cells and cell debris were pelleted for 10 min at 10,000g, and the supernatant 
containing membrane vesicles was centrifuged for 1 h at 100,000g. The membrane pellet 
was resuspended in 25 mM NaPi, pH 7.5, 150 mM NaCl and 3% β-OG. The insoluble 
fraction was pelleted for 1 h at 100,000g and 4 °C, and the supernatant containing solubilized 
TamA was used for all further procedures. Further purification steps were performed at room 
temperature. 
Solubilized TamA including 10 mM imidazole was loaded onto a HisTrap FF column (GE 
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Healthcare), washed with 25 mM NaPi, pH 7.5, 150 mM NaCl, 0.8% β-OG and 10 mM 
imidazole, and eluted with a gradient from 10 mM to 500 mM imidazole. Eluted TamA 
fractions were pooled and diluted 1:3 with 25 mM NaPi, pH 7.0, and 0.8% β-OG before being 
loaded onto a MacroPrep High S (Bio-Rad) column. After the column was washed with 25 
mM NaPi, pH 7.0, 50 mM NaCl and 0.8% β-OG, the protein was eluted with a gradient from 
50 mM to 1 M NaCl in the same buffer. Eluted TamA fractions were pooled. For overnight 
digest at 15 °C with TEV protease, 5 mM β-mercaptoethanol was added to the protein 
solution. Digested protein was subjected again to a HisTrap FF column, and the flow through 
containing cleaved protein without His6-tag or His6-tagged TEV protease was concentrated 
in Amicon Ultra units (Millipore). TamA was gel-filtered on a Superdex 75 column (GE 
Healthcare) in 25 mM NaPi, pH 7.5, 150 mM NaCl and 0.8% β-OG, and eluted TamA 
fractions were analyzed by SDS-PAGE, pooled and concentrated to 12.5–25 mg mL–1. 
Purified TamA was dialyzed overnight at 10 °C in 3.5-kDa-cutoff Slide-A-Lyzer cassettes 
(Pierce) against 80 mL 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.8% β-OG and again for 
5 h against fresh buffer. Finally, the protein concentration was set to 12.5 mg mL–1 with 
dialysis buffer. The sample used for crystallization contained 2% β-OG, as determined by 
NMR spectroscopy. TamA yields were ~0.4 mg purified protein per 1 L culture. 
The construct of the three TamA POTRA domains was overproduced in E. coli  
BL21(λ DE3) pRIL pL1SL2 (Betancor et al. 2008). After growth of cells in Terrific broth 
medium at 37 °C to an OD600 of 1, temperature was decreased to 20 °C, and protein 
expression was induced by the addition 0.1 mM IPTG overnight. After lysis in 50 mM 
HEPES, pH 7.4, 500 mM NaCl and 40 mM imidazole, the lysate was centrifuged and the 
protein in the supernatant purified by metal-chelate affinity (elution with 250 mM imidazole) 
and size-exclusion chromatography in 20 mM HEPES, pH 7.4, 250 mM NaCl, 5% glycerol 
and 5 mM DTT on a Superdex 75 column (GE Healthcare). The protein-containing fractions 
were pooled and concentrated in Amicon Ultra units (Millipore). Yields were ~20 mg purified 
protein per 1 L culture. 
 
2.4.3. Crystallization 
Crystallization of TamA was performed in bicelles composed of DMPC and CHAPSO. The 
bicelle stock solution consisted of 40% (w/w) bicelle mixture in H2O with a molar ratio of 
DMPC to CHAPSO of 2.43:1. TamA was mixed 4:1 with the bicelle stock solution and 
incubated for at least half an hour at 4 °C before crystallization drops were set up with the 
sitting-drop method with a ratio of protein solution to reservoir of 1:2. After incubation at 4 °C 
for 5–10 min, the crystallization plates were transferred to 20 °C. Initial plate-like crystals 
were obtained in 0.1 M imidazole, pH 6, and 0.6 M sodium acetate after one week and used 
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for seed stock preparation. Well-diffracting plate-like crystals were obtained in 0.1 M 
imidazole and 1.2 M sodium acetate with the following seeding approach: appropriately 
concentrated seeds in mother liquor were added in a 1:9 ratio to TamA in bicelles before 
crystallization was set up as described above. Crystals were frozen with perfluoropolyether 
cryo-oil as cryoprotectant. 
The periplasmic domain of TamA was crystallized by vapor diffusion with the sitting-drop 
method at 20 °C. The protein crystallized with several organic acids within a few days. The 
best crystals were grown from 15% PEG 3350, 0.1 M di-Na tartrate and 0.1 M HEPES,  
pH 7.5. The crystals were frozen after a gradual increase (5% steps) of the ethylene glycol 
concentration to 20% (v/v) over 2 h. 
 
2.4.4. Data collection, molecular replacement and refinement 
Diffraction data were collected at the Swiss Light Source on beamline PXIII at 100 K for 
full-length TamA and for the POTRA1–3 fragment and processed with XDS (Kabsch 2010). 
The structure of the POTRA domains was solved by SIRAS phasing with sodium iodide. The 
derivative was prepared by incubation of the crystals for 1 h with 300 mM NaI dissolved in 
harvesting buffer. Iodide sites were localized with SHELXD (Sheldrick 2010). Initial phases 
were calculated with Phaser (McCoy et al. 2007), and the initial model was built in space 
group P43212 by wARP (Langer et al. 2008) with one molecule per asymmetric unit. Model 
building and structure refinement were performed with Coot (Emsley and Cowtan 2004) and 
PHENIX (Adams et al. 2002) at 1.84 Å resolution, yielding Rwork/Rfree of 0.17/0.20. The model 
starts at residue 25, the fourth residue after the native signal sequence, and misses residues 
84–92, which are part of the loop between β-strands 1 and 2 of POTRA1, owing to weak 
electron density. The final model contains 95% of the residues in favored Ramachandran 
regions and 0.4% outliers. 
For full-length TamA, molecular replacement was performed with Phaser in space group 
P21212, with one molecule per asymmetric unit and a solvent content of 74%. TamA POTRA 
domain structure and a polyalanine β-barrel without loops from the FhaC structure (PDB 
entry 2QDZ (Clantin et al. 2007)) were used as search models. Initial model building was 
done automatically by ARP/wARP, and manual rebuilding and ligand modeling were done in 
Coot. Additionally, SAD data with a resolution of 4 Å for selenomethionine-labeled full-length 
protein was collected at a wavelength of 0.9794 Å and processed with XDS. Resulting 
anomalous difference maps confirmed methionine positions. Refinement was carried out with 
PHENIX against native data at 2.25 Å resolution, yielding Rwork/Rfree of 0.19/0.22. The model 
starts at residue 25, the fourth residue after the native signal sequence, and misses residues 
84–92, which are part of the loop between β-strands 1 and 2 of POTRA1. Increased flexibility 
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of POTRA3 and around Gly574-Pro575 in the C-terminal region is indicated by increased 
temperature factors (Supplementary Fig. 2.4). The final model contains 95% of the residues 
in favored Ramachandran regions and 0.18% outliers. 
 
2.4.5. Mapping of conserved regions 
To map evolutionary conservation, 11 orthologous TamA sequences from different 
organisms were selected with pairwise identities between 25% and 33% (NCBI accession 
codes P0ADE4.1, WP_010374432.1, YP_006917734.1, YP_005378779.1, 
WP_006914415.1, WP_006956461.1, WP_007639592.1, YP_006416500, YP_007468392.1, 
WP_008316497.1 and YP_006721763.1). The sequences were aligned with Clustal Omega 
(Goujon et al. 2010, Sievers et al. 2011) and manual adjustments based on known 
secondary structure information. Ten orthologous BamA sequences with pairwise identities 
between 19% and 36% were aligned separately (NCBI codes YP_002998039.1, 
YP_001121414.1, WP_003783125.1, YP_001219350.1, WP_010501263.1, YP_865762.1, 
YP_007459313.1, YP_004865655.1, YP_002549812.1 and WP_008996841.1), and ten 
sequences of FhaC homologs with pairwise identities between 18% and 35% were aligned 
separately (AAB30624.1, YP_335961.1, WP_005764711.1, YP_003741556.1, 
WP_002831157.1, YP_006646915.1, YP_004122309.1, WP_008291755.1, 
WP_005980414.1 and YP_003307097.1). 
The three resulting alignments were aligned as profiles with Clustal Omega and adjusted 
manually. The final alignment was used to create an evolutionary tree (Supplementary  
Fig. 2.1) and as input for AL2CO (Pei and Grishin 2001) to map conservation onto the E. coli 
TamA structure. To obtain a complete model of TamA for visualization of conservation, one 
loop of POTRA1 and the N-terminus of POTRA1 were inserted by modeling. 
 
2.5. Accession codes 
Coordinates and structure factors for full-length TamA and for TamA POTRA1–3 have 
been deposited in the Protein Data Bank under accession codes 4C00 and 4BZA, 
respectively. 
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2.8. Supplement 
 
Supplementary Figure 2.1 Evolutionary tree for 11 TamA, 10 BamA and 10 FhaC orthologues. 
Protein and species names are indicated. 
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Supplementary Figure 2.2 Interfaces between the TamA domains and structural comparison of 
BamA, TamA and FhaC POTRA domains. 
(a) Interface between POTRA1 (yellow) and POTRA2 (orange). (b) Interface between POTRA2 
(orange) and POTRA3 (red). (c) Interface between POTRA3 (red) and the barrel (blue). The 
conserved residues Y75, Y189 and P318 are shown in ball-and-stick representation. Additional 
aromatic residues that are part of the interfaces are indicated. The core of the interfaces is dominated 
by hydrophobic interactions, surrounded by polar interactions at the surface. (d) Model of BamA 
POTRA domains 3 to 5 (POTRA3: yellow, POTRA4: orange, POTRA5: red) by combining the 
structure of POTRA domains 4 and 5 (PDB entry 3Q6B (Zhang et al. 2011); similar conformation as in 
PDB entry 3OG5 (Gatzeva-Topalova et al. 2010)) with the structure of POTRA domains 3 and 4 (PDB 
entry 2QDF (Kim et al. 2007); similar conformation as in PDB entry 2QCZ (Kim et al. 2007) and PDB 
entry 3EFC (Gatzeva-Topalova et al. 2008)). The POTRA domains in this combined model adopt a  
C-shape. (e) Structure of TamA determined in this work. The POTRA domains of TamA (POTRA1: 
yellow, POTRA2: orange, POTRA3: red) are arranged in C-shape around the axis of the barrel (color 
gradient: blue – white – green from N- to C-terminus). The TamA barrel adopts a kidney shape.  
(f) Structure of FhaC (PDB entry 2QDZ (Clantin et al. 2007)). The orientation of POTRA1 (orange) of 
FhaC deviates significantly from the orientation of the corresponding POTRA2 of TamA. The FhaC 
barrel adopts a triangular shape. 
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Supplementary Figure 2.3 2D representation of the TamA barrel topology as viewed from the barrel 
exterior. 
Residues forming β-strands are indicated by rectangles, residues of loops and turns by circles. The 
side chains of orange residues point towards the membrane. The extracellular loops are numbered L1 
to L8 from N- to C-terminus, the periplasmic turns are numbered T1 to T7. Interstrand backbone 
hydrogen bond pairs are indicated by red lines between the corresponding residues, single hydrogen 
bonds by red dotted lines. Strand 1 is repeated on the left hand side to show the hydrogen bonds that 
form to strand 16. The conserved motifs (I/V)RG(Y/F) (residues 476–479) and (F/G)xDxG (residues 
519–523) are highlighted green. 
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Supplementary Figure 2.4 Crystallographic temperature factor distribution. 
The value of the temperature factors on a 1–200 Å2 scale is indicated by putty cartoon representation 
(low values thin, high values thick) and color gradient (low values in blue via white to high values in 
red). (a) B-factor distribution in the full-length TamA structure and (b) in the structure of the isolated 
POTRA domains fragment comprising the region corresponding to the first β-strand of the TamA-
barrel in a non-β-strand conformation. 
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Supplementary Table 2.1 Data collection and refinement statistics. 
 
*Values in parentheses are for highest-resolution shell. 
 TamA full-length TamA POTRA1–3 
Data collection   
Space group P 21 21 2 P 43 21 2 
Cell dimensions     
a, b, c (Å) 77.47, 261.06, 57.84 83.05, 83.05, 150.66 
α, β, γ (°) 90, 90, 90 90, 90, 90 
Resolution (Å) 74.27 – 2.25 (2.33 – 
2.25) * 
42.97 – 1.84 (1.95 – 
1.84) 
Rmerge 0.071 (0.854) 0.047 (1.731) 
I / σI 20.74 (2.39) 31.35 (1.99) 
Completeness (%) 98.4 (94.3) 99.8 (99.1) 
Redundancy 7.3 (7.0) 13.0 (12.5) 
Refinement   
Resolution (Å) 74.27 – 2.25 42.97 – 1.84 
No. reflections 55995 46484 
Rwork / Rfree 0.190 / 0.217 0.173 / 0.202 
No. atoms 5043 2287 
Protein 4389 1989 
Ligand/ion 428 8 
Water 226 290 
B-factors   
Protein 76.77 71.25 
Ligand/ion 90.10 80.85 
Water 56.38 61.84 
R.m.s. deviations   
Bond lengths (Å) 0.003 0.018 
Bond angles (°) 0.96 1.46 
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3.1. Abstract 
TamA is an Omp85 protein involved in autotransporter assembly in the outer membrane 
of Escherichia coli. It comprises a C-terminal 16-stranded transmembrane β-barrel as well as 
three periplasmic POTRA domains, and is a challenging target for structure determination. 
Here, we present a method for crystal structure determination of TamA, including 
recombinant expression in E. coli, detergent extraction, chromatographic purification, and 
bicelle crystallization in combination with seeding. As a result, crystals in space group P21212 
are obtained, which diffract to 2.3 Å resolution. This protocol also serves as a template for 
structure determination of other outer membrane proteins, in particular of the Omp85 family. 
 
3.2. Introduction 
The insertase proteins of the Omp85 family are responsible for the assembly of β-barrel 
proteins in the outer membrane of Gram-negative bacteria, mitochondria, and chloroplasts 
(Chacinska et al. 2009, Kim et al. 2007, Walther et al. 2009). Omp85 insertases comprise a 
16-stranded C-terminal transmembrane β-barrel and between one and five attached 
periplasmic POTRA domains (Clantin et al. 2007, Gruss et al. 2013, Noinaj et al. 2013), 
which are involved in initial substrate interaction via β-strand augmentation (Delattre et al. 
2011). The β-barrel domain is characterized by an unusually weak lateral connection 
between the N-terminal and C-terminal strand. The latter strand is not fully zipped up but 
kinks to the inside of the barrel, thus creating a gate to the lipid phase of the membrane 
(Gruss et al. 2013, Noinaj et al. 2013). 
TamA and BamA are the only Omp85 proteins in E. coli K12. BamA is the core subunit of 
the general β-barrel assembly machinery (BAM) (Kim et al. 2007). TamA is more specialized 
and involved in the biogenesis of a subset of autotransporters (Selkrig et al. 2012, Stegmeier 
et al. 2007), which typically consist of a 12-stranded membrane-embedded β-barrel linked to 
a large extracellular passenger domain (Dautin and Bernstein 2007, van den Berg 2010). 
For structure determination, TamA is recombinantly expressed into the outer membrane of 
its native host E. coli, using a pET vector that provides an N-terminal malE signal sequence 
for periplasmic targeting, followed by a hexahistidine purification (Hs6-) tag and a TEV 
protease cleavage site preceding the insertion site for the coding sequence of mature TamA 
without its native export signal sequence. TamA is overexpressed in a partially OMP-
deficient E. coli strain and extracted from membrane pellets using the mild detergent  
β-octylglucoside (β-OG). Immobilized metal affinity chromatography (IMAC) via the His6-tag 
is employed for initial purification, followed by cation-exchange chromatography (CIEX) for 
buffer exchange for subsequent TEV cleavage of the His6-tag. A second IMAC step removes 
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TEV protease and uncleaved TamA. Finally, the cleaved protein is subjected to size-
exclusion chromatography (SEC), yielding monodisperse monomeric TamA of high purity as 
determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). After buffer exchange 
and detergent concentration equilibration via dialysis, the protein is integrated into bicelles by 
mixing it with an aqueous solution of preformed DMPC/CHAPSO bicelles. The mixture is 
used directly for crystallization screening and optimization. Crystals diffracting to high 
resolution are obtained by adding seeds prepared from lower quality crystals grown in similar 
conditions to the protein-bicelle mixture prior to crystallization setup. This seeding strategy is 
generally applicable to bicelle crystallization of other membrane proteins. 
 
3.3. Materials 
3.3.1. Plasmid construction 
1. Vector: pET22b (Novagen). 
2. Cloning strain and genomic DNA source: E. coli DH10B. 
3. Oligonucleotides: 
sigseq_down: 5′-ATAGGAATTCCATATGAAAATAAAAACAGGTGCACGCATCCTCGCAT 
TATCCGCATTAACGACG-3′ 
sigseq_up: 5′-GAGCGCATGCCATGGCGAGAGCCGAGGCGGAAAACATCATCGTCGTT 
AATGCGGATAATGCGAGG-3′ 
histev_down: 5′-CATGGCCCACCACCACCACCACCACGAGAATCTGTATTTCCAGGG-3′ 
histev_up: 5′-AATTCCCTGGAAATACAGATTCTCGTGGTGGTGGTGGTGGTGGGC-3′ 
tama_down: 5′-GGAATTCAAGCGAACGTCCGTCTACAGGTCG-3′ 
tama_up: 5′-CCGCTCGAGTCATAATTCTGGCCCCAGACCGATG-3′ 
4. DNA polymerase for PCR amplification. 
5. Restriction endonucleases: NdeI, NcoI, EcoRI, XhoI (New England BioLabs). 
6. Ligation enzyme: T4 DNA ligase (New England BioLabs). 
 
3.3.2. Expression 
1. Expression strain: E. coli BL21(λ DE3)omp3 (Prilipov et al. 1998). 
2. LB medium (400 mL) for pre-cultures. 
3. LB medium (18 L) for main cultures. 
4. Flasks (4 x 500 mL) for pre-cultures. 
5. Baffled flasks (12 x 5 L) for main cultures. 
6. Ampicillin. 
7. Isopropyl β-d-thiogalactopyranoside (IPTG). 
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3.3.3. Purification 
1. Stock solutions for buffer preparations: 
(a) 500 mM Na2HPO4. 
(b) 500 mM NaH2PO4. 
(c) 5 M NaCl. 
2. Lysis buffer (500 mL): 25 mM NaPi, pH 7.5 (86.6% Na2HPO4, 13.4% NaH2PO4), 150 mM 
NaCl (see Note 1). 
3. High-pressure homogenizer (e.g., Microfluidizer by Microfluidics). 
4. Extraction buffer (250 mL): 25 mM NaPi, pH 7.5, 150 mM NaCl, 3% β-OG (n-octyl-β-d-
glucopyranoside, >99% chemical purity and >98% β-anomer purity, Anatrace) (see  
Note 1). 
5. High-performance liquid chromatography system (e.g., Äkta by GE Healthcare, NGC by 
Bio-Rad). 
6. HisTrap FF column (5 mL) (GE Healthcare). 
7. Immobilized metal affinity chromatography (IMAC) buffers (see Note 1): 
(a) A (250 mL): 25 mM NaPi, pH 7.5, 150 mM NaCl, 0.8% β-OG. 
(b) B (150 mL): 25 mM NaPi, pH 7.5, 150 mM NaCl, 0.8% β-OG, 500 mM imidazole. 
8. CIEX (cation exchange) column: 6 mL column with MacroPrep High S resin (Bio-Rad). 
9. CIEX buffers (see Note 1): 
(a) Dilution buffer (150 mL): 25 mM NaPi, pH 6.9 (53.3% Na2HPO4, 46.7% NaH2PO4), 
0.8% β-OG. 
(b) A (300 mL): 25 mM NaPi, pH 7.0, 50 mM NaCl, 0.8% β-OG. 
(c) B (200 mL): 25 mM NaPi, pH 7.0, 1 M NaCl, 0.8% β-OG. 
10. TEV protease (His6-tagged) (Addgene plasmid 8827 (Kapust et al. 2001)). 
11. β-Mercaptoethanol. 
12. Syringe filters (0.45 µm) (PTFE based for particle removal). 
13. Superdex 75 16/60 column (GE Healthcare). 
14. Size-exclusion chromatography (SEC) buffer (400 mL) (see Note 1): 25 mM NaPi,  
pH 7.5, 150 mM NaCl, 0.8% β-OG. 
15. Concentrator: Amicon Ultra unit 30 kDa c/o (Millipore). 
16. Slide-A-Lyzer cassette, 3.5 kDa c/o (Pierce). 
17. Dialysis buffer (200 mL): 20 mM Tris–HCl, pH 7.5 (adjusted at 10 °C), 150 mM NaCl, 
0.8% β-OG. 
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3.3.4. Crystallization 
1. 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC, Anatrace). 
2. 3-[(3-Cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO, Ana-
trace). 
3. Vortex mixer. 
4. Crystallization screens: MembFac (Hampton Research), MemGold (Molecular Dimens-
ions), MemStart & MemSys (Molecular Dimensions). 
5. Crystallization solutions: Initial crystals: 0.1 M imidazole pH 6, 0.6 M Na-acetate; crystals 
with seeding: 0.1 M imidazole pH 6, 1.2 M Na-acetate. 
6. Crystallization plates: MRC 2 Well (Swissci, Hampton Research). 
7. Crystallization robot (e.g., OryxNano by Douglas Instruments, optional but recommended). 
8. Cryoprotectant: Perfluoropolyether oil (dried, Hampton Research). 
 
3.3.5. Data processing and model building software 
1. XDS (Kabsch 2010). 
2. CCP4 (Winn et al. 2011). 
3. PHENIX (Adams et al. 2010). 
4. COOT (Emsley and Cowtan 2004). 
 
3.4. Methods 
3.4.1. Plasmid construction 
1. Anneal the oligonucleotides sigseq_down and sigseq_up to obtain the malE signal 
sequence DNA. 
2. Digest individually the malE signal sequence DNA and the pET22b vector using NdeI and 
NcoI restriction enzymes to remove the pelB signal sequence from the vector and purify 
digested DNA via agarose gel electrophoresis (see Note 2). 
3. Ligate the purified DNA into the pET22b vector using T4 DNA ligase. 
4. Transform the ligation product into electrocompetent E. coli DH10B, and plate out and 
select positive colonies for plasmid purification to obtain the pET22b-malEss vector  
(Fig. 3.1a). 
5. Repeat steps 1–4 using the oligonucleotides histev_down and histev_up, the pET22b-
malEss vector obtained from step 4 and NcoI and EcoRI restriction enzymes to obtain the 
pET22b-malEss-his6-tev vector containing the malE signal sequence followed by a His6-
tag and a cleavage site for TEV protease (Fig. 3.1b). 
6. Amplify genomic tamA DNA without the tamA signal sequence from an E. coli K12 strain 
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(e.g., DH10β) using oligonucleotides tama_down and tama_up and purify the PCR 
product via agarose gel electrophoresis. 
7. Repeat steps 2–4 using the tamA PCR product from step 6, the pET22b-malEss-his6-tev 
vector obtained from step 5, and EcoRI and XhoI restriction enzymes to obtain the final 
TamA expression vector containing the malE signal sequence followed by a His6-tag and 
a cleavage site for TEV protease followed by tamA (Fig. 3.1c). 
 
 
Figure 3.1 Cloning strategy for the TamA expression vector. 
(a) In the first step, the pelB signal sequence of the pET22b vector is replaced by the malE signal 
sequence. (b) In the second step, DNA coding for a His6-tag followed by a cleavage site for TEV 
protease is put 3′ of the signal sequence. (c) Last, the tamA DNA without its own signal sequence is 
inserted 3′ of the TEV site. 
 
CHAPTER 3  Purification and Crystallization of TamA 
65 
 
3.4.2. Expression 
1. Transform chemically competent E. coli BL21(λ DE3)omp3 cells (Prilipov et al. 1998) with 
the TamA expression vector obtained from Subheading 3.4.1. Inoculate 4 x 100 mL LB 
medium containing 100 mg L-1 ampicillin with the transformed cells and grow overnight by 
shaking at 37 °C. 
2. Inoculate 12 x 1.5 L LB medium in baffled 5 L flasks containing 100 mg L-1 ampicillin with 
the overnight cultures from step 1 to an OD600 (optical density at 600 nm) of around 0.06 
and grow by shaking at 100 rpm and 37 °C. 
3. When the cultures reach OD600 = 0.8 set temperature to 20 °C and continue shaking the 
cells for 2 h before inducing protein expression by addition of IPTG to a final concentration 
of 0.1 mM. 
4. Continue shaking at 20 °C for 18 h before harvesting. The obtained bacterial pellet is used 
directly or stored at −80 °C (see Note 3). 
 
3.4.3. Purification 
1. Resuspend the bacterial pellet obtained from Subheading 3.4.2 in 450 mL lysis buffer and 
lyse the cells by processing the suspension twice with the microfluidizer (see Note 4). 
Centrifuge for 10 min at 10,000g and 4 °C to remove inclusion bodies and cell debris. 
Centrifuge the supernatant containing soluble protein and membrane vesicles for 1 h at 
100,000g and 4 °C to pellet membrane vesicles containing TamA. Remove the 
supernatant, and gently wash the pellet three times using lysis buffer. 
2. Add 250 mL extraction buffer to the membrane pellet and stir overnight at 10 °C to extract 
TamA. Centrifuge the resuspended membranes for 1 h at 100,000g and 10 °C to pellet 
the detergent-insoluble components. Harvest the supernatant containing solubilized 
TamA. 
All the following steps should be performed at temperatures between 10 and 15 °C, 
because the detergent-solubilized protein solution tends to precipitate reversibly at low 
temperatures. Chromatographic purification steps are carried out at room temperature 
(see Note 5). 
3. Add 4% v/v IMAC buffer B to the protein solution to adjust the imidazole concentration to 
approx. 20 mM. Load this solution onto a 5 mL or larger HisTrap FF column equilibrated 
with IMAC buffer A (see Note 6). Wash the column with a mixture of 96% IMAC buffer A / 
4% IMAC buffer B until the A280 reaches a stable baseline (typically 5–6 column volumes) 
and collect the flow-through. Elute the bound protein with a linear gradient from 4 to 100% 
IMAC buffer B in 5 column volumes. When using a 5 mL column, repeat this step from 
column loading to elution using the flow-through of the first loading step to increase the 
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yield by capturing remaining unbound protein. 
4. Pool the fractions of the elution peak (resp. peaks if using a 5 mL HisTrap FF column) to 
obtain about 30–40 mL total volume of elution fractions containing TamA. Slowly add 
three times the volume of dilution buffer to adjust ionic strength for CIEX (cation 
exchange). 
5. Load the protein solution onto a 6 mL MacroPrep High S column, equilibrated with CIEX 
buffer A. Wash the column with CIEX buffer A until the A280 reaches a stable baseline. 
Elute the protein with a linear gradient from 0 to 100% CIEX buffer B in 100 mL volume. 
Pool peak fractions to obtain a total volume of 30–50 mL (Fig. 3.2a). 
6. Add 5 mM β-mercaptoethanol to the solution before adding about 1 mg of His6-tagged 
TEV protease. Digest the protein overnight. The digested protein solution may appear 
slightly cloudy due to precipitation. Centrifuge or filtrate to remove the precipitate. 
7. Load the solution onto a HisTrap FF 5 mL column, equilibrated with IMAC buffer A without 
imidazole. Collect the flow-through containing cleaved TamA and concentrate it with  
30 kDa c/o centrifugal concentrator units to a volume of 1 mL. At this step, TamA should 
be essentially pure (Fig. 3.2b). 
8. Load the protein onto a Superdex 75 16/60 column, equilibrated with SEC buffer, collect 
the peak fractions to obtain about 10 mL total volume, and concentrate it with 30 kDa c/o 
centrifugal units to a concentration of 15–20 mg mL-1 and about 0.5 mL volume (Fig. 3.3). 
9. Dialyze the protein solution overnight against 80 mL dialysis buffer in a 3.5 kDa c/o Slide-
A-Lyzer cassette. Dialyze it again against 80 mL fresh dialysis buffer for 5 h. Adjust the 
protein concentration to 12.5 mg mL-1 by adding the appropriate volume of dialysis buffer 
to obtain the final protein sample for crystallization. Typical yields of purified TamA are in 
the range of 5–10 mg from an 18 L LB culture. 
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Figure 3.2 CIEX chromatogram and SDS-PAGE analysis of TamA purification. 
(a) Chromatogram of CIEX chromatography. Blue curve: absorbance at 280 nm; green curve: buffer B 
concentration; brown curve: conductivity; the red line indicates pooled fractions. (b) SDS-PAGE 
analysis of TamA expression and purification. Lane M shows a molecular weight standard and 
molecular weights in kDa for the bands are indicated on the left-hand side. Lane 1: E. coli expression 
cells before induction with IPTG; lane 2: E. coli expression cells after induction and growth overnight; 
lane 3: membrane pellet containing TamA suspended with extraction buffer; lane 4: supernatant after 
ultracentrifugation of the suspension; lane 5: first load onto HisTrap FF 5 mL column, flow-through; 
lane 6: pooled peak fractions of first HisTrap elution; lane 7: second load onto HisTrap FF 5 mL 
column, flow-through; lane 8: pooled peak fractions of second HisTrap elution; lane 9: Macroprep High 
S column load; lane 10: Macroprep High S flowthrough; lane 11: MacroPrep High S pooled peak 
fractions; lane 12: TamA after TEV digest; lane 13: flow-through of HisTrap FF 5 mL column after TEV 
digest, containing TamA without His6-tag; lane 14: elution from the HisTrap FF 5 mL column with  
500 mM imidazole, containing TamA with non-cleaved His6-tag and His6-tagged TEV protease. 
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Figure 3.3 Size-exclusion chromatogram and SDS-PAGE analysis of peak fractions. 
Blue curve: absorbance at 280 nm; red lines indicate pooled fractions. Lane M shows a molecular 
weight standard and molecular weights in kDa for the bands are indicated on the left-hand side.  
Lanes 1–5: SEC fractions 1–5. 
 
3.4.4. Crystallization 
1. To prepare 500 µL 40% w/w bicelle stock solution composed of DMPC and CHAPSO in a 
molar ratio of 2.43:1, weigh out 144.6 mg DMPC in a 1.5 mL vial, and add 55.4 mg 
CHAPSO on top. Cover it with 300 µL H2O. Mount the 1.5 mL vial on a vortex mixer and 
vortex overnight at 4 °C to dissolve the bicelle mixture. If it has not dissolved completely, 
apply a few cycles of heating to 50 °C, cooling on ice, vortexing, and freezing (Ujwal and 
Bowie 2011) until the solution is homogenous and clear. You can store the bicelle solution 
at −20 °C or keep it at 4 °C for immediate use. 
2. To prepare a solution of TamA in 8% bicelles (see Note 7), add one-fourth the volume 
bicelle stock solution to TamA solution (e.g., add 50 µl bicelle stock to 200 µl TamA), mix 
by pipetting up and down, and incubate for at least 30 min at 4 °C. Do not store this 
solution on ice as a phase transition may occur resulting in a cloudy inhomogeneous 
sample (see Note 8). 
3. Setting up crystallization plates must be performed at 4 °C either using a robot (e.g. 
OryxNano) or manually. Pipette the crystallization solution on top of the protein-bicelle 
mixture or add both at the same time when using an OryxNano robot. After pipetting, 
immediately seal the crystallization plates and keep at 4 °C for 10 min before shifting to  
20 °C. Initial crystallization trials may be set up using the sitting-drop vapor diffusion 
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method with commercial membrane protein crystallization screens (e.g., MembFac, 
MemStart & MemSys, MemGold). Initial plate-like crystals for seeding can be obtained in 
0.1 M imidazole pH 6 and 0.6 M sodium acetate with a ratio of protein to reservoir solution 
in the drop of 1:2 after about 1 week. 
4. Seed preparation: Prepare a solution resembling the mother liquor of the crystals: Mix 
dialysis buffer in a 4:1 ratio with bicelle stock solution and mix the resulting solution in a 
1:2 ratio with 0.1 M imidazole pH 6 and 0.6 M sodium acetate. Transfer crystals into a 1.5 
mL vial containing 50–100 µL mother liquor solution using a loop or a pipette. Pipette up 
and down to crush crystals. Finally, vortex for 1 min. Prepare a dilution of the seed stock 
of 1:10 by mixing part of the seed solution 1:9 with mother liquor solution. Repeat to 
obtain a dilution series of 1:1, 1:10, 1:100, 1:1000, 1:10,000, and 1:100,000 (see Note 9). 
5. To grow high-quality crystals, prepare TamA-bicelle solutions of different protein 
concentrations (e.g., 5–10 mg mL-1 in 1 mg mL-1 steps) by diluting the TamA solution with 
dialysis buffer before mixing with bicelle stock solution. Split each TamA-bicelle mixture 
into 6 parts and add one-ninth the volume of each of the seed stocks (e.g., add 1 µl 
1:1000 seed stock to 9 µl TamA in bicelles with a protein concentration of 6 mg mL-1). Set 
up a 2D-grid screen of protein concentration versus seed dilution using 0.1 M imidazole 
pH 6 and 1.2 M sodium acetate as reservoir solution and set up drops as before, mixing 
the TamA-bicelle / seed solutions in a 1:2 ratio with reservoir solution. The seed stocks 
can be frozen in liquid nitrogen and stored at −80 °C to later reproduce conditions 
producing optimal crystals (see Note 9) (Fig. 3.4). 
6. To freeze crystals, cover the respective drop with perfluoropolyether oil for cryo-protection 
before fishing crystals with a loop, moving them through the oil layer and immediately 
vitrifying them in liquid nitrogen. 
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Figure 3.4 TamA bicelle crystallization with seeding. 
(a) Crystals grown using TamA in a concentration of 7 mg mL-1 and a 1:1000 diluted seed stock, which 
diffracted to a resolution of 2.25 Å. (b) Lower quality crystals grown using TamA in a concentration of 
8 mg mL-1 and a 1:100 diluted seed stock. 
 
3.4.5. Data processing and model building 
1. Diffraction data can be processed using standard programs, e.g., XDS (Kabsch 2010). 
The space group should be P21212 with unit cell axis dimensions of a = 77.5 Å, b =  
261.1 Å, c = 57.8 Å, and α = β = γ = 90°. 
2. Initially, phases could be solved by molecular replacement with the CCP4 program Phaser 
(McCoy et al. 2007, Winn et al. 2011) using the separately solved structure of the POTRA 
domains of TamA (PDB entry 4BZA (Gruss et al. 2013)) and the barrel of FhaC (PDB 
entry 2QDZ (Clantin et al. 2007)). 
3. Model building and refinement can be done using the programs COOT (Emsley and 
Cowtan 2004) and PHENIX (Adams et al. 2010), respectively. The TamA crystal structure 
is provided under the PDB entry 4C00 (Gruss et al. 2013). 
 
3.5. Notes 
1. The pH of NaPi buffers can be adjusted at room temperature by mixing Na2HPO4 and 
NaH2PO4 stock solutions in appropriate ratios to obtain near-final values and fine-tuning 
by addition of HCl or NaOH to the buffer solutions containing all ingredients. 
2. It is possible that the pelB signal in the pET22b vector can also be used for expression 
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and does not need to be replaced by the malE signal sequence. 
3. After induction of expression and overnight growth, the bacterial pellet appears partially 
lysed, which has no detectable effect on protein quality. 
4. French pressure cell and sonication may be suitable alternative lysis methods. 
5. When keeping TamA below 4 °C it may aggregate. This aggregation is reversible upon 
shifting to 4 °C again. 
6. The choice of the IMAC resin material may affect yield and purity. 
7. The β-OG concentration of final TamA samples before mixing with bicelles is measured by 
NMR spectroscopy and may be adjusted to 2.0%. 
8. It is recommended to keep the TamA-bicelle mixture at 4 °C. Neither put it on ice nor warm 
it up as phase transitions occur, which may affect sample quality. Phase transitions are 
usually reversible but for a warmed-up sample it may take hours or even days until the 
solution turns clear again at 4 °C. 
9. Seed dilution series and crystal growth testing have to be repeated each time a new seed 
stock is prepared as the concentration of seeds differs between preparations. For these 
2D-grid screens manual setup may be necessary as different protein solutions are used. 
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4.1. Abstract 
TamB is a large protein of 140 kDa, forming the TAM complex together with the outer 
membrane protein TamA, which is involved in autotransporter assembly. TamB presumably 
contains an N-terminal transmembrane α-helix inserted in the inner membrane, while the 
remaining β-sheet-rich structure is located in the periplasm. Here, we characterize the 
interaction of TamB and TamA theoretically and experimentally. The existence of interaction 
between TamB and the POTRA domains of TamA is demonstrated by analytical size 
exclusion chromatography (SEC) as well as isothermal titration calorimetry (ITC) and the 
binding sites are mapped using computational co-evolution analysis. In addition, co-evolution 
hints to a second binding site of TamB at the TamA barrel. These data provide exciting new 
insights into the TAM architecture. 
 
4.2. Introduction 
Many Gram-negative bacteria possess an operon encoding for the proteins TamA and 
TamB, which together form the TAM complex (Heinz and Lithgow 2014, Selkrig et al. 2012, 
Stegmeier et al. 2007). This complex was shown to be involved in the assembly of a subset 
of autotransporter proteins (Selkrig et al. 2012), which often mediate bacterial virulence (van 
Ulsen et al. 2014). Whereas the 65 kDa Omp85 protein TamA consists of an outer 
membrane embedded β-barrel and three N-terminal periplasmic POTRA domains (Gruss et 
al. 2013), the 140 kDa TamB is presumably tethered to the inner membrane via an  
N-terminal α-helix. The rest of TamB is located to the periplasm (Selkrig et al. 2015, Selkrig 
et al. 2012, Shen et al. 2014). A C-terminal region of TamB interacts with the TamA POTRA 
domains and therefore the TAM complex is assumed to span the whole periplasm from inner 
to outer membrane (Selkrig et al. 2015, Shen et al. 2014). 
Crystal structure determinations of TamA (Gruss et al. 2013) and the general OMP 
insertase BamA (Noinaj et al. 2013) revealed insights into the OMP assembly mechanism: 
Presumably, unfolded substrate OMP substrates integrate their β-barrel into the Omp85 
barrel between the loosely connected terminal strands 1 and 16 (Estrada Mallarino et al. 
2015, Gruss et al. 2013, Noinaj et al. 2014). Necessity of opening between these two strands 
was demonstrated by crosslinking experiments in vivo (Noinaj et al. 2014). 
The structure of TamB is unknown, but predicted to be rich in β-strands (Heinz et al. 
2015). Noteworthy, the very C-terminus of TamB resembles the β-signal found in the last 
transmembrane strand of OMPs, which is crucial for their assembly (Struyvé et al. 1991). 
The functional involvement of TamB, however, has largely remained elusive. It was 
demonstrated that TamA and TamB knock out mutants show similar phenotypes in E. coli, 
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including growth defects, decreased cell adhesion, and accumulation of autotransporter 
proteins in the periplasm (Selkrig et al. 2012). In addition, the presence of TamB reduces 
autotransporter assembly in vitro (Shen et al. 2014), together suggesting an essential 
regulatory role for TamB. 
 
4.3. Results 
4.3.1. Analytical size exclusion chromatography 
To confirm previously published results demonstrating binding of TamB to TamA and 
TamA POTRA domains only (Selkrig et al. 2015, Selkrig et al. 2012, Shen et al. 2014), 
separately purified TamB and TamA POTRA domains 1–3 were incubated and subjected to 
SEC. Three runs were performed, each with a total sample volume of about 85 µl. The first 
sample contained only TamB at a concentration of 32 µM, the second sample only TamA 
POTRA domains at a concentration of 159 µM and the last sample TamB and TamA POTRA 
domains mixed at the same concentrations as in the individual runs, leaving the POTRA 
domains in about fivefold molar excess over TamB. 
Whereas the A280 profiles of the SEC runs in presence of 0.05% DDM do not allow 
unambiguous conclusions about protein co-migration, SDS-PAGE analysis of the eluted 
fractions demonstrates a clear co-migration of TamA POTRA domains with TamB. From an 
inspection of the band sizes and intensities, a 1:1 molar ratio in the co-migrating fractions 
seems plausible (Fig. 4.1). 
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Figure 4.1 SEC runs of TamB and TamA POTRA domains. 
A280 profiles for the Superose 12 10/300 GL SEC runs and SDS-PAGE analysis of the respective 
column load (L) and individual fractions (1–13, as indicated) is shown for (a) 32 µM TamB, (b) 159 µM 
TamA POTRA domains, and (c) 32 µM TamB + 159 µM TamA POTRA domains. M = molecular 
weight marker. The position of void volume peaks is indicated by an arrow. 
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4.3.2. Isothermal titration calorimetry 
The binding interaction between TamB and TamA POTRA domains was further 
characterized by ITC. Purified TamB, TamA POTRA domains 1–3 and POTRA domain 1 
samples (Fig. 4.2) had the same buffer composition for the ITC measurements. The DDM 
detergent concentration was 0.05% in the POTRA domains samples and 0.1% in the TamB 
and control samples, as determined by refractive index measurements. TamB was used at a 
concentration of 5 µM and POTRA domains at concentrations of 35 or 50 µM for ITC 
experiments (Fig. 4.3). 
 
 
Figure 4.2 SDS-PAGE analysis of purified proteins used for ITC. 
Each SDS-PAGE includes a molecular weight marker and shows purified protein for (a) TamB in DDM 
micelles, (b) TamA POTRA domains 1–3, and (c) TamA POTRA domain 1 after final SEC purification. 
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Figure 4.3 ITC measurements of TamB and TamA POTRA domain constructs. 
Raw data and processed data with fitted curves are shown for (a) TamA POTRA1–3 at 50 µM titrated 
to TamB, (b) TamA POTRA1–3 at 35 µM titrated to TamB, (c) TamA POTRA1 at 50 µM titrated to 
TamB, and (d) TamA POTRA1–3 at 50 µM titrated to buffer. The buffer in TamA POTRA samples 
contained 0.05% DDM, in TamB samples and the control 0.1% DDM.  
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TamB binding can be observed only for TamA POTRA domains 1–3. For data analysis, 
curve fitting with a two-sets-of-sites model in the Origin 7 software (OriginLab, Northamton, 
MA, USA) was applied. The calculated values for enthalpy (ΔH), number of binding sites (N), 
dissociation constant (KD) and entropy change (ΔS) for both measurements of TamB in 
combination with TamA POTRA domains 1–3 are listed in Table 4.1. In both experiments the 
determined KD values are of similar magnitude in the pM or nM range for the first and second 
transitions, respectively, but have high errors. This uncertainty is plausibly based on the two 
transitions being not well separated, which leads to a missing baseline between them, as 
well as a missing baseline before the first transition and too few data points in the second 
transition. As a consequence of the large difference between the concentration of TamB in 
the cell and the determined KD values for the single transitions, the calculated C-values, 
which are a measure of the steepness of the sigmoidal curves, are in the unwanted range of 
> 500 (Turnbull and Daranas 2003). The data clearly show that there are two binding 
transitions. However, the derived numerical thermodynamic data are highly dependent on the 
choice of data model. Besides the two-sets-of-sites model also more complex models, e.g. 
involving cooperativity, may be possible for the TamB – TamA POTRAs binding, but the 
correct model cannot be inferred from the ITC data. 
 
Table 4.1 ITC measurements of TamB and TamA POTRA domains 1–3. 
c(TamB) (µM) 5 5 
c(POTRAs) (µM) 50 35 
 1st transition 2nd transition 1st transition 2nd transition 
ΔH (kcal mol-1) -13.4 ± 0.5 -9.2 ± 0.3 -13.4 ± 0.6 -9.6 ± 0.3 
ΔS (cal mol-1 deg-1)* -0.3 7.2 -2.6 4.9 
N (sites)* 0.28 ± 0.02 0.58 ± 0.02 0.22 ±0.02 0.42 ± 0.02 
KD (nM)* 0.06 ± 0.05 1.5 ± 1.4 0.18 ± 0.11 3.2 ± 1.2 
C-value* 
(:= c(TamB) x KD-1 x N) 
2.4 x 105 1.9 x 104 4.3 x 104 5 x 103 
*These data are approximations for a two-sets-of-sites model. 
 
4.3.3. Co-evolution analysis 
To investigate possible binding sites of TamA and TamB from a bioinformatics approach, 
co-evolution analysis using the Gremlin server was performed. Sufficiently many TamA – 
TamB DUF490 sequence pairs could be obtained to allow for the analysis of intermolecular 
co-evolution. Remarkably, four amino acid pairs with the highest interaction probabilities 
cluster in the sequence and are found in distinct regions of the two proteins: Residues 
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D1252, L1253, E1258 and F1259 from the very C-terminus of TamB form pair with residues 
R281, V272, T267 and I268, respectively, located at the N-terminus of the TamA barrel. 
Three of the TamA residues belong to strand 1 and one residue to strand 2. Additionally, two 
pairs of lower probability, yet still ranking 9th and 11th, D1248–S275 and A1250–S275 are 
found in the cluster as well, involving one additional residue from TamA barrel strand 1 
(Table 4.2, “Cluster A” in Fig. 4.4). The ranks 5 to 7 are taken by the amino acid pairs 
V1007–K70, V1007–L168 and M1009–L172. The two residues involved from TamB are 
located approximately at quarter the DUF490 domain sequence. Residue 70 of TamA is 
located in POTRA domain 1 and residues 168 and 170 in POTRA domain 2 (Table 4.2, 
“Cluster B” in Fig. 4.4). Corresponding co-evolution analyses between any other region of 
TamB and full-length TamA do not reveal probable co-evolving amino acid pairs. 
 
Table 4.2 Gremlin co-evolution scores of the eleven top-ranked intermolecular amino acid pairs. 
Residue TamB Residue TamA Scaled Score* Probability* I_Probability* 
D1252 R281 2.38 0.99 0.97 
L1253 V272 2.30 0.99 0.96 
E1258 T267 1.89 0.94 0.86 
F1259 I268 1.83 0.93 0.84 
V1007 K70 1.77 0.91 0.81 
V1007 L168 1.59 0.84 0.69 
M1009 L172 1.53 0.81 0.63 
L1082 A556 1.39 0.71 0.50 
D1248 S275 1.35 0.68 0.45 
V1034 V260 1.32 0.66 0.42 
A1250 S275 1.30 0.64 0.40 
*As calculated by Gremlin (Ovchinnikov et al. 2014). 
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Figure 4.4 Co-evolution analysis of the TamB DUF490 domain and TamA. 
Each large square represents 100 residues of the joined sequences TamB DUF490 – TamA as used 
for the multiple sequence alignment (MSA). The boundaries between the proteins in horizontal and 
vertical direction are indicated by black lines within the plot. The vertical and horizontal bars on the 
left-hand side and on top of the plot indicate the TamB DUF490 domain (“DUF490”, green), the TamA 
signal sequence (“SS”, black), TamA POTRA domain 1 (“P1”, yellow), TamA POTRA domain 2 (“P2”, 
orange), TamA POTRA domain 3 (“P3”, red), and the TamA barrel (“Barrel”, blue). Blue dots in the 
plot represent the amino acid pairs with the highest Gremlin scores. The darker the color of a dot, the 
higher the interaction probability. Intermolecular pairs of high interaction probability are encircled; 
“Cluster A” and “Cluster B” are indicated according to the text. 
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4.4. Discussion 
4.4.1. Binding of TamB to TamA POTRA domains 
TamA POTRA domains 1–3 bind strongly to TamB, with a very low dissociation constant, 
but TamA POTRA domain 1 alone does not bind TamB with detectable affinity. Furthermore, 
TamA POTRA domains have two distinct TamB binding modes. For both of these binding 
events the ITC measurements indicate that more than one TamB molecule bind to the 
POTRA domains. However, not all TamB molecules may be in a binding-competent state as 
implied by SEC profiles (Fig. 4.1). Therefore, the determined ratios represent upper limits 
and it cannot be excluded that binding occurs in a lower ratio, such as 1:1 for the second 
binding event. 
The two binding modes observed in the ITC measurements are compatible with several 
scenarios. The most plausible model appears to be that initially an unfolded part at the  
C-terminus of TamB forms non-specific transient interactions via β-augmentation with all 
three POTRA domains under fast rearrangements. For such a binding mode, even a second 
TamB molecule may be involved, giving rise to the observed sub-stoichiometric ratio of 
POTRA domains to TamB molecules. The high affinity may therefore be an effect of avidity 
and the interactions would mainly involve hydrogen bonding. The second ITC transition 
would arise from specific binding of a presumably folded part of TamB DUF490 to a distinct 
site of the TamA POTRA domains. Moreover, folding of this part of the DUF490 domain may 
possibly be initiated by the transient initial binding. The specific binding sites of TamB and 
the TamA POTRA domains can be located using the results of the co-evolution analysis: 
Cluster B (Fig. 4.4) contains TamB residues V1007 and M1009 that interact with TamA 
residues K70, L168, L170, located at the hinge between POTRA domains 1 and 2  
(Fig. 4.5a). The high amount of hydrophobic residues involved in interaction at these sites 
could be a possible explanation of the positive entropy change observed in the second 
transitions of the ITC measurements (Table 4.2). The involvement of residues L168 and 
L170 from POTRA domain 2 rationalizes the inability of POTRA domain 1 alone to bind 
TamB as observed by ITC. Importantly, this scenario would be in agreement with published 
data, showing that truncation of POTRA domain 1 also abolishes the TamA – TamB 
interaction (Selkrig et al. 2015). 
 
4.4.2. Co-evolution suggests binding of the TamB C-terminus to the TamA barrel 
The co-evolved residues in cluster A (Fig. 4.4) show that the C-terminus of TamB interacts 
with the TamA barrel in vicinity of strand 1. A structural explanation for this interaction would 
be an insertion of a hairpin from the TamB C-terminus between TamA strands 1 and 16  
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(Fig. 4.5), which would correspond to the first step of a hybrid barrel formation mechanism 
with an autotransporter substrate (Gruss et al. 2013). 
 
 
Figure 4.5 TamB – TamA interactions and a model for the TAM complex. 
(a) Ribbon representation of TamA. The barrel is shown in grey, the POTRA domains in yellow – 
orange – red. Residues interacting with TamB, as suggested by co-evolution analysis, are colored and 
the side chains are shown as sticks. Segments of TamB, suggested to interact with TamA by co-
evolution analysis, are shown next to TamA barrel strand 1 and POTRA domains 1 and 2. Residues in 
TamA and TamB that co-evolve are shown in the same color; “Cluster A” and “Cluster B” are indicated 
according to the text. (b) A possible model for the TAM complex. The C-terminus of TamB (cyan) 
would integrate into the TamA barrel (blue) between strands 1 and 16, while other residues of TamB 
are involved in interactions with the TamA POTRA domains (yellow – orange – red). The N-terminus 
of TamB spans the inner membrane as an α-helix. 
 
Structurally, such an insertion is reasonable: Co-evolving residues in TamA include 
sidechains that head both to the membrane and the barrel interior. The side chains of the 
respective co-evolving residues in TamB would be located exactly next to the TamA side 
chains, if the C-terminus inserted as a strand into the TamA barrel with side chains 
alternatingly heading towards the barrel lumen and the membrane environment (Fig. 4.5a). 
Similar co-evolution between TamA strand 16 and the TamB C-terminus is not detected and, 
importantly, also for TamA strands 1 and 16 no intramolecular co-evolving residues are 
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found (Fig. 4.4). Therefore, the existence of co-evolving residues between TamA strand 16 
and the TamB C-terminus is not necessarily expected. Since TamB is not a substrate of 
TamA and since it does not contain a predicted β-barrel, TamB could mediate a regulatory 
function for substrate selectivity by competing with incoming substrates for hairpin insertion 
into the TamA barrel. 
The additional binding of TamB to the POTRA domains of TamA via cluster B (Fig. 4.4) 
may be important both for initial TamB hairpin insertion into the TamA barrel, since a TamA 
truncation variant lacking POTRA domain 1 fails to bind TamB (Selkrig et al. 2015), and 
during autotransporter substrate assembly: The autotransporter will displace the C-terminal 
TamB hairpin integrated into the TamA barrel when inserting its own β-barrel, but TamB can 
stay in proximity by interacting with the POTRA domains until the hybrid TamA – 
autotransporter barrel has disintegrated. The distance between the TamA POTRA binding 
site for TamB and the TamA barrel rim is about 4.5 nm, which could well be spanned by the 
~250 residues between the two binding sites in TamB, if they adopted a β-helical structure. 
MorC, the TamB homologue from Aggregatibacter actinomycetemcomitans, is important 
for the integrity of the cell envelope (Smith et al. 2015). The E. coli TAM complex in the 
proposed conformation where the C-terminus of TamB is bound to TamA and the N-terminal 
hydrophobic transmembrane helix is embedded in the IM (Fig. 4.5b) may thus plausibly also 
have a similar function in cell shape maintenance in addition to autotransporter biogenesis. 
 
4.5. Methods 
4.5.1. Plasmid construction 
Full-length E. coli TamB was cloned into a pET21d vector (Novagen) by standard cloning 
methods. Briefly, the genomic tamB DNA was amplified from E. coli DH10β using the 
oligonucleotides 5’-CATGCCATGGCGAGTTTATGGAAAAAAATCAGCCTCGGCG-3’ and  
5’-CCGCTCGAGAAACTCGAACTGATAGAGCAAATCCAGTGC-3’. The empty vector and 
the PCR product were individually digested using restriction enzymes NcoI and XhoI (NEB). 
The digested vector and the tamB DNA were ligated using T4 DNA ligase (NEB) to yield the 
TamB expression vector. It encodes TamB in full-length with an additional Ala after the  
N-terminal Met and an additional sequence Leu-Glu followed by a His6-tag at the C-
terminus. 
E. coli TamA POTRA domains 1–3 and POTRA domain 1 alone were constructed 
similarly using oligonucleotides 5’-CATGCCATGGCGAACGTCCGTCTACAGGTCG-3’  
and 5’-CGGAATTCTCAGTGATGGTGATGGTGATGTGTTCGCGGCGAAACCACGCC-3’ 
(POTRA1–3) resp. 5’-CGGAATTCTCAGTGATGGTGATGGTGATGCACGCCTGGCGTGA 
CTTTGGC-3’ (POTRA1 alone) for PCR amplification from E. coli DH10β. The PCR products 
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and pET21d vector were digested using restriction enzymes NcoI and EcoRI. The digested 
DNA for TamA POTRA1 and TamA POTRA1–3 were ligated into pET21d to yield the 
POTRA1 and POTRA1–3 expression vectors. They encode TamA 21-102 resp. TamA 21-
264 with an additional N-terminal Met and C-terminal His6-tag. 
 
4.5.2. Expression and purification 
TamA POTRA1–3 and TamA POTRA1 were expressed and purified according to the 
procedure described in Chapter 2.4.2 for a similar POTRA domains construct. 
Electrocompetent E. coli BL21(λ DE3) cells were transformed with the TamB expression 
plasmid. After growth of cells in LB medium at 37 °C to an OD600 of 0.4–0.6, the temperature 
was decreased to 20 °C. After 45 min to 1 h, expression of TamB was induced by addition of 
0.1 mM IPTG. Expression continued overnight before cells were harvested, resuspended in 
50 mM HEPES, pH 7.4, 150 mM NaCl and lysed. 
Unbroken cells and cell debris were pelleted for 10 min at 10,000g, and the supernatant 
containing membrane vesicles was centrifuged for 1 h at 100,000g. The membrane pellet 
was resuspended in 50 mM HEPES, pH 7.4, 150 mM NaCl, 2% DDM, 5 mM  
β-mercaptoethanol (β-ME), 10% glycerol. The insoluble fraction was pelleted for 1 h at 
100,000g and 4 °C, and the supernatant containing solubilized TamB was used for the 
further procedure. 
Solubilized TamB including 10 mM imidazole was loaded onto a 5 mL HisTrap FF column 
(GE Healthcare), then washed with 20 mM HEPES, pH 7.4, 500 mM NaCl, 0.05% DDM,  
10% glycerol, 5 mM β-ME and subsequently with 20 mM HEPES, pH 7.4, 150 mM NaCl, 
0.05% DDM, 10% glycerol, 5 mM β-ME. TamB was eluted from the column with a gradient to 
500 mM imidazole in the same buffer. Eluted TamB fractions were pooled and diluted 1:2 
with 20 mM HEPES, pH 7.4, 10% glycerol and 0.05% DDM before being loaded onto a 6 mL 
column containing PL-SAX anion exchange resin (4000 Å, 10 µm, Agilent). After the column 
was washed with 20 mM HEPES, pH 7.4, 50 mM NaCl, 10% glycerol, 5 mM β-ME and 
0.05% DDM, the protein was eluted with a gradient from 50 mM to 500 mM NaCl in the same 
buffer. Eluted TamB fractions were pooled. TamB sample was cleaned from aggregates by 
centrifugation before it was gel-filtered on a Superose 6 or 12 10/300 GL column (GE 
Healthcare) in 20 mM HEPES, pH 7.4, 150 mM NaCl, 5% glycerol, 5 mM DTT and 0.05% 
DDM. Eluted TamB fractions were analyzed by SDS-PAGE, then pooled, but avoiding 
fractions from the void volume peak, and finally concentrated to the desired concentration for 
the respective purpose with 30 kDa c/o centrifugal units. 
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4.5.3. Analytical size exclusion chromatography 
For co-migration runs on a Superose 12 10/300 GL column (GE Healthcare), TamB was 
used at a concentration of 4.4 mg mL-1 (32 µM) and TamA POTRA1–3 at 4.5 mg mL-1  
(159 µM). Runs were performed with either of the two proteins and both in combination in  
20 mM HEPES pH 7.4, 150 mM NaCl, 5% glycerol, 0.05% DDM and 5 mM DTT. 
 
4.5.4. Isothermal titration calorimetry 
For ITC experiments the purified POTRA constructs were dialyzed in a volume ratio of at 
least 1:200 against 20 mM HEPES, pH 7.4, 150 mM NaCl, 5% glycerol, 5 mM DTT and 
0.05% DDM, using dialysis cassettes with a MW c/o of 3 kDa. ITC measurements were 
performed at 10 °C using a VP-ITC MicroCalorimeter (Malvern). About 2 mL of TamB 
solution at a concentration of 5 µM was used for the 1.415 mL cell. TamA POTRA domain 1 
and POTRA domains 1–3 were used at concentrations of 35 or 50 µM. The first 
compensation injection of 1 µl was excluded from the data processing. 29 more injections of 
10 µl volume were performed each in 20 s and in intervals of 5 min. Data was evaluated with 
the ITC data analysis software Origin 7 (OriginLab, Northamton, MA, USA). 
 
4.5.5. Co-evolution analysis 
For co-evolution analysis of the C-terminal TamB DUF490 domain and full-length TamA, 
the Gremlin server (http://gremlin.bakerlab.org) was used (Ovchinnikov et al. 2014). The full-
length E. coli TamA sequence and E. coli TamB residues 923-1259 were provided. To 
generate the multiple sequence alignment (MSA) HHblits was chosen, the E-values for both 
sequences were set to 10-2 and for each 8 iterations were performed. The minimal and 
maximal values for Δgene were set to 1 and 20, which means that sequence pairs are only 
considered for the MSA if the distance between the genes corresponding to the submitted 
protein sequences on a genome lies within these thresholds. 
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5.1. Abstract 
Omp85 proteins mediate translocation of polypeptide substrates across and into cellular 
membranes. They share a common architecture comprising substrate-interacting POTRA 
domains, a C-terminal 16-stranded β-barrel pore and two signature motifs located on the 
inner barrel wall and at the tip of the extended L6 loop. The observation of two distinct 
conformations of the L6 loop in the available Omp85 structures previously suggested a 
functional role of conformational changes in L6 in the Omp85 mechanism. Here we present a 
2.5 Å resolution structure of a variant of the Omp85 secretion protein FhaC, in which the two 
signature motifs interact tightly and form the conserved ‘lid lock’. Reanalysis of previous 
structural data shows that L6 adopts the same, conserved resting state position in all 
available Omp85 structures. The FhaC variant structure further reveals a competitive 
mechanism for the regulation of substrate binding mediated by the linker to the N-terminal 
plug helix H1. 
 
5.2. Introduction 
Omp85 proteins, such as the general Escherichia coli insertase BamA and the 
mitochondrial Sam50, are responsible for the insertion of β-barrel membrane proteins into 
the outer membranes of Gram-negative bacteria, mitochondria and chloroplasts (Chacinska 
et al. 2009, Kim et al. 2007, Walther et al. 2009). In Gram-negative bacteria, Omp85 family 
members also act as translocases (TpsB) for the secretion of specific partner proteins (TpsA) 
across the outer membrane (Fan et al. 2012, Poole et al. 1988). Such two-partner-secretion 
(TPS) systems are commonly contributing to bacterial pathogenicity (Jacob-Dubuisson et al. 
2001, Yen et al. 2002). One of the best-studied TPS systems comprises the translocase 
FhaC and its substrate filamentous hemagglutinin (FHA), which is functionally involved in 
virulence and biofilm formation in Bordetella pertussis (Serra et al. 2011). Crystallographic 
structure determination of FhaC has provided the first depiction of the general Omp85 
architecture (Clantin et al. 2007). This architecture builds upon a C-terminal, membrane-
integrated β-barrel with 16 strands and up to six N-terminal POTRA domains directly 
attached to it. In FhaC, the two POTRA domains are involved in substrate recognition 
(Delattre et al. 2011), while the barrel forms a translocation pore for FHA secretion (Baud et 
al. 2014). The FhaC pore in its crystallized state is plugged with an N-terminal helical 
extension, the H1 helix, which is absent in Omp85 insertases but generally found in TpsB 
transporters. 
The mechanism of Omp85-mediated protein insertion had remained enigmatic until the 
recent structure determinations of bacterial BamA and TamA (Gruss et al. 2013, Ni et al. 
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2014, Noinaj et al. 2013). BamA and TamA are characterized by an unusually weak 
connection between their β-strands 1 and 16, which facilitates unzipping and inward kinking 
of strand 16. A lipid head group occupies the position of the displaced strand in the 2.3 Å 
crystal structure of TamA, demonstrating the formation of a gate towards the lipid phase 
(Gruss et al. 2013). Molecular dynamics simulations of BamA recognized a distorted lipid 
bilayer around the kink and suggest that the initial gate promotes further unzipping up to a 
complete lateral barrel opening (Noinaj et al. 2013). The functional requirement for unzipping 
of strands 1 and 16 was elegantly demonstrated for BamA by disulfide bond trapping (Noinaj 
et al. 2014). 
The barrels of BamA and TamA are tightly closed on the extracellular side by a lid, which 
is mainly formed by the large extracellular loop L6. This arrangement brings the two most 
conserved sequence motifs in the entire Omp85 family in close contact. These motifs are 
located at the tip of L6, and in the central inner barrel wall, respectively (Delattre et al. 2010, 
Gruss et al. 2013, Jacob-Dubuisson et al. 2013, Noinaj et al. 2013). To emphasize the nature 
of the strong interactions between these two motifs and its role for the lid conformation, the 
emerging structural feature has been termed the ‘lid lock’ (Gruss et al. 2013). Despite the 
pronounced sequence conservation, the conformation of the L6 loops in the Omp85 
insertases is drastically different from the one observed in the crystal structure of FhaC, 
where loop L6 reaches to the periplasmic face of the barrel (Clantin et al. 2007). 
On the basis of the available structural insights, several models have been formulated for 
the Omp85 mechanism (van den Berg 2013), involving lateral gating (Gruss et al. 2013, 
Noinaj et al. 2013), hybrid barrel formation (Gruss et al. 2013, Kim et al. 2012), alteration of 
the lipid bilayer structure (Gessmann et al. 2014, Noinaj et al. 2013) and conformational 
switching of POTRA domains and the L6 lid loop for pore opening and substrate transport 
(Clantin et al. 2007, Noinaj et al. 2013). Here we present the 2.5 Å resolution structure of the 
FhaC variant (V169T,I176N), which is characterized by disrupted substrate recognition and 
referred to as ‘FhaCDIS’ (disruption). The data provide evidence for the general conservation 
of the L6 loop conformation, and thus a new perspective on the role of the lid-lock 
arrangement in pore opening and substrate translocation. The mutant structure resolves 
interactions of the H1 plug helix and its linker with the pore and the POTRA domains as a 
structural basis for the dynamic plugging mechanism of FhaC. 
 
5.3. Results and Discussion 
5.3.1. Intermolecular helix swap in the FhaCDIS crystal structure 
FhaCDIS carries two point mutations, V169T and I176N, which locate to the POTRA2 
domain and abolish the secretion activity of FhaC due to a disruption of POTRA2–substrate 
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interaction (Delattre et al. 2011). FhaCDIS was crystallized from micelles in space group 
C2221, isomorphous to wild-type (WT) FhaC crystals, but with considerably better diffraction 
than previous WT- or mutant FhaC crystals (Clantin et al. 2007, Delattre et al. 2010). The 
structural model of FhaCDIS was refined to Rwork/Rfree of 21.7% / 25.9% at 2.5 Å resolution 
(Table 5.1). It comprises the N-terminal extension helix H1, connected via a 25-residue linker 
to two POTRA domains and a C-terminal 16-stranded β-barrel (Fig. 5.1a). In contrast to 
previous FhaC structures (Clantin et al. 2007, Delattre et al. 2010), the register of the H1 
helix was unambiguously determined from side-chain electron density. The polypeptide linker 
between POTRA1 and helix H1 in FhaCDIS was found to be well ordered. Tracing of the linker 
revealed that in the current crystal structure two adjacent FhaCDIS molecules form an 
intermolecularly swapped dimer via exchange of their helices H1 (Fig. 5.1b,c). 
 
 
Figure 5.1 Structure and crystal packing of FhaCDIS. 
(a) Structural overview. Individual protein domains are colour-coded: Helix H1 with linker, yellow; 
POTRA1, orange; POTRA2, red; Barrel, blue; Lid Loop, magenta. (b) Formation of a swapped dimer 
in crystals of FhaCDIS by exchange of helix H1. The two crystallographically related protein molecules 
involved in swapping are coloured blue and green, respectively. (c) Crystal packing of FhaCDIS. Two 
molecules equivalent to b are shown in the respective colours. 
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The FhaCDIS structure triggered a reanalysis of the previous 3.15 Å resolution WTFhaC 
data, which were reprocessed from raw images to 2.9 Å resolution using state-of-the-art 
techniques. Reinterpretation of the WTFhaC diffraction data on the basis of the FhaCDIS 
structure clearly revealed modelling ambiguities in the previous WTFhaC structure (PDB 
entry 2QDZ (Clantin et al. 2007), referred to as ‘WTFhaCold’) and yielded a revised model of 
WTFhaC (referred to as ‘WTFhaCnew’). 
 
Table 5.1 Data collection and refinement statistics. 
 WTFhaCnew FhaCDIS 
Data collection   
Space group C 2 2 21 C 2 2 21 
Cell dimensions     
a, b, c (Å) 108.60, 136.65, 112.27 106.38, 136.95, 110.97 
α, β, γ (°) 90, 90, 90 90, 90, 90 
Resolution (Å) 50 – 2.90 (2.95 – 2.90) * 50 – 2.50 (2.55 – 2.50) 
Rsym or Rmerge 0.090 (0.847) 0.057 (0.886) 
I / σI 19.88 (3.28) 23.04 (2.13) 
CC(1/2) (%) 99.8 (75.6) 99.9 (68.9) 
Completeness (%) 98.8 (98.3) 99.7 (99.9) 
Redundancy 10.90 (10.70) 4.91 (4.93) 
Refinement   
Resolution (Å) 39.34 – 2.90 41.95 – 2.50 
No. reflections 18626 28332 
Rwork / Rfree 0.222 / 0.279 0.217 / 0.259 
No. atoms 3731 4474 
Protein 3726 4095 
Ligand/ion 5 304 
Water - 75 
B-factors   
Protein 91.4 78.9 
Ligand/ion 78.8 77.6 
Water - 63.8 
R.m.s. deviations   
Bond lengths (Å) 0.010 0.010 
Bond angles (°) 1.09 1.08 
*Values in parentheses are for highest-resolution shell. 
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5.3.2. Comparison of FhaC structural models: H1 linker and L6 loop 
To clarify these differences, we compare the three structural models of WTFhaCold, 
WTFhaCnew and FhaCDIS in Fig. 5.2a–c. The structural models feature relevant differences in 
three regions: (i) The register of helix H1 in FhaCDIS and WTFhaCnew is shifted by three 
residues relative to the partly modelled H1 helix of WTFhaCold. (ii) The linker segment 
between POTRA1 and helix H1 (residues 33–58) is well-ordered in FhaCDIS, but largely 
disordered in WTFhaCold and WTFhaCnew. Due to the isomorphous nature of the crystals, the 
intermolecular swap of helix H1 between two crystallographically related molecules of FhaC 
is also the most likely explanation for the WTFhaC crystal packing and therefore the 
assignments of helix H1 and the symmetry-related helix H1’ have been swapped in 
WTFhaCnew relative to WTFhaCold. (iii) The positioning and structure of loop L6 and the 
adjacent strand is well-resolved in FhaCDIS in contrast to WTFhaCold. FhaCDIS differs from 
WTFhaCold by a massive register shift in loop L6 and the following strand 12 and a 
concomitant change in the position of the tip of loop L6 by 17 Å (Fig. 5.2 and 5.3, 
Supplementary Fig. 5.1). 
 
 
Figure 5.2 Overall comparison of FhaCDIS and WTFhaC structural models. 
The structural models of (a) superseded WTFhaCold, (b) WTFhaCnew and (c) FhaCDIS are shown in 
backbone representation. Strand12 and lid loop L6 (red), helix H1 and its linker (orange, blue for the 
linker segment disordered in WTFhaCnew) are shown thick and in colour. For the superseded 
WTFhaCold structure, the symmetry-related helix H1’ is shown to indicate that it has the same position 
as H1 in WTFhaCnew and FhaCDIS. For FhaCDIS, the locations of the V169T and I176N mutations are 
indicated by green spheres. 
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In WTFhaCold, loop L6 was depicted in a conformation, where its tip touches the 
periplasmic rim of the barrel (cyan conformation in Fig. 5.3a), but in the 2.5 Å resolution 
FhaCDIS structure the tip of loop L6 touches the inner side of the barrel wall at strand 13 
(magenta conformation in Fig. 5.3a, Supplementary Fig. 5.2). In particular, this ‘lid lock’ 
conformation of loop L6 describes the WTFhaC data unambiguously better than the 
periplasmic conformation in WTFhaCold, as directly evidenced by omit maps calculated for 
these two conformations against the respective data sets (Fig. 5.3b–e) and has thus been 
adopted in WTFhaCnew. We discuss the relevance of the L6 loop positioning for FhaC and 
Omp85 biology in general in the following. 
 
 
Figure 5.3 Comparison of L6 conformations in FhaCDIS and WTFhaCold. 
(a) Superposition of L6 loop conformations in the superseded WTFhaCold structure (cyan, PDB entry 
2QDZ (Clantin et al. 2007)) and the FhaCDIS structure (magenta, PDB entry 4QL0; this work). Grey: 
The barrel of the FhaCDIS structure. (b–e) Simulated annealing composite omit maps for different 
combinations of structures and diffraction data. Maps are shown at 1.5σ contour level in a radius of 
2.5 Å around atoms belonging to the L6 loop and are calculated based on (b) FhaCDIS model and the 
FhaCDIS diffraction data. (c) FhaCDIS model and WTFhaC diffraction data. (d) Superseded WTFhaCold 
model and FhaCDIS diffraction data. (e) Superseded WTFhaCold model and WTFhaC diffraction data. 
 
5.3.3. A conserved lid-lock structure in the Omp85 family 
In the WTFhaCnew and the FhaCDIS structures, the two signature motifs (V/I)RG(Y/F) at the 
tip of the loop L6 and (F/G)xDxG in the inner barrel wall on strand 13 are in close spatial 
contact and interact directly via a salt bridge between the conserved central residues R450 
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and D492. This ‘lid lock’ formation is closely related to those previously found for TamA and 
BamA (Fig. 5.4a,b) (Gruss et al. 2013, Ni et al. 2014, Noinaj et al. 2013). 
 
 
Figure 5.4 Conformation of loop L6 in the Omp85 family. 
(a) Cross-section through FhaC and structural and sequence alignment of L6 in B. pertussis FhaC 
(PDB entry 4QL0; this work), E. coli TamA (PDB entry 4C00 (Gruss et al. 2013)) and H. ducreyi BamA 
(PDB entry 4K3C (Noinaj et al. 2013)). Yellow: helix, grey: barrel. Conserved regions of L6 are shown 
in magenta, purple and light magenta for FhaC, TamA and BamA, respectively; loop extensions in 
TamA and BamA in cyan and light cyan, respectively. (b) Variations in the signature motifs correlate to 
barrel shape alterations in FhaC (left), TamA (center) and H. ducreyi BamA (right). Loop L6 and the 
barrel are coloured magenta and grey, respectively. Selected side chains are shown as sticks, highly 
conserved residues as ball-and-stick. Lower panel: Sequence alignments of signature motifs for 10 
representative members of the FhaC (TpsB), TamA and BamA families, respectively (see Methods). 
The conserved arginine of the (V/I)RG(Y/F) motif is highlighted by magenta, the conserved interacting 
aspartate and phenylalanine of the (G/F)xDxG by blue. Other motif residues are indicated in black. 
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Interestingly, the arrangement of the entire lid loop is not even affected by the presence of 
a variable insertion site in loop L6, which can incorporate up to 30 additional amino-acid 
residues in TamA and BamA. In B. pertussis FhaC, the insertion region contains only two 
residues, which structurally bridge the insertion point in the shortest possible way (Fig. 5.4a). 
In Haemophilus ducreyi BamA and E. coli TamA, the insertion site is flanked by glycine or 
alanine residues, which permit a sharp outward kinking of the entire insert region (Fig. 5.4a, 
Supplementary Fig. 5.3). In consequence, the entire conserved regions of the L6 loop adopt 
almost identical conformations as demonstrated by very low backbone rmsd values 
(FhaC:TamA: 1.21 Å, FhaC:BamA: 1.37 Å; insertions excluded). The L6 loop is thus 
structurally conserved in all structures of Omp85 known so far, including the BamA insertase 
and the FhaC translocase, strongly suggesting a general functional role of the ‘lid lock’ region 
for protein translocation and insertion in the entire Omp85 family. 
 
5.3.4. Structural variations around the lid lock 
A key difference between FhaC and BamA/TamA is the presence of the N-terminal helix 
H1 in FhaC, which plugs the FhaC pore by traversing the entire length of the barrel. Two 
structural adaptations of FhaC relative to BamA/TamA pave the way for complete insertion of 
H1: first, the loops L3 and L4 are opened up in FhaC, whereas they tightly interact with L6 to 
close the extracellular face of the barrel in BamA/TamA (Fig. 5.5a,b). Second, FhaC features 
a wider and rounder barrel shape, which enlarges the pore at the periplasmic face relative to 
the kidney-shaped structures of BamA and TamA. 
The FhaCDIS and WTFhaCnew structures indicate an involvement of the lid-lock motif on 
strand 13 in barrel shape determination: The sequence motif on strand 13 has the form 
FxDxG in TamA/BamA, but GxDxG in FhaC proteins (Fig. 5.4b). In TamA and BamA 
insertases, the central arginine of the (V/I)RG(Y/F) motif stacks on top of the phenylalanine 
residue of the FxDxG motif. This phenylalanine side chain bends towards a conserved 
glycine residue of neighboring strand 14 (G539/G754 in TamA/BamA). Accommodation of 
the phenylalanine side chain requires a pronounced bend in strand 14, which correlates with 
a strongly curved region of the barrel. 
In contrast, FhaC features a glycine as the first residue in its GxDxG motif and 
additionally, strand 14 contains a conserved alanine (A512) at the adjacent position  
(Fig. 5.4b). These two adaptations in FhaC permit lid-lock formation without requiring a bend 
of strand 14. They may contribute to an inherently expanded barrel shape, which prepares 
FhaC for helix H1 insertion, although a contribution of the H1 insertion itself to barrel shape 
alterations cannot be ruled out. The FhaC structure describes an Omp85 conformation, in 
which a polypeptide – not a native substrate, but the H1 plug helix – can traverse an Omp85 
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pore without release of the conserved lid-lock structure. 
 
 
Figure 5.5 Barrel shape, lid lock and H1 helix insertion in FhaC. 
(a) Top-view ribbon representation of the barrels of B. pertussis FhaC (left; PDB entry 4QL0; this 
work), E. coli TamA (center; PDB entry 4C00 (Gruss et al. 2013)) and H. ducreyi BamA (right; PDB 
entry 4K3C (Noinaj et al. 2013)). The β-barrels are shown grey, the helix of FhaC is shown yellow. 
Using the same colour code as in Fig. 5.4, conserved regions of loop L6 are shown in magenta, 
extensions of L6 in TamA and BamA relative to FhaC are shown in cyan. (b) Cross-sectional surface 
representation of the barrels of B. pertussis FhaC (left), E. coli TamA (center) and H. ducreyi BamA 
(right), in the same colour code. POTRA domains are shown in red. 
 
5.3.5. Intermolecular swapping occurs in a defined linker region 
Previous biochemical experiments have shown that the N-terminal helix H1 of FhaC acts 
as a dynamic plug, which spontaneously inserts into the barrel lumen of FhaC both in lipid 
vesicles and in vivo and occupies its central pore (Guérin et al. 2014). In the absence of 
substrates, helix H1 preferentially traverses the FhaC pore in a defined, rigid conformation 
and extends its N-terminus into the extracellular space, while blocking channel activity. On 
substrate transport it is released from the pore and is flexibly posed on the periplasmic face 
of the membrane in the vicinity of the POTRA domains (Guérin et al. 2014). The interaction 
mode of a swapped dimer in the crystal structure of FhaCDIS is not compatible with a native-
like topology of the bacterial outer membrane (Fig. 5.1b,c). However, the unswapped form 
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would correspond to a state of H1, which has all characteristics of the resting, plugged state 
of FhaC. 
From an inspection of the structure, we suggest that the swapping occurs in the 15 amino-
acid region between residues 42 and 58 (Fig. 5.6), because all linker residues N-terminal to 
this segment remain in direct interaction with POTRA2 and all linker residues C-terminal to 
this segment remain in close contact to POTRA1 (Fig 5.6a,b). The role of residue 58 as a 
fixed anchor for the H1 linker agrees well with all available data: In reconstituted systems of 
FhaC transport, the mobility of residue 58 is not altered by substrate addition (Guérin et al. 
2014) and in many FhaC-related TpsB proteins, residue 58 is mutated to a cysteine and 
presumably disulfide bonded to a nearby cysteine residue in POTRA1 (Guérin et al. 2014) 
(Supplementary Fig. 5.3). 
In the crystallographic intermolecularly swapped dimer, the distance between the two 
ends of the segment 42–58 is only 21 Å, which is spanned by the 15-residue polypeptide 
segment in a crouched conformation. The corresponding distance for an intramolecular  
H1 – barrel interaction has a length of 39 Å, which could still be spanned by the 15-residue 
segment in a more extended conformation (Fig. 5.6a). Presumably, the shorter 
intermolecular swapping conformation was preferentially selected by crystal packing. The 
fact that the native membrane topology would readily prevent the existence of the swapped 
dimer configuration observed in the crystal, explains the lack of selective pressure on the 
linker segment to prevent such an arrangement. 
 
Conserved Lid-Lock in Omp85  CHAPTER 5 
98 
 
 
Figure 5.6 FhaCDIS linker and helix H1 interactions. 
(a) 2FoFc map for FhaCDIS shown in a radius of 2.5 Å around atoms belonging to the linker (yellow) at 
1σ contour level. Residues Ser42 and Thr58, which encompass the domain-swapping segment are 
shown as yellow spheres. (b) 2FoFc map for WTFhaC shown in the same region as for FhaCDIS at 1σ 
contour level. Residues 35 and 57, which encompass the disordered linker segment are shown as 
black spheres. (c) Interactions at the C-terminus of the helix including cation-π stacking and salt 
bridges. (d) Ribbon representation of the linker region in FhaCDIS showing the hydrogen bond between 
Leu38 and the mutated Thr169. For comparison, the linker region disordered in WTFhaC is indicated 
by black spheres for residues 35 and 57. 
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5.3.6. Competitive interplay of substrates and the H1 plug helix 
The FhaCDIS structure, together with published biochemical and biophysical studies, 
rationalizes the plugging mechanism of TpsB proteins. The H1 helix comprising residues  
1–32 shows numerous interactions with the barrel wall, including 5 salt bridges, 12 hydrogen 
bonds and a total interaction interface of 988 Å2. Yet, this interaction interface almost 
completely lacks elements of side-chain interlocking, which would hinder a sliding of H1 
along the barrel wall (Supplementary Fig. 5.4). The FhaCDIS structure now points to a key 
role of the N-terminal residues 29–38 for defining H1 interactions (Fig. 5.6c). In this segment, 
Arg33 is positioned by a salt bridge to Asp173, providing an interdigitation of side chains by 
stacking between Tyr177 of POTRA2 and Arg320 at the periplasmic rim of the barrel. Arg29 
of the terminal winding of H1 may contribute to this interaction by stacking to the other face 
of Tyr177. 
In WTFhaCnew, the polypeptide region 36–56 is disordered and thus remains structurally 
unresolved (Fig. 5.6a,b). In contrast, in FhaCDIS carrying the (V169T,I176N) double mutation, 
the full linker is ordered. In fact, Leu38, the third residue of the segment that is disordered in 
WTFhaCnew, directly interacts in FhaCDIS with the mutated residue Thr169 by formation of a 
hydrogen bond between the Leu38 backbone-N and the Thr169 side chain-OH (Fig. 5.6d). 
Apparently, this interaction triggers ordering also of the entire segment, where residues 39 to 
42 are involved in further interactions with the same POTRA2 domain. 
Biochemical data clearly indicate that the observed interactions around residues 33 and 
38 (Fig. 5.6c,d) play a key role for the functional mechanism of FhaC. The double mutation 
(V169T,I176N), which was designed to interfere with β-augmentation substrate interactions 
of POTRA2, not only abolishes transport, but directly interferes with substrate interaction 
(Delattre et al. 2011); it thus affects a direct substrate binding site. We hypothesize that also 
in WTFhaC, the linker region 33–38 interacts at least transiently with the region around 
residues V169 and I176 on POTRA2. The H1 linker could thus be displaced by substrate 
binding, resulting in a destabilization of the contacts that lock the position of helix H1 to the 
barrel around residue Arg33. Indeed, EPR-based mobility assays on membrane-inserted 
FhaC have demonstrated a direct effect of substrate interaction on the mobility of residue 33 
(Guérin et al. 2014): This residue is mostly immobile in the absence of a substrate and even 
remains partly immobile on deletion of the entire downstream H1 helix, demonstrating an 
inherent H1-independent component of tethering to POTRA1. In both cases, with and without 
H1, substrate addition drastically increases the mobility of residue 33. Altogether, this 
mechanism directly couples substrate binding to a preferential release of helix H1 into the 
periplasm (Fig. 5.7). 
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Figure 5.7 Plug helix H1 release mechanism of FhaC. 
(a) In WTFhaC, the linker interacts weakly with POTRA domain 2, and the helix is preferentially inside 
the barrel. On substrate arrival, FHA competes with the linker for interaction with POTRA2, extruding 
the helix from the barrel and allowing the substrate to be transported. (b) In FhaCDIS, the introduced 
hydrogen bond between Leu38 and Thr169 leads to stronger interactions between the linker and 
POTRA2, with which an arriving substrate cannot compete and thus will not be transported. 
 
While recent structural and functional studies have provided important insights into 
Omp85 function, the underlying principles of the distinct translocase and insertase function 
remain unknown. The crystal structure of FhaCDIS now demonstrates a general structural 
conservation of the signature motifs in the lid-lock region in translocases and insertases of 
the Omp85 family. It also correlates variations in the signature sequences to the wider barrel 
shape of FhaC, which permits passage of the plug helix H1 all the way through the pore 
while the lid lock is formed. 
Altogether with detailed previous studies on substrate interaction and FhaC mobility, the 
FhaCDIS structure reveals a competitive mechanism for coupling of substrate recognition and 
plug helix release. Most TpsB proteins are predicted to harbour a helical segment followed 
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by a disordered region at the N-terminus (Guérin et al. 2014). It is therefore probable that the 
mechanism revealed by this study will prove generally relevant to two-partner secretion. 
FhaC and related TPS systems play a prominent role in bacterial pathogenesis; identification 
of the competitive plugging mechanism may ultimately expose a novel target site for fighting 
bacterial infection. 
 
5.4. Methods 
5.4.1. Protein production and purification 
The plasmid pFJD138–V169T–I176N, which encodes FhaCDIS with an N-terminal His6-tag 
(Delattre et al. 2011), was used to produce FhaCDIS for crystallization experiments. E. coli 
BL21(λ DE3)-omp5 transformed with pFJD138–V169T–I176N were grown at 37 °C in liquid 
LB broth to an OD600 of 1 and protein expression was induced overnight at 20 °C with 1 mM 
IPTG. Cells were collected, washed in 20 mM sodium phosphate (pH 7) and resuspended in 
the same buffer containing 0.01 mg mL-1 DNase and a mixture of protease inhibitors 
(Roche). Cells were broken by passages through a French pressure cell. After collecting the 
membrane fractions by ultracentrifugation (100,000g for 1 h), two steps of extraction were 
performed successively with 0.8 and 1.5% β-octyl glucoside. The second extract was 
subjected to chromatography onto a cation-exchange column Poros HS20 (Perkin-Elmer) 
equilibrated in 20 mM sodium phosphate (pH 7.0) with 1% β-octyl glucoside. FhaC was 
eluted with a linear 0–1 M gradient of NaCl. The FhaC-containing fractions were pooled and 
applied onto a 1 mL HiTrap chelating column (Amersham Biosciences) equilibrated in 20 mM 
sodium phosphate (pH 7.0), 1% β-octyl glucoside. FhaC was eluted by a pulse of 500 mM 
imidazole (pH 6.5) in the equilibration buffer. For crystallization, FhaC was concentrated to 
26 mg mL-1 by using Vivaspin centrifugal devices with a 50 kDa cut-off (Vivascience). 
 
5.4.2. Crystallization and data collection 
Crystals were obtained at 20 °C using the hanging drop vapour diffusion method. The 
protein and precipitant solutions were mixed in a 1:1 ratio. Crystals were grown at a protein 
concentration of 26 mg mL-1 in 34% PEG1000, 1% β-octyl glucoside and 500 mM imidazole 
(pH 6.5). Diffraction data were collected at 100 K on beamline ID14-4 at the European 
Synchrotron Radiation Facility (Grenoble, France). All diffraction data were processed with 
XDS (Kabsch 2010). Data collection and refinement statistics are summarized in Table 5.1. 
Whereas the crystal packing remained isomorphous to the old crystal form, the diffraction 
limit increased to 2.5 Å. Model building was accomplished manually with Coot 
(Crystallographic Object Oriented Toolkit) (Emsley et al. 2010) from the CCP4 suite (Winn et 
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al. 2011). The refinement with Buster (Bricogne et al. 2011) led to an Rwork of 21.7% and an 
Rfree of 25.9% using data to 2.5 Å for FhaCDIS and Rwork/Rfree of 22.2% / 27.9% using data to 
2.9 Å for the reprocessed WTFhaC data (Clantin et al. 2007). The final model for the FhaCDIS 
structure lacks the first two N-terminal residues, residues 296 and 297 of extracellular loop 
L3, 381 to 399 of L5, 478 to 481 of periplasmic turn T6, 499 to 503 of L7 and residues 537 
and 538 of L8. Loop L6 and the linker between the helix and POTRA1 are well defined in the 
electron density. Furthermore, a total of three detergent molecules were well ordered and 
bound to FhaC. In addition, three PEG molecules were found inside the barrel and two PEG 
molecules are located close to the periplasmic pore in vicinity of the POTRA domain anchor. 
The updated WTFhaCnew model lacks the first five N-terminal residues, residues 36–56 of the 
linker connecting the helix and POTRA1, residues 294–301 of L3, 342–350 of L4, 381–399 
of L5, 475–481 of T6, 500–502 of L7 and 533–543 of L8. All structural differences between 
the FhaCDIS model and the superseded WTFhaCold model (PDB entry 2QDZ (Clantin et al. 
2007)) are summarized in Supplementary Table 5.1. Composite omit maps after simulated 
annealing of the FhaCDIS structure and the superseded WTFhaCold structure against the 
FhaCDIS and the WTFhaC diffraction data (PDB entry 2QDZ (Clantin et al. 2007)) were 
generated using PHENIX (Adams et al. 2010). 
 
5.4.3. Sequence alignments 
Eleven TamA orthologs, ten BamA orthologs and ten TpsB proteins were selected from 
the NCBI database, showing pairwise sequence identities between 18 and 36% within each 
group (Gruss et al. 2013) (accession codes P0ADE4.1, WP_010374432.1, YP_006917734.1, 
YP_005378779.1, WP_006914415.1, WP_006956461.1, WP_007639592.1, 
YP_006416500.1, YP_007468392.1, WP_008316497.1, YP_006721763.1, 
YP_002998039.1, YP_001121414.1, WP_003783125.1, YP_001219350.1, 
WP_010501263.1, YP_865762.1, YP_007459313.1, YP_004865655.1, YP_002549812.1, 
WP_008996841.1, AAB30624.1, YP_335961.1, WP_005764711.1, YP_003741556.1, 
WP_002831157.1, YP_006646915.1, YP_004122309.1, WP_008291755.1, 
WP_005980414.1, YP_003307097.1). In addition, the H. ducreyi BamA sequence was 
added (NCBI accession code 4K3C_A) and a TpsB sequence (WP_004649222.1). 
Alignments, starting with the second last POTRA domains, were performed with Clustal 
Omega (Goujon et al. 2010, Sievers et al. 2011) and further edited taking into consideration 
available structural data (Supplementary Fig. 5.3). 
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5.5. Accession codes 
Atomic coordinates and structure factors have been deposited in the Protein Data Bank 
with accession code 4QL0 for FhaCDIS, and 4QKY for WTFhaCnew. 
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5.8. Supplement 
 
Supplementary Figure 5.1 Comparison of β-strand topologies in models of FhaC. 
2D topology representations of (a) the superseded wtFhaCold structure (PDB entry 2QDZ (Clantin et al. 
2007)) and (b) the structures of FhaCDIS (PDB entry 4QL0; this work) and wtFhaCnew (PDB entry 
4QKY; this work) as viewed from the barrel exterior. Residues forming β-strands are indicated by 
rectangles, residues of loops and turns by circles. The side chains of orange residues point towards 
the membrane. The extracellular loops are numbered L1 to L8 from N- to C-terminus, the periplasmic 
turns are numbered T1 to T7. Interstrand backbone hydrogen bond pairs are indicated by red lines 
between the corresponding residues. Strand 1 is repeated on the left hand side to show the hydrogen 
bonds that form to strand 16. The conserved motifs (I/V)RG(Y/F) (residues 449–452) and GxDxG 
(residues 490–494) are highlighted green. Residues of strand 12 are highlighted blue to show the 
register shift that appeared in the superseded wtFhaCold structure (Clantin et al. 2007) due to wrong 
tracing of the L6 loop. 
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Supplementary Figure 5.2 Stereo view of electron density around the L6 loop of FhaCDIS. 
The 2FoFc map for FhaCDIS is shown in a radius of 2 Å around atoms belonging to the L6 loop 
(magenta) at 1σ contour level. Side chains of the L6 loop are shown as lines, selected side chains of 
the barrel (grey) are shown as sticks, and highly conserved residues as ball-and-stick. 
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Supplementary Figure 5.3 Alignment of Omp85 sequences. 
11 TpsB, 11 TamA and 11 BamA sequences beginning with the second last POTRA domains. For the 
known structures of B. pertussis FhaC (PDB entry 4QKY; this work), E. coli TamA (PDB entry 4C00 
(Gruss et al. 2013)) and H. ducreyi BamA (PDB entry 4K3C (Noinaj et al. 2013)), α-helices and  
β-strands are indicated by red tubes and blue arrows, respectively, on top of the sequences. The 
sequences for the N-terminal helices and linkers of TpsB proteins are shown unaligned. Cysteines in 
the linker region and POTRA1 domain of TpsB proteins, plausibly forming disulfide bonds (see text), 
are highlighted in red. 
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Supplementary Figure 5.4 Electron density around helix and barrel of FhaCDIS. 
The 2FoFc map for FhaCDIS is shown in a radius of 2.5 Å around atoms belonging to helix and linker 
(yellow) and the barrel (blue) at 1σ contour level. 
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Supplementary Table 5.1 Differences between FhaC structural models. 
Region FhaCDIS, 
residues 
wtFhaCold, 
corresponding 
residues 
Variation 
N-terminal 
helix 
Gln3-Asp10 Gln3-Gly7 Residues from symmetry-related 
molecules in different conformations 
N-terminal 
helix 
Leu11-Arg33 Ala8-Ala30 Residues from symmetry-related 
molecules aligned with offset 3 
Linker Pro34-His57 Leu31-Asp52 Not built in superseded wtFhaCold model, 
well resolved in FhaCDIS structure 
POTRA1 Thr58-Thr60 Ala53-Ser55 Aligned with offset 5 
POTRA1 Val61 Gly56-Val61 Extra loop in wtFhaCold model 
POTRA1 Val70-Glu71 Val70-Gly72 Different conformations 
POTRA1 Gly72-Pro77 Arg73-Ala78 Aligned with offset -1 
POTRA1 Ala78-Asp83 Pro79-Asp83 Different conformations 
Barrel L1 Pro222-G228 Pro222-G228 Different conformations 
Barrel L3 Leu294-
Lys295 
Leu294-Lys295 Different conformations 
Barrel L3 Thr296-Arg297 The296-Arg297 Not built in FhaCDIS model 
Barrel L4 Gly343-
Leu346 
Gly343-Leu346 Different conformations 
Barrel L5 Val381-Val383 Val381-Val383 Not built in FhaCDIS model 
Barrel L5 Gly398-
Asn399 
Gly398-Asn399 Not built in FhaCDIS model 
Barrel L6 Arg432  Position skipped in wtFhaCold model 
Barrel L6 Gln433-
Asn437 
Arg432-Leu436 Aligned with offset 1 
Barrel L6 Ser438  Position skipped in wtFhaCold model 
Barrel L6 Tyr439-Glu446 Asn437-Gly444 Aligned with offset 2 
Barrel L6 Tyr447 Asp445-Thr456 Extra loop in wtFhaCold model 
Barrel L6 Thr448-Gly451 Ser457-Gly460 Aligned with offset -9 
Barrel L6 Tyr452-Thr456 Asp461-Val464 Different conformations 
Barrel L6, 
S12 
Ser457-Gln475 Tyr465-Ala483 Aligned with offset -8 
Barrel T6 Phe476-
Ser477 
 Positions skipped in wtFhaCold model 
Barrel T6 Leu478-
Lys481 
 Not built in FhaCDIS model, positions 
skipped in wtFhaCold model 
Barrel T6 Gln482-Ala483  Positions skipped in wtFhaCold model 
Barrel L7 Asn499-
Ala503 
Asn499-Ala503 Not built in FhaCDIS model 
Barrel T7 Leu519-
Pro520 
Leu519-Pro520 Different conformations 
Barrel L8 Gly533-Pro536 Gly533-Pro536 Different conformations 
Barrel L8 Gly537-Gly538 Gly537-Gly538 Not built in FhaCDIS model 
Barrel L8 Ala539-Ala542 Ala539-Ala542 Different conformations 
Comparison of differences between the superseded wtFhaCold structure (PDB entry 2QDZ (Clantin et 
al. 2007)) and FhaCDIS (PDB entry 4QL0; this work). Strands are indicated by “S”, extracellular loops 
by “L” , periplasmic turns by “T”. 
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6.1. Abstract 
Tom40 is the central protein translocation pore of the TOM complex in the outer 
membrane of mitochondria. Whereas Tom40 has been investigated with various biophysical 
methods, also on the single molecule level, it has so far resisted structural research by NMR 
spectroscopy or X-ray crystallography. Here, a protocol for the preparation of Tom40 
samples suitable for NMR experiments is described. Tom40 is recombinantly expressed in 
inclusion bodies in E. coli and refolded in vitro. The obtained NMR spectra prove the 
presence of β-strand secondary structure, but feature low experimental sensitivity due to 
micro-aggregation of refolded Tom40. 
 
6.2. Introduction 
The TOM complex in the outer membrane of mitochondria (OMM) mediates the import of 
nuclear encoded and cytosolic translated proteins across this membrane into mitochondria 
(Neupert and Herrmann 2007). Mitochondria-destined proteins either contain an N-terminal 
sorting signal, called presequence, with a length of 15 to 50 residues, which is positively 
charged and forms an amphipathic α-helix, or intrinsic targeting signals (Höhr et al. 2015, 
Neupert and Herrmann 2007, Schmidt et al. 2010). As about 99% of all mitochondrial 
proteins are encoded in the nucleus and mitochondria fulfill essential functions, including 
ATP synthesis, signaling and apoptosis, a functional TOM complex is crucial to eukaryotic 
cells (Chacinska et al. 2009). 
Tom40 forms a β-barrel structure with presumably 19 strands, as suggested by close 
homology to the protein VDAC (Hiller et al. 2008) and biochemical experiments (Gessmann 
et al. 2011, Lackey et al. 2014). It constitutes the central translocation pore of the TOM 
complex (Chacinska et al. 2009, Hill et al. 1998, Suzuki et al. 2004, Vestweber et al. 1989). 
In addition, Tom5, Tom6 and Tom7 are part of the core complex and Tom20, Tom22 and 
Tom70 are associated receptors for substrates to be translocated (Ahting et al. 1999, Kato 
and Mihara 2008, Künkele et al. 1998, Model et al. 2002, Schmitt et al. 2005). These proteins 
span the OMM with a single α-helix and have cytosolic domains. Tom22 and Tom7 in 
addition possess small intermembrane space (IMS) domains. The TOM import mechanism is 
not understood in detail, but usually proteins are translocated in N- to C-terminal direction 
and it is thought that affinities for the substrates increase from the cytosolic parts of the 
receptors across the Tom40 pore to the IMS exposed domains, which thus directs the 
translocation path (Neupert and Herrmann 2007). 
The TOM complex and Tom40 have resisted to structural characterization on an atomic 
level by NMR spectroscopy or X-ray crystallography due to unfavorable biochemical 
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properties of the protein (Yao et al. 2014). Electron micrographs of single particles show that 
the TOM complex contains two or three channels (Ahting et al. 1999, Becker et al. 2005, 
Künkele et al. 1998). Electrophysiology measurements of Tom40 or full TOM complex 
reconstituted in lipid bilayers, as well as liposome import assays evidence the channel 
properties of Tom40 and the ability to bind and transport presequences (Ahting et al. 1999, 
Becker et al. 2005, Hill et al. 1998, Künkele et al. 1998, Kuszak et al. 2015, Mahendran et al. 
2012, Suzuki et al. 2004). Nevertheless, for understanding the molecular mechanisms of 
transport, structural information on the atomic level remains a key goal. 
 
6.3. Results 
6.3.1. hTom40 NMR spectroscopy 
For NMR spectroscopy experiments, deuterated and 15N-labeled hTom40 was expressed 
in inclusion bodies, purified via Ni-beads, refolded with detergent and then further purified via 
ion exchange chromatography. Purified protein was concentrated and the detergent 
concentration was adjusted for optimal properties in NMR measurements. To have a 
comparison for NMR spectral quality, the homologous hVDAC was prepared similarly 
following well-established protocols (Hiller et al. 2008). 15N-filtered 1D-TROSY spectra of 
hTom40 show signal between 8.5 ppm and 9.5 ppm (Fig. 6.1a), indicating β-sheet content. 
Comparison with a high quality spectrum of hVDAC (Fig. 6.1b) however demonstrates that 
hTom40 reaches a relative sensitivity of only 3.5% of hVDAC (see Methods). 
 
 
Figure 6.1 15N-filtered 1D-TROSY of hTom40 and hVDAC. 
The NMR signal between 6 ppm and 10.4 ppm is shown for (a) hTom40 in LDAO micelles of two 
independent protein preparations (red and blue curve) and (b) hVDAC in LDAO micelles (green 
curve). The spectral regions showing β-sheet and random coil signal are indicated. 
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6.3.2. Analytical size exclusion chromatography 
To analyze the reasons for the difference in spectral quality between the structurally 
similar hTom40 and hVDAC, refolded hTom40 was subjected to size exclusion 
chromatography (SEC). The chromatogram of the run demonstrates that the majority of the 
protein elutes in the void volume of the Superose 12 10/300 GL column (GE Healthcare) 
(Fig. 6.2a). Therefore, hTom40 forms soluble micro-aggregates, which is the reason for weak 
NMR signal due to slow tumbling rates. SDS-PAGE analysis shows that Tom40 even forms 
SDS-resistant dimers (Fig. 6.2b). 
 
 
Figure 6.2 hTom40 SEC and SDS-PAGE analysis. 
(a) A280 profile of a Superose 12 10/300 GL run of hTom40. The position of the void volume peak is 
indicated by an arrow. (b) SDS-PAGE analysis of unboiled hTom40 (“U”) and hTom40 boiled for 
approx. 10 min at 95 °C (“B”) in comparison with a molecular weight marker (“M”). 
 
6.4. Discussion 
6.4.1. hTom40 sample quality evaluation 
The observation of β-sheet signal in the NMR spectrum of hTom40 (Fig 6.1a) suggests 
the presence of folded protein in our sample. However, the overall signal intensity is too 
weak for structure determination by NMR spectroscopy with the current preparations. A 
comparison with hVDAC indicates a relative signal intensity of only 3.5%. Since nearly 100% 
of hVDAC molecules in the sample are folded and monomeric, the current sample quality 
corresponds to 3.5% of all hTom40 molecules being folded and monomeric and thus 
contributing to β-sheet signal in the NMR spectra while the remaining majority of the protein 
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forms higher oligomers. Presumably, several different oligomeric hTom40 species exist in the 
sample, contributing in different extent to the overall signal. This latter view is additionally 
plausible regarding the elution profile of the analytical SEC (Fig. 6.2a). 
 
6.4.2. hTom40 sample quality improvement 
To come within reach of structure determination by NMR spectroscopy, the signal 
intensity needs to be significantly improved. A simple increase in protein concentration is not 
applicable and thus improvement can only be achieved by decreasing the micro-aggregation 
of the sample. This may be done by prevention of micro-aggregation during refolding, which 
would imply that once properly folded, hTom40 stays low-oligomeric. In a scenario where 
hTom40 would also continue forming micro-aggregates after refolding, a simple modification 
of the refolding protocol is not sufficient. The latter scenario is likely the case as in vivo 
Tom40 forms a complex with other proteins that surround it with single-span α-helices in the 
membrane and thus might contribute to stability. Therefore, the strong differences in 
behavior between the structurally similar proteins hTom40 and hVDAC may be partly based 
on the fact that the former is part of a protein complex, whereas the latter exists in 
monomeric form. Thus, one future way to go might be to purify the full TOM complex from 
isolated mitochondria instead of refolding Tom40, but this complex is likely not susceptible to 
NMR spectroscopy because of its large size of approx. 500 kDa (Ahting et al. 1999, Künkele 
et al. 1998). Alternatively, the regions of Tom40 that promote aggregation may be identified 
and mutated, or Tom40 may be stabilized in a different way by small molecules or peptides. 
For larger complexes, X-ray crystallography is the method of choice for obtaining atomic 
structures. Since crystallization usually demands monodisperse samples, the same principal 
issues as for NMR spectroscopy need to be overcome in order to obtain material suitable for 
crystallization. 
 
6.5. Methods 
6.5.1. Plasmid construction 
The DNA for human Tom40 was ordered from GenScript (Piscataway, NJ, USA) with 
optimized codons for expression in E. coli. Tom40Δ76 was amplified from this plasmid by 
PCR and then inserted into pET21d vector (Novagen) using restriction sites NcoI and XhoI to 
yield the hTom40Δ76 expression vector. It encodes hTom40Δ76 with an additional  
N-terminal Met-Ala and an additional C-terminal Leu-Glu followed by a His6-tag. 
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hVDAC was expressed from the plasmid described in Hiller et al. 2008, which encodes 
full-length human VDAC isoform 1 with an additional C-terminal Leu-Glu followed by a His6-
tag in a pET21a vector (Novagen). 
 
6.5.2. Expression, purification and refolding 
Chemically competent E. coli BL21(λ DE3) or Lemo21(λ DE3) cells were transformed with 
the hTOM40 or hVDAC expression plasmid. After growth of cells in M9 medium containing 
D2O and 15NH4Cl at 37 °C to an OD600 of 0.7–0.8, expression of the protein was induced by 
addition of 1 mM IPTG. Expression continued for 4–5 hours before cells were harvested. 
Cells that expressed hTom40 were resuspended in PBS, supplemented with lysozyme, 
and lysed. Lysed cells containing expressed protein in inclusion body were pelleted for 30 
min at 20,000g. The pellet was washed twice with 50 mM Tris, pH 8, and 100 mM NaCl and 
then resuspended in 20 mM Tris, pH 8, 150 mM NaCl, 6 M Guanidine hydrochloride  
(Gu-HCl), 5 mM imidazole and 5 mM β-mercaptoethanol (β-ME). The suspension was 
centrifuged and the supernatant added to 5 mL Ni-beads (GenScript). After incubation at 
room temperature the Ni-beads were first washed with the same buffer, before the protein 
was eluted with 500 mM imidazole in the same buffer. The eluted protein was dialyzed 
against 4 L of 20 mM Tris, pH 8, 150 mM NaCl and 5 mM β-ME and the precipitated protein 
then solubilized in 20 mM Tris, pH 8, 150 mM NaCl, 6 M Gu-HCl and 5 mM β-ME. Finally the 
protein solution was centrifuged to obtain a particle-free solution of Gu-HCl-denatured 
hTom40. 
For hVDAC purification, well-established protocols were applied (Hiller et al. 2008) In 
brief, cells that expressed hVDAC were resuspended in TE-buffer, supplemented with 
lysozyme, and lysed. Lysed cells containing expressed protein in inclusion body were 
pelleted for 30 min at 20,000g. The pellet was first washed in TE buffer containing 2% Triton 
X-100 and then in detergent-free TE-buffer. Then, it was resuspended in 50 mM Tris, pH 7.5, 
100 mM NaCl, 8 M Urea and 20 mM imidazole. The suspension was centrifuged and the 
supernatant added to 5 mL Ni-beads (GenScript). After incubation at room temperature the 
Ni-beads were first washed with the same buffer, before the protein was eluted with 250 mM 
imidazole in the same buffer. The eluted protein was dialyzed against 4 L of 50 mM Tris,  
pH 7.5, 50 mM NaCl, 1 mM EDTA and 5 mM DTT and the precipitated protein then 
solubilized in 50 mM NaPi, pH 7, 100 mM NaCl, 6 M Gu-HCl, 1 mM EDTA and 5 mM DTT. 
Finally the protein solution was centrifuged to obtain a particle-free solution of Gu-HCl-
denatured hVDAC. 
For protein refolding, denatured hVDAC or hTom40 was added dropwise into refolding 
buffers with tenfold volume, stirred rapidly with magnetic stirring bar. For hVDAC refolding, 
CHAPTER 6  NMR Sample Preparation of Tom40 
119 
 
well-established protocols were applied (Hiller et al. 2008). The refolding conditions for 
hVDAC were: 25 mM NaPi, pH 7, 100 mM NaCl, 1% LDAO, 5 mM DTT, 1 mM EDTA. The 
hVDAC refold was dialysed o/n against 25 mM NaPi, pH 6.5, 1 mM EDTA and 5 mM DTT 
and then centrifuged. The supernatant was loaded on a HiTrap SP HP cation exchange 
column (GE Healthcare). After the column was washed with 25 mM NaPi, pH 6.5, 0.1% 
LDAO and 5 mM DTT, the protein was eluted with a gradient to 1 M NaCl in the same buffer. 
The buffer of the eluted protein was exchanged by three rounds of concentrating in a 10 kDa 
c/o centrifugal unit and subsequent dilution with 25 mM MOPS-BisTris, pH 6.5, 0.05% LDAO 
and 5 mM DTT. Final protein concentration in the VDAC sample was 12.4 mg mL-1 (390 µM), 
the LDAO concentration was adjusted to 4.6% (200 mM). 
The refolding conditions for hTom40 were: 20 mM Tris, pH 8, 150 mM NaCl, 1% LDAO 
and 5 mM β-ME. The hTom40 refold was dialysed o/n against 20 mM Tris, pH 9, 10 mM 
NaCl and 5 mM β-ME and then centrifuged. An equal volume of 20 mM Tris, pH 8.5, 15 mM 
NaCl, 0.1% LDAO and 5 mM β-ME was added to the supernatant, which was then loaded on 
a HiTrap Q FF anion exchange column (GE Healthcare). After the column was washed with 
20 mM Tris, pH 8.5, 15 mM NaCl, 0.1% LDAO and 5 mM β-ME, the protein was eluted with a 
gradient to 1 M NaCl in the same buffer. The buffer of the eluted protein was exchanged by 
two rounds of concentrating in a 10 kDa c/o centrifugal unit and subsequent dilution with 20 
mM Tris, pH 9, 50 mM NaCl, 0.05% LDAO and 5 mM β-ME. Final protein concentration in 
the hTom40 sample was 4.2 mg mL-1 (130 µM), the LDAO concentration was adjusted to 
3.5% (150 mM). 
 
6.5.3. NMR spectroscopy 
NMR spectra were recorded at 35 °C on Bruker Avance-800 spectrometer triple-
resonance probes. The total experiment time for the 2D [15N,1H]-TROSY HSQC was 6 h for 
hVDAC and 75 min for hTom40. The 1H carrier was centered on the water resonance, the 
15N carrier at 117 ppm (hVDAC) / 115 ppm (hTom40). The interscan delay was set to 1 s. In 
the direct dimension, 1024 complex points were recorded in an acquisition time of 40 ms 
(hVDAC) / 32 ms (hTom40), multiplied with a 75°-shifted qsine bell (hVDAC) / sine bell 
(hTom40), zero-filled to 2048 points and Fourier transformed. NMR data were processed and 
analyzed using Topspin 2.1. 
In order to compare the quality of hTom40 NMR spectra with hVDAC spectra, 15N-filtered 
1D-TROSY spectra of VDAC and hTom40 were overlaid. The hTom40 spectrum was scaled 
to superimpose with the VDAC spectrum in the β-sheet region between 8.5 and 9.5 ppm. To 
obtain a concentration- and acquisition-parameter-independent comparison of the sample 
qualities, the following formula was applied: 
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fhTom40fhVDAC = NhVDAC×RGhVDAC×chVDAC×τ90hTom40NhTom40×RGhTom40×chTom40×τ90hVDAC×SFhTom40 
where f is a quality comparison factor, N the number of scans of the NMR measurements, 
c the protein concentration, RG the receiver gain during the NMR measurement; τ90 the 
length of the 90° 1H-pulse and SFhTom40 is a scaling factor to overlay the recorded hTom40 
spectrum with the hVDAC spectrum in the β-sheet signal region. For the actual acquisition 
parameters, sample concentrations and obtained NMR spectra in 6.3.1, the result of the 
formula with the variables replaced is: fhTom40fhVDAC = 64×203×350  µμM×10.8  µμs4096×203×130  µμM×8.65  µμs×1.5   = 0.035   = 3.5% 
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7.1. Summary 
This thesis revealed mechanistic insights into insertion and translocation processes 
mediated by Omp85 proteins. For the insertase TamA, which assembles autotransporter 
OMPs, a bona fide insertion mechanism based on coupled hybrid barrel formation with 
passenger domain secretion and subsequent lateral barrel release was inferred from the 
determined crystal structure. During TamA crystallization, a crystal seeding protocol for 
optimization of membrane protein crystals grown from bicelle solution was established. 
Interactions of TamA and its huge complex partner TamB could be demonstrated 
experimentally, and through computational co-evolution analysis the interaction sites in both 
proteins could be mapped. 
For the translocase FhaC, a mechanism for substrate selection could be deduced from 
the crystal structure of a double mutant defective in substrate recognition, which at the same 
time allowed the correction of a formerly mistraced region in the wild-type FhaC crystal 
structure (Clantin et al. 2007). This region contains two highly conserved signature motifs in 
Omp85 proteins, located in barrel strand 13 and the extracellular L6 lid loop, which were now 
shown to form the same general structures and interactions both in Omp85 insertases and 
translocases. This structural motif, the “lid lock”, was therefore demonstrated to be a 
conserved structural feature both in Omp85 insertases and translocases. As both FhaC and 
TamA contribute to virulence in various organisms, these surface-accessible outer 
membrane proteins are relevant antibiotic targets, for which atomic structures and 
purification protocols are of great relevance. 
For the VDAC-homologous translocase Tom40, which forms the central pore of the TOM 
complex in the outer mirochondrial membrane, an expression, refolding and purification 
protocol as a first basis towards in vitro experiments for functional and structural studies was 
established. 
 
7.2. Omp85 insertion and translocation mechanisms 
Autotransporter biogenesis has become a topic of controversial discussion (Bernstein 
2007), since the initial hypothesis of its apparent simplicity was challenged by the 
observations that (i) barrel assembly and passenger domain translocation are coupled 
processes (Pavlova et al. 2013) and (ii) folded secondary structure elements too big for the 
narrow 12-stranded β-barrel can be secreted (Jong et al. 2007, Skillman et al. 2005). The 
suggested hybrid-barrel mechanism with passenger domain secretion and subsequent lateral 
release (Fig. 2.3) would elegantly resolve these issues and, in a slightly simplified form, can 
hold true for general OMP assembly. Interestingly, this mechanism resembles conceptionally 
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the dual role of the α-helical SecYEG for translocation and membrane insertion at the IM for 
a completely different class of proteins. 
Even though the hybrid barrel mechanism has not yet been unambiguously proven 
experimentally, the computational co-evolution analysis between TamA and TamB in this 
work further supports the existence of hybrid barrels, in this case however with an interaction 
partner rather than a substrate. Furthermore, crosslinking studies demonstrated the 
necessity of opening between the first and the last BamA barrel strand (Noinaj et al. 2014) 
and a recent publication demonstrates that a BamA orthologue exhibits increased channel 
conductance, which correlates with barrel size, in presence of the last two strands of a 
substrate OMP, but not with the first two strands (Estrada Mallarino et al. 2015). 
Besides hybrid barrel formation (Estrada Mallarino et al. 2015, Gruss et al. 2013, Kim et 
al. 2012, Noinaj et al. 2014, Noinaj et al. 2015, van den Berg 2013) (Fig. 7.1a), other 
currently discussed OMP assembly mechanisms include: Local distortion of the lipid bilayer 
to passively facilitate β-barrel assembly (Fig. 7.1b) (Gessmann et al. 2014, Noinaj et al. 
2013, Noinaj et al. 2015, Selkrig et al. 2014, Sinnige et al. 2014), formation of an OMP barrel 
within the barrel lumen of BamA and subsequent lateral release into the membrane  
(Fig. 7.1c) (Bernstein 2007, van den Berg 2013), and preformation of an OMP barrel in the 
periplasm, stabilized by chaperones, before membrane insertion next to the Omp85 protein 
(Fig. 7.1d) (Bernstein 2015). The models of periplasmic preformation or formation inside 
BamA can be ruled out, as the former contradicts the observed fluid globule state of OMPs 
inside the chaperone Skp (Burmann et al. 2013, Callon et al. 2014) and the latter could only 
hold true for extremely small OMPs and misses any experimental evidence. 
Local distortion via a thinning of the membrane next to BamA at the side of the interface 
between barrel strand 1 and 16 was shown by molecular dynamics simulation (Noinaj et al. 
2013). In addition, the structures of BamA (Albrecht et al. 2014, Ni et al. 2014, Noinaj et al. 
2013) and TamA (Gruss et al. 2013) show a narrowing between the aromatic girdles at the 
barrel exterior on this side, which in OMPs usually correlate with membrane boundaries. 
Experimentally, it was demonstrated that OMP folding in vitro is lipid headgroup-dependent 
and facilitated for thin membranes (Burgess et al. 2008, Gessmann et al. 2014, Patel et al. 
2009, Patel and Kleinschmidt 2013, Pocanschi et al. 2006). This is well in line with the fact 
that in vivo spontaneous insertion of OMPs into the IM needs to be prevented to preserve the 
proton motive force and other concentration gradients across the IM and thus a local thinning 
of the OM could lead to spatially directed OMP assembly. Local membrane distortion next to 
TamA/BamA and hybrid barrel formation are mechanistically not mutually exclusive and a 
combination of both is in theory possible. 
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Figure 7.1 Current models for OMP assembly. 
(a) Hybrid barrel mechanism: An unfolded OMP substrate (cyan, bottom) is stabilized by chaperones 
(brown) and brought to the Omp85 insertase, where it starts integrating its own barrel between Omp85 
barrel strands 1 and 16 to form a hybrid barrel (cyan – blue, top right), which eventually disintegrates 
to release the mature membrane-inserted OMP (cyan, top left). (b) Distorted membrane mechanism: 
An unfolded OMP substrate (cyan, bottom) is stabilized by chaperones (brown) and brought to the 
Omp85 insertase (blue), where it inserts into the weakened lipid bilayer created by the Omp85 
insertase to form the mature OMP (cyan, top left). (c) Omp85 lumen folding mechanism: An unfolded 
OMP substrate (cyan, bottom) is stabilized by chaperones (brown) and brought to the Omp85 
insertase (blue), where it assembles in the lumen of the Omp85 barrel (blue) to form the mature OMP 
(cyan, top right) before lateral release into the membrane (cyan, top left). (d) Periplasmic preformation 
mechanism: A prefolded OMP substrate (cyan, bottom) is stabilized by chaperones (brown) and 
brought to the Omp85 insertase (blue), where it inserts into membrane (cyan, top left) next to the 
Omp85 protein (blue). 
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For the assumption of a passive insertion mechanism based on local membrane 
weakening, the directionality of OMP insertion, which in vivo is not random, needs to be 
considered. Moreover, the hydrophilic extracellular loops are generally longer than the 
periplasmic turns between the β-strands of an OMP (Mirus et al. 2010) and thus, at least for 
OMPs that do not contain additional periplasmic domains, it would seem energetically more 
favorable if such an OMP inserted upside down into the membrane in order to prevent the 
energetic barrier of membrane traversal of the long hydrophilic loops. Hence, at least a 
priming event in addition to facilitated insertion needs to take place to set the right orientation 
of the OMP. Furthermore, it makes sense for this priming event to occur in immediate 
membrane proximity in order to prevent reorientation before membrane insertion. The 
conserved β-signal in the most C-terminal strand of OMPs, which was shown to be 
necessary for OMP assembly (Struyvé et al. 1991), and to interact with several BAM 
subunits including BamA itself (Albrecht and Zeth 2011, Knowles et al. 2008, Robert et al. 
2006), is the most likely motif to mediate this priming. Because of the reduced interactions 
between strands 1 and 16 of TamA and BamA (Gruss et al. 2013, Noinaj et al. 2013), the 
proof of necessity for them to open (Noinaj et al. 2014), and the predicted binding site at 
TamA barrel strand 1 for the β-signal-like C-terminus of TamB, found in this work, 
incorporation of the β-signal between strands 1 and 16 is from the current knowledge the 
most likely priming mechanism. In order to maintain the usually antiparallel strand pairing in 
an OMP barrel, the incorporation of a full hairpin, composed of the two last β-strands of the 
OMP seems favorable, which is equivalent to the first step in the proposed hybrid barrel 
formation mechanism. 
Energetically, a hairpin insertion is reasonable: The hydrophilic loop between the two 
strands may use the aqueous TamA/BamA barrel interior for membrane traversal and after 
insertion, the hydrophobic and hydrophilic sidechains of the hairpin would be in a native-like 
membrane and aqueous environment, respectively. Broken hydrogen bonds between 
TamA/BamA strand 1 and 16, which are only few in comparison to other barrel strand pairs, 
would be replaced by even more hydrogen bonds: The hairpin replaces the lost hydrogen 
bonds on one side of the insertion site and forms additional ones on the other side. 
Moreover, the hairpin itself forms hydrogen bonds between its two strands. 
Now, as the hairpin has set the right direction of the OMP in the membrane, complete 
OMP assembly into the distorted bilayer next to TamA/BamA may take place. For this to 
happen, the hydrogen bonds between the inserted OMP hairpin and the neighboring 
TamA/BamA strands need to be broken to release the hairpin from TamA/BamA in order that 
the rest of the barrel can assemble. As broken hydrogen bonds will be replaced again by 
new ones, this should not be energetically unfavorable and, furthermore, the interactions 
between any OMP and TamA/BamA would always be similarly independent of the number of 
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strands of an OMP barrel. However, this mechanism cannot suffice to explain the special 
case of autotransporter assembly, in which passenger domain secretion to the extracellular 
space is coupled to β-barrel assembly (Pavlova et al. 2013), and does not occur through the 
assembled autotransporter barrel (Bernstein 2007, Jong et al. 2007, Skillman et al. 2005). 
A complete hybrid barrel formation resolves this mechanistic and topological riddle: After 
the first hairpin insertion, the next OMP strand pair would inserts next to the first strand pair 
and again more new hydrogen bonds are built than broken. This continues until the last 
strand pair has inserted and now the following N-terminal passenger domain can use the 
expanded hybrid barrel for membrane traversal. When its translocation has finished, the 
hybrid barrel disintegrates and the linker between the now extracellular passenger domain 
and barrel strand 1 at the periplasmic site ends up in the fully assembled autotransporter 
barrel. 
Despite elegantly resolving the autotransporter assembly mechanism, this model does 
have a few weak points: For BamA, the number of strands of the OMP substrates can vary 
significantly between 8 (Pautsch and Schulz 1998) and 26 (Qiao et al. 2014) and therefore 
the hybrid barrel disintegration event needs to be timed correctly for each OMP in order to 
have all strands inserted. A solution to this problem may be that the disintegration due to 
rising instability, also for large hybrid barrels, is always kinetically slower than the hybrid 
barrel formation and thus, this mechanism works irrespective of the number of strands of an 
OMP. The second weak point is that the tilt angles of OMPs vary between approx. 35° and 
45° (Pali and Marsh 2001) (Fig. 1.2b) and in a hybrid barrel both the tilt angles of 
TamA/BamA and the substrate need to be satisfied. However, the difference in tilt angles is 
not large and some flexibility in a hybrid barrel could suffice to satisfy the tilt angles both in 
the TamA/BamA region and the substrate OMP region. 
Like for the OMP insertion mechanism, a detailed description of the TpsA translocation 
mechanism through the TpsB pore is still missing. Since Omp85 proteins share the same 
overall fold, the question remains whether insertion and translocation processes share a 
common mechanistic basis or are independent processes. A hybrid barrel mechanism could 
constitute a common mechanism, even though it is conceptionally not necessary for 
translocation. However, TpsA proteins share an N-terminal, approx. 250 residues long TPS 
domain, which is necessary and sufficient for translocation (Grass and St Geme 2000, 
Jacob-Dubuisson et al. 1997, Renauld-Mongenie et al. 1996, Schönherr et al. 1993). Since 
this domain contains amphipathic stretches of residues, which in the secreted soluble TpsA 
protein adopt β-helical structure (Fig. 1.7b), the formation of a hybrid barrel between a TpsB 
translocase and its TpsA substrate may exist as part of a recognition mode and translocation 
intermediate. A disintegration of the hybrid barrel would however not lead to a new OMP in 
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the membrane but instead would exclude the TPS sequence from the membrane 
environment and release it to the extracellular space. 
 
7.3. L6 loop and lid lock function 
All Omp85 structures determined to date represent resting states of these proteins. The 
cell exterior side of the barrel is closed in all structures but the closure differs between the 
insertases TamA (Gruss et al. 2013) and BamA (Albrecht et al. 2014, Ni et al. 2014, Noinaj et 
al. 2013), and the translocase FhaC (Clantin et al. 2007, Maier et al. 2015): Whereas in 
TamA and BamA the long extracellular loop L6 is mainly involved in barrel closure, supported 
by the inwards facing loops L3 and L4 (Fig. 5.5), loop L6 also contributes to barrel closure in 
FhaC, but the outwards facing loops L3 and L4 create a large gap, which is plugged by helix 
H1 (Fig. 5.5). Loop L6 adopts a very similar overall conformation in all proteins, except for a 
variable insertion site, which harbors additional residues in TamA and BamA as compared to 
FhaC (Fig. 5.4a, Supplementary Fig. 5.3). These additional residues form a loop heading 
towards the extracellular space and therefore the barrel would still be closed without them. 
An outwards closed barrel thus seems to be a conserved principle in the resting state of both 
insertases and translocases. It possibly contributes to barrel stability by compensating the 
reduced interactions between the first and last barrel strand, and prevents additional 
leakiness of the OM. The length of the flexible variable insertion site in L6 (Maier et al. 2015, 
Morgado et al. 2015) correlates with the number of barrel strands of the substrates of an 
Omp85 protein. BamA, which has substrates with up to 26 strands, contains 18.5 ± 8.6 
additional residues (Supplementary Fig. 5.3), TamA, which has autotransporter substrates 
with 12 strands, contains 11.7 ± 4.2 additional residues, and for TpsB proteins, which have 
soluble secreted substrates, this variable insertion site is not filled at all (0 ± 0 residues). It is 
therefore tempting to speculate that in a hybrid barrel mechanism for OMP biogenesis these 
additional residues may structurally rearrange to stabilize the expanded hybrid barrel, 
possibly by interactions with other extracellular loops of TamA/BamA and/or the substrate 
OMP. This assumption would however speak against hybrid barrel formation as a common 
mechanistic principle for both insertion and translocation. 
Loop L6 harbors one of the two highly conserved sequence motifs in Omp85 proteins, 
VRG(Y/F) (Delattre et al. 2010), which in all solved and corrected structures forms very 
similar interactions, including a salt bridge, with the other conserved motif (F/G)xDxG (Jacob-
Dubuisson et al. 2013) at the barrel interior on strand 13. This conserved lid lock motif could 
therefore be essential to maintain the overall loop L6 structure and to contribute to stability 
during insertion or translocation. A more active role during insertion seems unlikely since 
crosslinking between the two motifs does not inhibit BamA function in vivo (Noinaj et al. 
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2014) and therefore unlocking of the two motifs is not required. However for FhaC, recent 
experimental data suggest that the salt bridge is broken during translocation of FHA, which 
would favor a more active role of the lid lock in translocation (Guérin et al. 2015). 
The observed effect on barrel shapes of the GxDxG vs. FxDxG motifs in FhaC-like TpsB 
proteins and bacterial insertases, respectively (Fig. 5.4b, 5.5a), further implies a difference 
between insertion and translocation mechanisms. However it should be mentioned that in the 
not discussed HMW1B-like subfamily of TpsB proteins the motif is the same as in the 
insertase family (Jacob-Dubuisson et al. 2013). In this respect, it would also be of great 
relevance to study the lid lock structures in mitochondrial and chloroplast Omp85 proteins: 
Toc75 and OEP80 proteins in chloroplasts, involved in translocation and presumably also 
insertion, have an Fx(D/E)xGxDxG motif (Jacob-Dubuisson et al. 2013), which is like a fusion 
of an insertase with a translocase motif. The question to be answered here is which of the 
two negatively charged side chains is actually involved in lid lock formation and whether this 
double motif may hint at a dual role for these proteins, since little is known about OMP 
insertion into the chloroplast OEM and the actual insertase has not been identified yet. In 
contrast, in the mitochondrial insertase Sam50 the motif has changed to FxNxG (Jacob-
Dubuisson et al. 2013), which abolishes the formation of a salt bridge with the still conserved 
Arg in the VRG(Y/F) motif. The question to be answered for Sam50 is whether still a lid lock-
like structure forms, and whether a spatially close Asp or Glu residue in a different strand 
replaces the missing residue in this motif. 
Overall, the Omp85 protein superfamily remains an exciting area of structural and 
functional studies. 
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